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ABSTRACT 
 
Primary brain injury in stroke is followed by oxidative stress and further neural 
damage. Glutathione (GSH) is critical in antioxidant defense. Since cysteine is limiting in 
GSH synthesis, Phase 1 of this study investigated the effect of a dietary sulphur amino 
acid deficiency (-SAA) on neural damage in global hemispheric hypoxia-ischemia 
(GHHI). Rats were fed a -SAA or control diet for 6 days, and subjected to GHHI after 3 
days. Histologically evaluated neural damage at 7 days post hypoxia-ischemia was 
greater in -SAA rats. Brain GSH concentration was decreased in -SAA rats 3 days after 
ischemia. A cysteine precursor, L-2-oxothiazolidine-4-carboxylic acid (OTC) 
administered to -SAA rats did not ameliorate neural damage. GSH is decreased by 
protein-energy malnutrition (PEM) in some tissues. Phase 2 investigated the effect of 
PEM on brain oxidative stress, neural damage and behaviour after global ischemia in 
adult male gerbils.  In a 2x2 factorial design, gerbils were fed an adequate protein (12%; 
C) or low protein (2%; PEM) diet for 4 weeks, then subjected to transient ischemia (I) or 
sham surgery (S). After 12 hours of reperfusion, brain from half the gerbils was collected 
for biochemical analyses. Remaining gerbils were fed pre-surgery diets for 10 more days. 
To assess functional consequences of ischemia, gerbils were placed in an open field on 
Days 3, 7 and 10 after surgery. On Day 10, viable hippocampal CA1 neurons were 
counted.  C-I gerbils did not habituate as readily in the open field on day 3 as C-S, but 
normalized by day 7. PEM-I gerbils failed to habituate by day 10, traveled greater 
distance than other gerbils and 7 of 12 displayed thigmotaxis, a ‘wall-hugging’ 
preference for the outer perimeter of the open field. CA1 neuron loss in I was 61.5% of S, 
but unaffected by PEM. Four of 12 PEM-I gerbils had marked increases in hippocampal 
glia. Hippocampus protein thiols were reduced by PEM and by ischemia, consistent with 
oxidative stress. GSH concentration, glutathione reductase activity and thiobarbituric acid 
reactive substances were not significantly affected by PEM or ischemia. Findings from 
these two studies suggest well-nourished but not nutritionally-deficient rodents tolerate a 
mild brain insult. This is clinically relevant because many elderly stroke victims suffer 
from PEM at the time of ischemia, which may compromise recovery. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 RATIONALE 
 
Health Canada and the Heart and Stroke Foundation of Canada define 
cerebrovascular disease (ICD-9, 430-438) as the sudden development of a focal 
neurologic deficit due to disease of one or more blood vessels of the brain. Stroke, either 
focal or global (ICD-9, 430-432, 434, 436) is simply a reduction in blood flow to the 
brain. Stroke can be thromboembolytic or ischemic, with blockage of a blood vessel 
supplying the central nervous system (CNS), or hemorrhagic, with bleeding into the 
parenchyma or subarachnoid space. Global ischemia results from conditions such as 
cardiac arrest, head trauma and shock, often secondary to an episode of significant 
systemic hypotension. At 7% of all deaths, stroke remains the third most common cause 
of death in Canada (Heart and Stroke Foundation of Canada,1999; Yager and 
Thornhill,1997). Direct and indirect costs of stroke in Canada total $2.8 billion annually, 
with mortality costs responsible for $1.2 billion or 44% of total costs (Heart and Stroke 
Foundation of Canada,1999). Although mortality rates for all cardiovascular disease 
have been declining since the 1960s, and rates of ischemic heart disease and acute 
myocardial infarction continue to decline modestly, mortality rates for stroke have not 
changed significantly in the last ten years in Canada. In Saskatchewan, 20% of stroke 
victims die and 30% suffer permanent disability (Juurlink,1999). There remains a need 
to identify both treatment strategies to improve outcome and compromised nutritional 
states that could worsen outcome after stroke. As in cardiovascular disease, diet and 
nutritional status may play a role in prevention of stroke and amelioration of deficits for 
survivors. The focus of this thesis is therefore on the effect of nutritional status on 
outcome in stroke.
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Although stroke occurs in all age groups, the elderly are at high risk for stroke. 
Many elderly have compromised nutritional status due to a variety of factors such as 
anorexia, poor dental status, drug therapy, decreased activity levels, and chronic 
diseases (Abbasi and Rudman,1994; Lipschitz,1991; Marcus and Berry,1998). Several 
studies have reported evidence of compromised protein-energy status at the time of 
admission to hospital for stroke and deterioration of this status during the hospital stay 
(Axelsson et al.,1988; Choi-Kwon et al.,1998; Davalos et al.,1996; Gariballa et 
al.,1998b; Gariballa et al.,1998a). In a Canadian study, 49% of stroke patients suffered 
from protein-energy malnutrition (PEM) at the time of admission to rehabilitation units 
(Finestone et al.,1995; Finestone et al.,1996). Authors suggested there was inadequate 
nutritional intervention immediately post-injury which could compromise antioxidant 
defense mechanisms. A large, multicentre randomized trial evaluating feeding policies 
after stroke, the Feed Or Ordinary Diet Trial (FOOD), has determined nutritional status 
at baseline and early after stroke to be an important predictor of long term outcome 
(FOOD Trial Collaboration,2003). Patients undernourished immediately after stroke 
suffered reduced survival, functional ability and living circumstances six months later. 
The length of time to start of feeding after stroke varies, and stroke patients fed within 
seventy-two hours of injury have a shorter hospital stay (Nyswonger and 
Helmchen,1992). Low serum albumin, often an indicator of poor protein status, has been 
associated with increased length of stay, complications, and death in medical, surgical 
and stroke patients, and is considered an indicator of poor outcome (Aptaker et al.,1994; 
Axelsson et al.,1988; Choi-Kwon et al.,1998; Davalos et al.,1996; Finestone et al.,1996; 
Gariballa et al.,1998b; Gariballa et al.,1998a; Gariballa and Sinclair,1998). 
Primary brain injury in stroke is followed by an excitotoxic cascade, production 
of reactive oxygen and nitrogen species, oxidative stress and further neural damage. The 
endogenous tripeptide glutathione (GSH) is critical in antioxidant defense, and depleted 
in conditions of oxidative stress. The sulphur amino acid cysteine, supplied primarily by 
dietary protein, is limiting in glutathione synthesis. Liver and erythrocyte glutathione are 
responsive to dietary protein or short-term food deprivation, while brain glutathione is 
relatively preserved (Bauman et al.,1988a; Benuck et al.,1995; Taylor et al.,1992). 
However, an acute dietary sulphur amino acid deficiency decreases brain glutathione 
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concentration in some brain regions (Paterson et al.,2001). Reduced availability of 
critical substrate for glutathione synthesis in the face of high demand for glutathione 
during oxidative stress may further deplete brain glutathione. Sub-optimal protein-
energy status or sulphur amino acid status due to inadequate intake may thus 
compromise antioxidant defense in stroke and increase neural damage. Delivery of 
various cysteine precursors has been shown to enhance glutathione synthesis in some 
tissues, particularly in conditions of glutathione depletion (Jain et al.,1995; Kamencic et 
al.,2001; Taylor et al.,1992; Yao et al.,1997).  
This research investigates first the effect of an acute dietary sulphur amino acid 
deficiency on brain and liver glutathione concentration and neural damage in a rat model 
of global hemispheric hypoxia-ischemia, followed by administration of a cysteine 
precursor in an attempt to ameliorate neural damage. Since it is extremely unlikely any 
human would be deficient only in sulphur amino acids, the second part of this research 
investigates the effect of a short-term, severe dietary protein-energy deficiency on 
functional outcome, neural damage, and some biochemical markers of oxidative stress 
in a gerbil model of transient bilateral carotid artery occlusion. Behaviour and function 
are investigated in the gerbil ischemia model, due to evidence suggesting histological 
assessment of neural damage is not necessarily reflective of cognitive and motor 
function (Bothe et al.,1986; Hori and Carpenter,1994; Ishimaru et al.,1995). 
 
1.2 HYPOTHESIS 
 
The research project described in this thesis tested the following hypotheses: 
1. Sulphur amino acid-deficiency or protein-energy deficiency will decrease 
brain glutathione concentration in critical regions secondary to reduced 
synthesis of glutathione and uptake of key glutathione precursors, 
compromising antioxidant defense and increasing neural damage in stroke.  
2. Administration of L-2-oxothiazolidine-4-carboxylic acid (OTC), a cysteine 
precursor, will enhance glutathione synthesis in brain and ameliorate neural 
damage due to stroke. 
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1.3 OBJECTIVES 
 
The objectives of this research were divided into two experiments as follows: 
 
Experiment 1: Sulphur amino acid deficiency, global hemispheric hypoxia-
ischemia and OTC in the rat 
1. To investigate the effect of sulphur amino acid deficiency on brain 
glutathione concentration after global hemispheric hypoxia-ischemia 
(GHHI) in the rat. 
2. To investigate whether OTC protects against neural damage in the 
sulphur amino acid-deficient rat subjected to GHHI. 
 
Experiment 2: Protein-energy malnutrition and temporary bilateral carotid artery 
occlusion in the Mongolian gerbil 
1. To characterize a gerbil model of moderate protein-energy malnutrition 
(PEM). 
2. To investigate whether PEM exacerbates neural damage in global 
ischemia, as measured by histological assessment and behavioural (open 
field) outcome.  
3. To determine whether moderate PEM depletes brain glutathione and 
increases oxidative stress in a gerbil model of transient bilateral carotid 
artery occlusion (TBCAO). 
 
1.4 SUMMARY 
Oxidative stress causes secondary damage after initial brain injury in stroke. 
Availability of substrates for antioxidant defense may be compromised by dietary 
deficiencies. Epidemiological evidence suggests poor nutritional status at the time of 
stroke is a predictor of worse outcome for survivors. This thesis, entitled Nutritional 
Influence on Oxidative Stress in Global Ischemia, was investigated first with an acute, 
severe dietary sulphur amino acid deficiency in a rat model of hemispheric hypoxia-
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ischemia, and secondly with moderate protein-energy malnutrition in a gerbil model of 
transient global ischemia with reperfusion.
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CHAPTER 2 
 
REVIEW OF LITERATURE 
 
 
2.1 PATHOPHYSIOLOGICAL MECHANISMS IN STROKE 
The brain comprises 2% of body weight, but receives 20% of cardiac output and 
accounts for 20% of total body oxygen consumed (Shivakumar et al.,1995). Under 
aerobic conditions, glucose is the major source of energy for metabolism in the brain, 
which has few endogenous reserves of either glucose or glycogen. Ketone bodies can act 
only as a limited energy source in times of chronic metabolic imbalance. Glucose 
crosses the blood brain barrier in an insulin-independent manner (Peters et al.,2002), is 
taken into neurons via a membrane transporter and phosphorylated, and enters 
glycolysis then the tricarboxylic acid pathway. Ultimately, reducing equivalents pass to 
oxygen in the mitochondria with release of adenosine triphosphate (ATP), the energy 
‘currency’ of the cell, to the cytoplasm (Gunter et al.,1994). The mitochondria produce 
~95% of cell ATP requirements. The brain cannot oxidize free fatty acids, and is 
therefore susceptible to injury resulting from disturbance of blood flow and interruption 
of oxygen and glucose supply, such as in stroke. Anaerobic metabolism is insufficient to 
meet the demands of nervous tissue. When lack of oxygen removes the final electron 
acceptor from the respiratory chain, the system fails.  
Several secondary mechanisms activated following primary brain injury and 
stroke contribute to extensive damage. These mechanisms resulting from reduction in 
blood flow involve depletion of glucose, ATP and ADP, membrane depolarization and 
glutamate release from the cell initiating an excitotoxic cascade, calcium overload and 
finally production of strong oxidants leading to oxidative stress and activation of 
inflammatory pathways (Juurlink and Paterson,1998; Schmidt-Kastner and 
Freund,1991). Oxidative stress is a threshold phenomenon occurring when antioxidant 
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defenses are overwhelmed and free radical production exceeds elimination 
(Wilson,1997). Ischemia and subsequent reperfusion generate reactive oxygen (ROS) 
and nitrogen (RNS) species, toxic to the brain. During reperfusion, oxidative stress 
increases as oxygen is restored to the brain (Grace,1994; Juurlink and Paterson,1998; 
Shivakumar et al.,1995; Yano et al.,1998). 
2.1.1 Excitatory amino acid transmitters in the central nervous system 
In order to understand the mechanisms leading to oxidative stress, some 
background on neurotransmitters will be discussed. The predominant excitatory 
neurotransmitters (EAA) in the mammalian CNS are L-glutamate (glutamate) and L-
aspartate, two structurally similar acidic amino acids. Glutamate is the most abundant 
free amino acid, able to stimulate almost every type of CNS neuron. Identified 
glutamatergic pathways include hippocampal, cerebellar, corticocortical and 
corticofugal (Greene and Greenamyre,1996). Glutamate is concentrated in synaptic 
vesicles at nerve terminals. Release of glutamate is calcium-dependent, with active, 
high-affinity, sodium-dependent re-uptake into perisynaptic astrocytes by excitatory 
amino acid transporter proteins (mainly EAAT-1, EAAT-2) (Milton et al.,1997; 
Rothstein et al.,1994). There is some re-uptake by neurons, but the majority is via the 
perisynaptic astrocytes, wherein glutamate is transaminated to glutamine via glutamine 
synthase, and diffused back into nerve terminals, where it is deaminated to glutamate via 
a mitochondrial phosphate-activated glutaminase (Greene and Greenamyre,1996). 
Glutamate receptors are of two types, ionotropic and metabotropic. Ionotropic 
receptors are linked to cation channels and fall into three categories, named for the 
agonists that specifically stimulate them: α-amino-3-hydroxy-5-methyl-4-
isoxazoleproprionic acid (AMPA), kainate, and N-methyl-D-aspartate (NMDA). Both 
AMPA and NMDA receptors are usually involved in excitatory post-synaptic potentials.  
Metabotropic receptors are coupled to second messenger systems. 
2.1.1.1 Ionotropic receptors 
AMPA and kainate receptors are mediators of fast, voltage-independent synaptic 
responses, and promote activation of voltage-dependent NMDA receptors 
(Nakanishi,1992). The AMPA receptors are usually heteromeric, made up of five 
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subunits in combinations of four types, GluR1-GluR4 (Nakanishi,1992; Nakanishi and 
Masu,1994). Receptors containing subunits GluR1, GluR3 or GluR4 are permeable to 
calcium, but presence of GluR2, which is in majority, will confer calcium 
impermeability (Hume et al.,1991). Each subunit consists of 4 transmembrane domains 
(TM-I - TM-IV). Substitution of arginine (as in GluR2) for a glutamine (as in 
GluR1,3,4) in TM-II confers calcium impermeability to the channel pore 
(Nakanishi,1992). The kainate receptors are similar in structure to AMPA receptors: 
subunits GluR5-GluR7 confer low-affinity kainate binding in brain membrane, while 
subunits KA-1 and KA-2 confer high affinity binding (Nakanishi and Masu,1994). 
AMPA/kainate receptors are found in both neurons and glia, including microglia (Noda 
et al.,2000; Steinhauser and Gallo,1996).   
 NMDA receptors are unique in that they are both voltage- and ligand-gated. At 
resting membrane potential, the ion channel is blocked by extra-cellular magnesium; 
post-synaptic depolarization is required for magnesium release. Both glutamate and 
glycine (‘co-agonist’) binding is required for activation (Nakanishi and Masu,1994). 
NMDA receptors are therefore activated by coincident post-synaptic depolarization and 
agonist binding. Unlike AMPA receptors, NMDA receptors have a high calcium 
conductance, and also can transduce sodium. Calcium is the primary mediator of both 
physiological and toxic properties of the NMDAs. Several NMDA subunits have been 
identified: NMDA R1, NMDA  R2A-R2D, NMDA-L(c-1) (Ciabarra et al.,1995; 
Nakanishi et al.,1998). 
 
2.1.1.2  Metabotropic Receptors 
 Metabotropic receptors are coupled to guanine nucleotide-binding proteins (G-
proteins) and, depending on cell type and receptor subtype, can be linked to 
phosphoinositol turnover, arachidonic acid metabolism or cyclic AMP (Greene and 
Greenamyre,1996; Nakanishi and Masu,1994). Eight identified subunits have been 
named mGluR1-mGluR8.  In contrast to ionotropic receptors, the metabotropic 
receptors have not been well-studied, since there are no specific, potent antagonists for 
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this class. The function of glutamate receptors is intimately involved in the 
pathophysiology of stroke. 
 
2.1.2 Ischemic Brain Damage 
 Ischemic brain damage is thought to be due to passive processes involving 
reduced oxygen availability leading to decreased energy production and subsequent 
diminished survival, as well as active processes leading to the production of free 
radicals, activation of inflammatory responses, and finally apoptotic mechanisms 
(Love,1999). At the onset of ischemia, anaerobic metabolism leads to a fall in tissue pH, 
depletion of ATP and first slowing, then failure of the critical sodium-potassium 
ATPase pump (Na+K+-ATPase ) (Sweeney et al.,1995). As a result of this failure, ion 
homeostasis is disturbed as ions move down their electrochemical gradients across 
plasma membranes, such that sodium moves into the cell and potassium moves out 
(Love,1999; Shuaib and Kanthan,1997). Although this is initially a gradual process, by 
two minutes after onset of ischemia, depolarization of the membrane is pronounced and 
ion movement is more rapid (Love,1999). The Na+K+-ATPase pump further depletes 
ATP as the cell attempts to correct the ion imbalance. Since even under normal 
conditions, 40% of neuronal ATP is used by this pump to maintain resting membrane 
potential and ion gradients, ATP can be rapidly depleted at a time when demand is high 
(Greene and Greenamyre,1996). As the membrane depolarizes, calcium also moves into 
the cell through voltage-gated channels, causing the release of excitatory 
neurotransmitters, especially glutamate. Extracellular glutamate activates post-synaptic 
glutamate receptors, allowing further sodium entry, depolarization and ATP 
consumption.  Depolarization of the membrane releases magnesium from the voltage- 
and ion-gated NMDA receptors, which are then activated by glutamate and yet more 
sodium and calcium enter the cell. There are many consequences to calcium influx, such 
as activation of ATP-consuming calcium pumps, futile mitochondrial calcium cycling, 
activation of second messenger pathways resulting in changes in gene expression and 
calcium-dependent phospholipases, proteases, kinases, phosphatases and endonucleases, 
and finally production of ROS, leading to activation of phospholipase C, the arachidonic 
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acid cascade, production of inflammatory molecules and further ROS production (Alexi 
et al.,2000; Juurlink and Paterson,1998; Siesjo et al.,1995; Sweeney et al.,1995). There 
is a biphasic rise in intracellular calcium (Love,1999). The primary rise is coupled to 
accumulation of extracellular glutamate and activation of NMDA receptors, while the 
secondary rise occurs two to three hours after reperfusion and indicates irreversible cell 
damage. While not believed to be tied to glutamate release, the secondary calcium rise 
may be due to a post-ischemic potentiation of calcium influx through NMDA and 
AMPA receptors and/or recurrent spreading depression (Obrenovitch and 
Richards,1995; Walz,1997). Surrounding the primary infarct core of damage is an area 
of reduced blood flow, the penumbra (Hakim,1987). Waves of depolarization from the 
ischemic core spread across the penumbric region (spreading depression), leading to 
depletion of ATP in an area already compromised by poor circulation (Walz,1997). The 
penumbra may be rescuable, however, if this process can be minimized or halted 
(Juurlink and Sweeney,1997; Walz,1997). 
 
2.1.2.1  The role of sodium 
 Sodium is an important mediator of secondary active transport in brain. In 
ischemia, glutamate re-uptake is impaired by the decrease in sodium gradient, leading to 
the calcium-independent release of glutamate via reversal of the sodium-dependent 
glutamate transporter (Blaustein et al.,1991). The sodium gradient is important for 
maintenance of intra-cellular calcium via the low-affinity, high-capacity calcium/sodium 
exchange, which is dependent on a large sodium gradient, and critical in reducing 
increased intracellular calcium levels, such as occur in ischemia (Mattson et al.,1989). 
Metabolic inhibition thus impairs the exchange, increasing neuronal intracellular 
calcium, with all its consequences (Mattson et al.,1989). The sodium /H+ exchange is 
critical in maintenance of neuronal pH, and is also thus impaired by the decreased 
sodium gradient in ischemia, resulting in acidic intracellular conditions (Greene and 
Greenamyre,1996).  
 
2.1.2.2  Mitochondrial calcium transport 
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 Mitochondrial calcium transport is integral to the evolution of oxidative stress.  
Extracellular calcium concentration is 1-2mM, while cytoplasmic calcium concentration 
is often less than 100nM (Gunter and Pfeiffer,1990). These concentrations are 
maintained by the outward calcium ATPase pump and the calcium/sodium exchange. 
When cytoplasmic calcium increases above 200-300nM, mitochondria begin to 
accumulate calcium in the matrix. Influx of calcium into the matrix is via a passive 
uniporter in the membrane, dependent on membrane potential, and modulated by 
calcium, magnesium, and ADP. Efflux of calcium from mitochondria is energy-
dependent via both sodium-dependent and sodium-independent mechanisms. 
Accumulation of calcium in mitochondrial matrix, as well as many other stimulants such 
as oxidative stress and decreased glutathione concentrations, activates a ‘transition pore’ 
in the membrane. Solutes can then move across the membrane by facilitated diffusion, 
driven by their concentration gradients, destroying membrane potentials and allowing 
the mitochondria to swell, resulting eventually in reduced ADP phosphorylation, and 
increased production of ROS (Gunter et al.,1994; Gunter and Pfeiffer,1990; Juurlink and 
Paterson,1998). 
 
2.1.2.3  Glutamate  
 The release of glutamate to the extracellular space during ischemia is 
contributory to oxidative stress through more than one mechanism. Three classes of 
membrane proteins in the CNS mediate the physiological consequences of increased 
extracellular glutamate, namely ionotropic receptors, metabotropic receptors, and the 
cystine/glutamate Xc- antiporter (Schubert and Piasecki,2001). 
 
2.1.2.3.1  Excitotoxicity 
 The action of glutamate released at synapses is normally terminated via neuronal 
and predominantly glial uptake by glutamate transporter proteins. Glutamate and sodium 
are co-transported into the cell while potassium moves out, resulting in one net proton-
equivalent into the cell (Love,1999). It remains unclear whether this proton-equivalent is 
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due to hydrogen ion (H+) in or hydroxyl ion (OH-) out. During ischemia, when the 
membrane is depolarized, this glutamate/sodium transporter cannot work efficiently, and 
glutamate thus accumulates extracellularly. Excessive stimulation of all types of 
ionotropic and even metabotropic glutamate receptors occurs, followed by neuronal 
damage or death (Greene and Greenamyre,1996). Calcium influx and loss of calcium 
homeostasis play an additional role in this process (Greene,1999; Greene and 
Greenamyre,1996; Siesjo et al.,1995), termed classic excitotoxic glutamate toxicity 
(Juurlink and Sweeney,1997; Tan et al.,1998). 
 
2.1.2.3.2  Oxidative glutamate toxicity 
 Glutamate can also be toxic in the CNS via a transporter-mediated mechanism 
known as oxidative glutamate toxicity, which has characteristics of both necrotic and 
apoptotic cell death (Tan et al.,1998). Necrotic cell death is a passive process, cell 
‘murder’ (Alexi et al.,2000), characterized by formation of vacuoles, cell swelling, 
random DNA degradation, and early loss of plasma membrane integrity (Ratan et 
al.,1994a; Tan et al.,1998). On the other hand, apoptotic cell death, or cell ‘suicide’ 
(Alexi et al.,2000), is associated with depolarization of the mitochondrial membrane, a 
rise in intracellular calcium, generation of ROS, chromatin condensation, cytoplasmic 
and nuclear shrinkage, ‘laddering’ of DNA into reproducible oligonucleosomal 
fragments, late loss of membrane integrity, and active RNA and protein synthesis 
(Pereira and Oliveira,2000; Tan et al.,1998). Oxidative glutamate toxicity appears to 
involve both a rapid necrotic phase and a delayed apoptotic phase that includes nuclear 
condensation and chromatin cleavage into oligonucleosomal fragments (Ratan et 
al.,1994a; Schubert and Piasecki,2001; Tan et al.,1998).   
 Almost all mammalian cells contain a sodium-independent, anionic amino acid 
transporter that is highly specific for cystine and glutamate (Sato et al.,1999). This Xc-  
antiporter, enriched in brain membranes and concentrated in neurons, exchanges 
extracellular cystine for intracellular glutamate in a 1:1 fashion, and has a higher affinity 
for cystine than glutamate (Murphy et al.,1989; Sato et al.,1999). Mammalian 
extracellular brain cysteine concentration is less than 1µM, intracellular glutamate 
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concentration is greater than 3mM, and extracellular glutamate can reach 200-300µM 
after initial excitotoxic cell lysis (Murphy et al.,1990; Schubert and Piasecki,2001). 
Since the Xc- antiporter is critical for intracellular supply of cystine, which is rapidly 
reduced to cysteine in the cell and used for synthesis of acetyl-CoA, protein and 
glutathione, the higher affinity for cystine is essential (Murphy et al.,1990). Transporter 
activity is induced by electrophilic agents, depletion of cystine, and oxygen, all of which 
can deplete glutathione (Sato et al.,1999). Cystine uptake is inhibited by glutamate. 
Thus, in conditions such as ischemia when there is excessive extracellular glutamate, 
transport of cystine to the cell via this mechanism is inhibited, there is a loss of cystine 
homeostasis, and intracellular glutathione concentrations fall (Pereira and Oliveira,2000; 
Tan et al.,1998). The subsequent rise in ROS leads to lipid peroxidation, decreased 
mitochondrial membrane potential, perturbation of calcium homeostasis, and ultimate 
mitochondrial dysfunction, decreased ATP production and cell death (Pereira and 
Oliveira,2000; Tan et al.,1998). This oxidative glutamate toxicity has been described in 
primary neuronal cultures (Davis and Maher,1994; Murphy et al.,1989; Murphy et 
al.,1990), neuronal cell lines (Davis and Maher,1994; Murphy et al.,1989), and tissue 
slices (Schubert et al.,1992). Oxidative glutamate toxicity can be blocked in vitro by 
antioxidants such as vitamin E (Murphy et al.,1990; Schubert et al.,1992), inhibition of 
arachidonic acid metabolism and 12-lipoxygenase (Li et al.,1997; Murphy et al.,1989) 
and by inhibition of macromolecular synthesis (Ratan et al.,1994a). It has been 
suggested that inhibitors of macromolecular synthesis may protect against oxidative 
glutamate toxicity via shunting of cysteine to glutathione synthesis (Ratan et al.,1994b). 
However, since apoptotic cell death requires some protein synthesis as well, perhaps 
inhibition of this synthesis may contribute to the observed protection. 
 
2.1.3 Oxidative Stress  
2.1.3.1  ROS/RNS 
A free radical is any species having one or more unpaired electrons (Halliwell 
and Gutteridge,1990). Free radicals and other chemically reactive species include the 
ROS superoxide anion (O2•-), hydrogen peroxide, hydroxyl radical (OH•), and singlet 
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oxygen, and the RNS nitric oxide radical (NO•) and peroxynitrite (ONOO-) (Juurlink 
and Paterson,1998).   
The superoxide anion is produced in the cell by various mechanisms, including 
normal mitochondrial respiration, in which 3% of oxygen consumed is only partially 
reduced to superoxide instead of water (Juurlink,1997). The superoxide anion has a 
number of reactions in the cell: reaction with thiols, de-esterifying membrane lipids and 
releasing arachidonic acid, which initiates a metabolic cascade, leading to increased 
formation of superoxide anion; depletion of cellular NADH stores via a chain reaction 
with NADH bound to lactate dehydrogenase; reaction with nitric acid, producing 
peroxynitrite, a strong oxidant; dismutation to hydrogen peroxide and singlet oxygen 
with release of iron (ferrous ion) from ferritin stores (Fe3+ÆFe2+) (Fridovich,1986; Hall 
and Braughler,1993; Juurlink and Paterson,1998). Hypoxanthine, a metabolite of ATP 
via AMP, adenosine and inosine, is normally converted to xanthine and then uric acid by 
xanthine dehydrogenase, using NAD+ as an electron acceptor. During and following 
ischemia, intracellular calcium rise activates proteases that convert xanthine 
dehydrogenase to xanthine oxidase. Xanthine oxidase uses molecular oxygen as its 
electron acceptor, thus increasing the potential for superoxide anion production and/or 
hydrogen peroxide (Juurlink,1997; McCord,1985). Significant is that in ischemia, ATP 
is depleted, resulting in elevation of AMP and thus a ready supply of hypoxanthine 
substrate for xanthine oxidase (Juurlink,1997; McCord,1985), i.e.- in ischemia, not only 
does the harmful enzyme appear, but also its substrate.  As well, reperfusion brings a 
ready supply of oxygen, the second substrate required by xanthine oxidase for free 
radical production (Sussman and Bulkley,1990). Superoxide dismutase can scavenge 
cellular superoxide by dismutation to hydrogen peroxide and molecular oxygen 
(Juurlink and Paterson,1998). 
Hydrogen peroxide is also formed by other mechanisms, such as by 
oxidoreductases in the cellular peroxisome organelles (Juurlink and Paterson,1998). 
Hydrogen peroxide is not a free radical as it does not have an unpaired electron.  
Although relatively unreactive, hydrogen peroxide diffuses easily across biological 
membranes (Halliwell and Gutteridge,1990), and in the presence of ferrous ion (Fe2+) or 
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cuprous ion (copper, Cu+), hydrogen peroxide converts to the hydroxyl radical (Fenton, 
reaction 2.1). Oxidized iron (Fe3+) can then be reduced by superoxide anion (reaction 
2.1).  Reactions 2.1 and 2.2 together are known as the Haber-Weiss reaction 
(Juurlink,1999). The hydroxyl radical is the most potent oxidant in biological systems. It 
will extract an electron from thiol-containing enzymes such as glutathione reductase and 
glutathione peroxidase, DNA and polyunsaturated lipids, or hydroxylate another 
molecule. Hydroxyl radical interferes with mitochondrial function, inactivating electron-
carrying proteins and mitochondrial ATPase and peroxidizing membrane lipids 
(Halliwell,1992; Juurlink and Paterson,1998).  
 Fe2+ + HOOH → Fe3+ + OH• + OH-      (2.1) 
 Fe3+ +  O2•- → Fe2+ + O2      (2.2) 
Singlet oxygen can be formed from the interaction of superoxide anion with 
superoxide anion, peroxynitrite with hydrogen peroxide, or superoxide anion with 
hydrogen peroxide. Singlet oxygen may inactivate calcium ATPase, denature proteins, 
inactivate superoxide dismutase and catalase, and oxidize polyunsaturated lipids to yield 
lipid hydroperoxides and endoperoxides. These peroxides, with transition ions, can 
initiate propagation of lipid peroxidation chains or produce more singlet oxygen 
(Juurlink and Paterson,1998).  
Nitric oxide, a normally innocuous signaling molecule used by most cells, is 
synthesized from arginine by nitric oxide synthase (NOS). Two constitutive isoforms, 
NOS-I in neuronal and epithelial cells, and NOS-III in endothelial cells, are calcium and 
calmodulin dependent, while a third isoform, NOS-II or iNOS is inducible through 
cytokine activation of second messenger pathways and does not require elevation of 
cytosolic calcium (Hara et al.,1996; Juurlink,1999).  Inducible NOS produces toxic 
levels of nitric oxide, and is expressed in CNS in pathological states such as cerebral 
ischemia (Iadecola et al.,1997). Nitric oxide can interact with superoxide anion to 
produce peroxynitrite, which generates nitrogen dioxide (an oxidant similar to hydroxyl 
radical in reactivity), oxidizes thiol-containing proteins, DNA bases and polyunsaturated 
lipids, and inhibits mitochondrial electron transport, leading to decreased ATP 
production and increased production of ROS (Halliwell,1992; Juurlink and 
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Paterson,1998). In brain injury, polymorphonuclear leukocytes can produce nitric oxide 
and superoxide. Neurons and oligodendrocytes are susceptible to nitric oxide and 
peroxynitrite effects on mitochondrial respiration (Juurlink and Paterson,1998).  
 
2.1.3.2  Lipid peroxidation 
 Since the brain is rich in polyunsaturated fatty acids, ROS can easily propagate 
lipid peroxidation (Shivakumar et al.,1995). Superoxide anion can de-esterify membrane 
phospholipids to release fatty acids. Hydroxyl radical extracts a hydrogen atom from the 
methylene carbon of unsaturated fatty acids (LH), yielding a carbon-centred lipid radical 
(L•, reaction 2.3).  The lipid radical reacts with molecular oxygen to form a peroxy 
radical (reaction 2.4), which is converted to a lipid hydroperoxide (LOO•) by abstraction 
of a hydrogen atom from the methylene carbon of an adjacent unsaturated fatty acid 
(reaction 2.5) (Juurlink,1997). The propagation (reactions 2.4 and 2.5) continues until 
either two lipid radicals interact, or an antioxidant (such as vitamin E) stops the chain 
reaction (Kinuta et al.,1989). 
   LH + OH• → L• + HOH       (2.3) 
   L• + O2 → LOO•       (2.4) 
   LOO• + LH → L• + LOOH      (2.5) 
Lipid peroxidation can also be initiated by non-radical ROS such as singlet oxygen and 
hypochlorite. As well, in the presence of iron or iron complexes, lipid hydroperoxides 
can form alkoxy (reaction 2.6) or peroxy (reaction 2.7) radicals to propagate new chains 
of peroxidation (reactions 2.8 and 2.9), particularly in acidic conditions such as arise 
during and following ischemia (Hall and Braughler,1993; Juurlink,1997). 
LOOH + Fe2+ → Fe3+ + LO• + OH-     (2.6) 
LOOH + Fe3+ → Fe2+ + LOO• + H+     (2.7) 
LO• + LH  → LOH + L•                  (2.8) 
LOO• + LH  → LOOH + L•      (2.9) 
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Lipid peroxidation can alter membrane fluidity and permeability, and function of 
membrane-bound ion pumps, further compromising ion homeostasis, resulting finally in 
loss of membrane integrity and cell rupture (Juurlink,1997). Lipid peroxides can also 
break down into harmful pro-inflammatory isoprostanoids and strong oxidants such as 
4-hydroxynonenal (4-HNE) (Christman et al.,2000).   
 
2.1.3.3  The Arachidonic Acid Cascade and Inflammation 
 Both normal physiological mechanisms and pathological conditions such as 
mechanical damage, lipid peroxidation, and increased cytosolic calcium can release the 
polyunsaturated 20-carbon arachidonic acid (5,8,1,14-cis-eicosotetraenoic acid) from 
esterified membrane phospholipids via activation of calcium-dependent phospholipase 
A2 (Dayton and Major,1996; Juurlink and Paterson,1998; Shimizu and Wolfe,1990). 
Phosphatidylcholine and phosphatidylinositol, where arachidonate is in the sn-2 
position, are the most important sources of arachidonic acid. Phospholipase C is also 
activated by high intracellular calcium, giving rise to diacylglycerol which can release 
arachidonic acid via the action of lipases (Juurlink and Paterson,1998). The resultant 
arachidonic acid cascade involves oxidation of arachidonic acid by several enzyme 
families to produce prostaglandins, thromboxanes, leukotrienes, lipoxins, epoxy-
eicosatrienoic acids, and hydroperoxy acids, potent biological signaling molecules 
acting as short-range messengers (Shimizu and Wolfe,1990). Arachidonic acid can also 
be transformed into hydroperoxy acids by nonenzymatic autooxidation. Collectively 
termed eicosanoids, these arachidonate derivatives are responsible for a wide variety of 
modulatory physiological responses.  
 Two isoforms of the enzyme cyclooxygenase, constitutive (COX-1) and 
inducible (COX-2) are responsible for the conversion of arachidonic acid to 
prostaglandins and thromboxanes. COX-1 activity regulates prostaglandins and 
thromboxanes production under normal physiological conditions. COX-2 is rapidly 
inducible by mitogens, cytokines, lipopolysaccharide, and hypoxia/ischemia, and 
promotes pro-inflammatory prostaglandins and thromboxanes and free radicals, leading 
to permeability changes in the blood brain barrier, neutrophil activation, platelet and 
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leukocyte adhesion to endothelium (Juurlink and Paterson,1998; Sairanen et al.,1998).  
COX-2 is the main isoform in the CNS, and is present in both neuronal and glial cells 
(Sairanen et al.,1998). 
 Leukotrienes and lipoxins are produced by the lipoxygenase pathways, are 
potent mediators of inflammation, are released in response to cerebral trauma/ischemia, 
and stimulate leukocyte chemotaxis, neutrophil superoxide generation and release, 
vasospasm, and increased microvascular permeability (Feuerstein and Hallenbeck,1987; 
Juurlink and Paterson,1998). Five-lipoxygenase requires calcium and ATP for activity, 
thus is activated following ischemia and intracellular calcium rise, and will further 
deplete ATP. Free radicals may also act directly on arachidonic acid, with resultant 
isoleukotrienes, biologically active free radicals (Harrison and Murphy,1995). 
 Platelet-activating factor can be formed after acetylation of the sn-2 position of 
phosphatidylcholine following phospholipase A2-mediated release of arachidonic acid 
from that position (Juurlink and Paterson,1998). Platelet-activating factor has several 
actions, including increasing permeability of microvessels, promotion of neutrophil 
transmigration and adhesion, acting as a second messenger to release more arachidonic 
acid and superoxide anion, and enhancing glutamate release (Juurlink and 
Paterson,1998).   
 Neutrophils become activated and invade CNS parenchyma following CNS 
injury and phopholipase-mediated lipid inflammatory molecule formation. Arachidonic 
acid stimulates neutrophil NADPH-oxidase, the ‘respiratory burst oxidase’ normally 
active in host defense against microbial invasion (Chanock et al.,1994). The consequent 
production of superoxide anion, however, can cause considerable tissue damage as well 
(Juurlink and Paterson,1998). 
 
2.1.3.4  Nuclear factor kappa B 
 Nuclear factor kappa B (NF-κB) is a protein transcription factor, required for the 
transcription of pro-inflammatory molecules such as intracellular adhesion molecule-1 
(ICAM-1), the enzymes inducible nitric oxide synthase (iNOS) and COX-2, cytokines 
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interleukin-1 B (IL-1B), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α), 
and chemokines regulated upon activation normal T-cell expressed and secreted protein 
(RANTES) and monocytes chemoattractant protein-1 (MCP-1) (Christman et al.,2000; 
Schneider et al.,1999). NF-κB is thus a mediator of the inflammatory cascade. In 
resting, unstimulated cells, NF-κB is sequestered in the cytoplasm as a complex with an 
inhibitory component, IκB. Upon stimulation, the IκB is phosphorylated, 
polyubiquitinated and degraded by the 26S proteasome, unmasking a nuclear location 
signal on NF-κB, which then locates to the nucleus to activate gene transcription 
(Schneider et al.,1999). NF-κB is stimulated by both receptor-dependent signals such as 
lipopolysaccharide, TNF-α, and IL-1B, and by non-receptor activation such as 
ultraviolet radiation, physical stress/trauma, hydrogen peroxide and 
ischemia/reperfusion, whose mechanisms are not well understood. 
 
2.1.3.5  Advanced Glycation Endproducts 
 Advanced glycation endproducts (AGEs) are formed by the nonenzymatic 
interaction of highly reactive dicarbonyls, or 2-oxo-aldehydes, with the nitrogen of 
protein-bound amino acids and nucleic acids (Juurlink,1999). The dicarbonyls glyoxal 
and methylglyoxal are derived from glucose via transition metal ion catalyzed oxidation, 
and glycolysis, respectively. Alternatively, glucose can undergo Amadori rearrangement 
to yield another dicarbonyl, 3-deoxyglucosone. Advanced glycation endproduct 
formation is accelerated in hyperglycemia and oxidative stress (Juurlink,1999). 
Advanced glycation endproducts inactivate proteins such as glutathione reductase, and 
act with receptors that increase ROS and NF-κB activation, as well as with scavenger 
receptors whose activation causes release of arachidonic acid and ROS (Juurlink,2001; 
Shinpo et al.,2000).  
 
2.1.4 Summary 
 Many complicated and as yet incompletely understood mechanisms contribute to 
tissue damage during and following stroke, and pathways are interrelated and 
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interwoven. Juurlink (1999) talks of four phenomena: glutamate excitotoxicity, 
intracellular calcium influx, oxidative stress and ATP depletion as responsible for 
activation of a vicious spiral ending in cell death, with additional influence of oxidative 
stress in promotion of inflammatory processes, also damaging. Alexi et al. (2000) 
describe the ‘lethal triplet’ of metabolic compromise, excitoxicity and oxidative stress in 
both acute and chronic pathological states. It is clear that cell death in stroke occurs by 
rapid necrotic and delayed apoptotic mechanisms, the latter providing some hope of 
intervention before irrevocable damage occurs. 
 
2.2 ANTIOXIDANT DEFENSE 
 Antioxidant defense is essential to survival, since cells are exposed to free 
radicals from the environment and from normal physiological processes. Both 
enzymatic and non-enzymatic cellular systems exist, designed to scavenge or inactivate 
free radicals. 
 
2.2.1 Enzymatic defense 
 The superoxide dismutase (SOD) family removes superoxide anion and converts 
it to hydrogen peroxide, according to reaction 2.10.  Mammalian cells contain two types 
of SODs, a tetrameric mitochondrial SOD containing manganese (MnSOD), and a 
dimeric cytosolic SOD containing copper and zinc (CuZnSOD) (Halliwell,1994; 
Nordberg and Arner,2001). Leakage of electrons from the respiratory chain in 
mitochondria produces much of the superoxide anion encountered in the cell, and 
MnSOD can be induced by thioredoxin and by oxidative stress. In contrast, CuZnSOD 
is not induced by oxidative stress (Chan,1994; Nordberg and Arner,2001). 
            SOD 
2 O2•- + 2H+ → H2O2 + O2      (2.10) 
  The catalase enzymes are mainly heme-containing, located in peroxisomes. They 
remove hydrogen peroxide (reaction 2.11) and can detoxify phenols and alcohols 
(reaction 2.12), but cannot affect lipid peroxides (Halliwell,1994; Nordberg and 
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Arner,2001). Catalase also lowers the risk of hydroxyl radical formed from hydrogen 
peroxide via the Fenton reaction, thus acting as an antioxidant.  Binding of catalase to 
NADPH will protect the enzyme from inactivation as well as increase its efficiency 
(Nordberg and Arner,2001). 
2 H2O2  → O2 + H2O       (2.11) 
H2O2  + R´H2  → R´ + 2H2O      (2.12) 
The peroxiredoxins (thioredoxin peroxidases), only recently discovered, can 
directly reduce peroxides such as hydrogen peroxide  and alkyl hydroperoxides and can 
inhibit apoptosis (Chae et al.,1999).  Oxidized peroxiredoxin is regenerated by 
thioredoxin. The glutaredoxins, whose function overlaps that of thioredoxins, can reduce 
glutathione mixed protein disulfides formed in oxidative stress, and are themselves 
reduced by glutathione (Nordberg and Arner,2001). 
The selenocysteine-containing glutathione peroxidases (GPx) catalyze the 
reduction of both hydrogen and lipid peroxides using glutathione as a substrate (reaction 
2.13). This is in contrast to catalase, which can act only on hydrogen peroxides. The 
cytosolic glutathione peroxidase 1 and the membrane-bound glutathione peroxidase 4 
(phospholipid hydroperoxide glutathione peroxidase) isoforms are present in most 
tissues. Glutathione peroxidase 4 has broad specificity for membrane-bound 
hydroperoxides, fatty acid peroxides and others, including hydrogen peroxide (Ursini et 
al.,1985). Glutathione peroxidase 2 is the gastrointestinal isoform, and glutathione 
peroxidase 3, or plasma glutathione peroxidase, is mainly expressed in the kidney 
(Nordberg and Arner,2001), although has also been found in the eye, lung, brain, heart, 
breast, placenta, and liver (of humans, but not rodents) (Arthur,2000; Chu et al.,1992). 
Glutathione peroxidase 3 can be catalytically regenerated by the thioredoxin system. 
           GPx   
     ROOH + 2GSH  →  ROH + GSSG + H2O   (2.13) 
The thioredoxin system consists of two oxidoreductase enzymes: thioredoxin, a 
general protein disulfide reductant, and thioredoxin reductase, which catalyzes reduction 
of the active site disulfide in thioredoxin using NADPH (Nordberg and Arner,2001).  
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Thioredoxin is ubiquitous in mammalian cells, targeting ribonucleotide reductase, 
protein-disulfide isomerase, and transcription factors including p53, NF-κB, and 
Activator Protein-1 (AP-1) for reduction. In humans, the isoform thioredoxin 1 is in 
cytosol, thioredoxin 2 in mitochondria, and Sp thioredoxin in spermatozoa, all 
containing a cysteine-glycine-proline-cysteine active site (Nordberg and Arner,2001). 
Thioredoxin is an electron donor for the peroxiredoxins, thus important in reduction of 
peroxides. When reduced, thioredoxin prevents apoptosis via inhibitory binding to 
apoptosis signal-regulating kinase 1. Expression of thioredoxin is induced by oxidative 
stress, some forms of which cause translocation of thioredoxin to the nucleus where it 
enhances DNA binding of NF-κB by reduction of its cysteine residue, exacerbating the 
production of pro-inflammatory molecules (Matthews et al.,1992).   
All thioredoxin reductase isoenzymes contain selenocysteine, which is essential 
for their activity. Thioredoxin reductase is NADPH-dependent and directly reduces 
hydrogen peroxide and lipid peroxides, especially when peroxide levels are elevated.  
This function is thought to be handled normally by glutathione peroxidase 4 (Nordberg 
and Arner,2001). In addition to thioredoxin, some thioredoxin reductase substrates are 
protein-disulfide isomerases, L-cystine, dehydroascorbic acid, α-lipoic acid, ubiquinone, 
and glutathione peroxidase (Nordberg and Arner,2001). Inhibition of thioredoxin 
reductase impairs function of thioredoxin system-dependent or -regulated reactions, 
resulting ultimately in significant intracellular oxidative stress. 
 
2.2.2 Non-enzymatic defense 
2.2.2.1  Glutathione 
2.2.2.1.1  Roles of glutathione 
The tripeptide glutathione (L-γ-glutamyl-L-cysteinylglycine), the most prevalent 
nonprotein intracellular thiol, is involved in many functions in the body, including 
regulation of cellular redox balance, leukotriene and prostaglandin metabolism, 
deoxyribonucleotide synthesis, immune function, cell proliferation, transport and 
storage of cysteine, detoxification of xenobiotics, and antioxidation of reactive oxygen 
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species and free radicals (Akerboom and Sies,1981; Bray and Taylor,1993; Bray and 
Taylor,1994; Halliwell and Gutteridge,1990; Juurlink,1999; Philbert et al.,1991). 
Intracellular concentrations of glutathione range from ~1-2µmol/g in brain to ~8-
10µmol/g in liver (Bauman et al.,1988a ; Bray and Taylor,1994; Paterson et al.,2001). 
The most abundant thiol in the CNS, glutathione, along with glutathione peroxidase, is 
the major protection against peroxide and reactive oxygen species in the cell, and is thus 
critical in antioxidant defense (Barker et al.,1996; Bray and Taylor,1993; Bray and 
Taylor,1994; Jain et al.,1991; Juurlink,1997; Wullner et al.,1999).   
As mentioned, glutathione peroxidase converts any peroxide (including lipid 
peroxides) to water and molecular oxygen (or hydroxy group) through oxidation of 
glutathione, which acts as the electron donor (reaction 2.13). Oxidized glutathione 
(GSSG) can then be reduced to glutathione, dependent on glutathione reductase (GRed) 
and NADPH (reaction 2.14). The activity of glutathione reductase and availability of 
NADPH thus can regulate the activity of glutathione peroxidase. The ability of 
glutathione peroxidase to scavenge peroxides is dependent on the concentration of 
glutathione, increasing markedly with small increases in glutathione (Juurlink,1999; 
Thorburne and Juurlink,1996). 
                                                        
              GRed 
 GSSG + NADPH + H+  →  2GSH + NADP+    (2.14) 
 2GSH + 2R•  → 2RH + 2GS•      (2.15) 
 GS• + GS• → GSSG       (2.16) 
 
Glutathione can also scavenge free radicals directly, forming glutathiyl radicals 
(GS•), which interact to form GSSG (reactions 2.15, 2.16) (Dringen et al.,2000). 
Vitamin E (α-tocopherol, TOH) can inactivate lipid radicals, forming the tocopherol 
radical which is in turn reduced by ascorbate (AscH2) (reactions 2.17, 2.18). Two 
ascorbate radicals dismutate to ascorbate and dehydroascorbate (oxidized), which is 
reduced back to ascorbate by glutathione (reactions 2.19, 2.20) (Juurlink,1997). 
Glutathione and ascorbate together prevent oxidative damage to mitochondria. Meister 
and co-workers found glutathione can spare ascorbate, and ascorbate can spare 
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glutathione (Martensson et al.,1993; Martensson et al.,1991a; Martensson and 
Meister,1989; Martensson et al.,1991b; Meister,1991; Meister,1994). Ascorbate 
increased mitochondrial glutathione in glutathione-deficient animals, while 
administration of glutathione esters delayed the onset of scurvy in ascorbate-deficient 
animals. Ascorbate may provide an alternative cytosolic antioxidant defense in neuronal 
somata (Philbert et al.,1991). 
 
 LOO• + TOH → LOOH + TO•     (2.17) 
 TO• + AscH2 → TOH + AscH•     (2.18) 
 2AscH• → AscH2 + Asc      (2.19) 
 2GSH + Asc → GSSG + AscH2     (2.20) 
 
The hydroperoxides produced in reaction 2.17, in the presence of free iron, can 
be converted to alkoxyl and peroxyl radicals, potentially initiating more lipid 
peroxidation (reactions 2.6, 2.7) (Juurlink and Paterson,1998). Glutathione and the 
glutathione peroxidase family scavenge these radicals. Glutathione also forms 
glutathione S-conjugates, nonenzymatically or via glutathione S-transferase enzymes, 
important in detoxification of endogenous and exogenous compounds, as well as in 
normal cellular metabolism, such as leukotriene C formation (Anderson and Luo,1998). 
Lipid peroxides can break down into strong oxidant aldehydes such as 4-
hydroxynonenal, which can be inactivated through the action of glutathione S-
transferase to form glutathiyl adducts (Christman et al.,2000). Glutathione S-
transferases also form these adducts with lipid epoxides and hydroperoxides (Christman 
et al.,2000).   
The transcription factor NF-κB mediates the inflammatory response in brain 
ischemia, and, through its redox capacity, glutathione can inhibit the signal transduction 
pathway that results in NF-κB activation (Christman et al.,2000). Glutathione plays an 
important role in prevention of advanced glycation endproduct formation, via reaction of 
glutathione with methylglyoxal and glyoxalase I, for example, to produce a 
hemithioacetyl, which is then converted to D-lactic acid and glutathione with glyoxalase 
II (Thornalley,1988). 
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Glutathione deficiency leads to mitochondrial damage in tissues, including lung, 
gastrointestinal tract, eye, skeletal muscle, liver, kidneys, and brain (Meister,1995a).  
Decreased tissue glutathione levels have been associated with several diseases, 
including hereditary glutathione deficiencies, hepatitis C, AIDS, myocardial infarction, 
stroke, ischemic reperfusion injury, Parkinson’s disease, adult respiratory distress 
syndrome, chronic digestive diseases and burns (Anderson and Luo,1998; Bray and 
Taylor,1994). Deficient glutathione status contributes to a weakened antioxidant defense 
system (Jain et al.,1991; Juurlink et al.,1998; Mizui et al.,1992; Thorburne and 
Juurlink,1996) and decreased immune response in malnourished individuals, especially 
when associated with these diseases (Bray and Taylor,1994).  
In summary, glutathione plays many roles in antioxidant defense, such as direct 
scavenging of free radicals, scavenging of hydrogen and lipid peroxides as well as their 
peroxidation products, interaction with vitamin E and ascorbate in lipid peroxidation 
defense, prevention of advanced glycation endproduct formation, and finally redox 
regulation of NF-κB activation. 
 
2.2.2.1.2  Metabolism and homeostasis of glutathione 
Glutathione is synthesized in two ATP-requiring steps in almost all animal cells 
(Meister,1995a).  Step 1 (reaction 2.21) requires the enzyme glutamate-cysteine ligase 
(GL, γ-glutamylcysteine synthetase, GCS), is the rate-limiting step in glutathione 
synthesis, and is regulated by glutathione via negative feedback inhibition (Juurlink et 
al.,1998). The feedback inhibition of γ-glutamylcysteine synthetase can be alleviated by 
glutamate, suggesting that high intracellular glutamate may be able to increase 
intracellular glutathione (Juurlink,1999).  Step 2 (reaction 2.22) is catalyzed by 
glutathione synthetase. 
 
L-glutamate + L-cysteine + ATP → L-γ -glutamyl-L-cysteine + ADP + Pi (2.21) 
L-γ -glutamyl-L-cysteine + glycine + ATP → glutathione + ADP + Pi (2.22) 
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Glutathione is synthesized in the cytoplasm (Anderson and Luo,1998; Meister,1995a; 
Wullner et al.,1999). Since mitochondria do not contain the enzymes required for 
glutathione synthesis, about 10-20% of total cellular glutathione is transported into 
mitochondria from the cytoplasm by at least two transport systems (Cooper,1997). 
Activity of γ-glutamylcysteine synthetase and availability of cysteine are the rate-
limiting factors for glutathione synthesis (Bauman et al.,1988a; Lu,1999). Glutamate 
and glycine are readily synthesized via several metabolic pathways, and are not believed 
to limit the rate of glutathione synthesis (Bannai and Tateishi,1986). The most important 
source of cysteine is dietary, but it can also be supplied by cleavage of cystine or by 
trans-sulphuration of methionine via the cystathionine pathway in the liver (Bauman et 
al.,1988a; Bray and Taylor,1994). Although glutathione is exported from many cells 
under normal conditions, and exported glutathione enters plasma (Meister and 
Anderson,1983), the liver is the main source of plasma glutathione (Cooper,1997). 
Sources of glutathione in the intestine include the diet, hepatic glutathione exported into 
bile, desquamated epithelial cells, and export from epithelial cells of the stomach and 
intestine (Bray and Taylor,1994; Cooper,1997). Generally, glutathione does not freely 
enter cells, but uptake depends on γ-glutamyl transpeptidase, an enzyme present on the 
external surface of the cell membrane in many tissues (Anderson and Luo,1998; Bray 
and Taylor,1994; Jain et al.,1991). However, there is some evidence for direct 
absorption and local use of intact glutathione in the small intestine (Bray and 
Taylor,1994; Hagen and Jones,1987), and transport of intact glutathione from the blood 
into the brain by carriers identified in capillaries and endothelial cells (Kannan et 
al.,2000; Kannan et al.,1990). Cellular glutathione concentration is determined by 
several factors including consumption by formation of conjugates via glutathione S-
transferase, oxidation to GSSG, de novo synthesis and by reduction of oxidized 
glutathione by glutathione reductase (Juurlink,1999). Changes in γ-glutamylcysteine 
synthetase activity and gene expression will also alter glutathione concentration, and are 
mediated by factors such as oxidative stress, Phase II enzyme inducers, and antioxidants 
(Juurlink,2001; Lu,1999).  
 At the centre of glutathione homeostasis is the γ-glutamyl cycle. The enzyme γ-
glutamyl transpeptidase is bound to the outer surface of most cell membranes, is 
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enriched in secretory and absorptive cells, and has also been found in brain (Jain et 
al.,1991; Meister and Anderson,1983). Breakdown of glutathione, oxidized glutathione 
or S-substituted glutathione can occur at the cell membrane in the presence of γ-
glutamyl transpeptidase, which transfers the γ-glutamyl moiety to acceptors such as 
cystine, glutamate, methionine, some dipeptides, water, or even glutathione (Meister and 
Anderson,1983). Plasma or extracellular glutathione can react with amino acids or water 
to form γ-glutamyl amino acids or glutamate, respectively, and cysteinylglycine. The γ-
glutamyl amino acids are transported into the cell and split into amino acid and 5-
oxoproline by γ-glutamylcyclotransferase. Five-oxoproline is then ring-opened by 5-
oxoprolinase, with ATP, to glutamate. If the γ-glutamyl moiety is transferred to cystine 
by γ-glutamyl transpeptidase, then γ-glutamylcystine transported into the cell can enter 
Step 2 of glutathione synthesis directly, thus by-passing the glutathione feedback 
inhibition of γ-glutamyl cysteine synthetase (Anderson and Luo,1998). Cysteinylglycine 
can be hydrolyzed by dipeptidases at the cell membrane to free amino acids for 
transport, or can be transported as the dipeptide and cleaved by intracellular dipeptidases 
to cysteine and glycine to be used in protein or glutathione synthesis (Anderson and 
Luo,1998). Inhibition of γ-glutamyl transpeptidase will increase plasma glutathione, 
while inhibition of γ-glutamyl cysteine synthetase will decrease plasma glutathione, 
confirming that glutathione is exported from the cell (Meister and Anderson,1983). 
Nonenzymatic or enzymatic (via glutathione S-transferase) reaction of glutathione with 
electrophilic compounds forms S-substituted glutathione derivatives. Gamma-glutamyl 
transpeptidase can remove the γ-glutamyl moiety of these compounds, resulting in a γ-
glutamyl amino acid and an S-substituted cysteinylglycine moiety. The dipeptide can 
then be cleaved by dipeptidase to yield corresponding S-substituted cysteines which 
may be either N-acetylated or undergo a further transpeptidation to yield a γ-glutamyl 
derivative (Meister and Anderson,1983). By these mechanisms, referred to as the 
‘salvage pathway’, there is transport of various amino acids across cell membranes, as 
well as conservation and redistribution of glutathione constituents (Anderson and 
Luo,1998; Meister and Anderson,1983). If dietary cysteine is decreased, glutathione 
may be used to supply cysteine for critical proteins, limiting glutathione available for 
antioxidant defense (Hunter and Grimble,1997). 
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2.2.2.1.3                        Brain glutathione and glutathione peroxidase 
Brain glutathione and glutathione peroxidase activity help regulate the extent of 
tissue damage in stroke.  Brain glutathione arises from synthesis from amino acids and 
reduction of oxidized glutathione, and concentration decreases with age (Benuck et 
al.,1995). Jain et al. (1991) suggest brain glutathione may exist in several distinct pools, 
such as mitochondria, neurons and glial cells. Philbert and co-workers (1991) examined 
cellular and regional distribution of glutathione in the nervous system of the rat. They 
found glutathione in the CNS appears localized in the non-neuronal components of 
neuropil and in the white matter tracts, with only small amounts in the neuronal somata, 
confirming results demonstrated by others (Slivka et al.,1987). Brain cells have been 
shown to release glutathione into the extracellular space during conditions such as 
ischemia (Janaky et al.,1999).  Neurons contain lower concentrations of glutathione than 
astrocytes, and in culture, neurons cannot utilize exogenous cystine, relying on cysteine 
either in the culture medium or released by astrocytes/glia for glutathione synthesis 
(Dringen and Hamprecht,1999; Dringen et al.,1997; Iwata-Ichikawa et al.,1999; 
Juurlink,1996; Raps et al.,1989). Wang and Cynader (2000) suggest cystine is 
transported from blood to the CNS extracellular fluid, where it reacts in a 
thiol/disulphide exchange with glutathione released from astrocytes. The resultant 
formation of cysteine and a cysteine-glutathione disulphide allows neurons access to 
cysteine. There is some evidence that neurons can utilize cysteine, or cysteinylglycine 
and γ-glutamylcysteine as cysteine precursors at lower concentrations than those 
required by astrocytes (Dringen et al.,1999). As well, buthionine sulfoximine, an 
inhibitor of γ-glutamyl cysteine synthetase, inhibits utilization of both cysteinylglycine 
and γ-glutamylcysteine, suggesting these dipeptides are hydrolyzed before glutathione 
synthesis in neurons (Dringen et al.,1999). In contrast, in cultured astroglial cells, the 
first step of glutathione synthesis can be bypassed (Dringen et al.,1997). There is some 
breakdown and re-synthesis of glutathione via γ-glutamyl transpeptidase on the luminal 
side of brain capillaries (Jain et al.,1991).   
Husain and Juurlink (1995) cultured rat astrocytes and oligodendrocyte 
precursors under conditions of anoxia and hypoxia. Both cell types survived anoxia, but 
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only astrocytes survived twenty-four hours of hypoxia. More lipid peroxidation was 
seen under hypoxia than anoxia, suggesting free radical induced damage. 
Oligodendroglial precursors in culture contain more iron, less glutathione, and suffer 
more oxidative stress than astrocytes in the same culture medium (Thorburne and 
Juurlink,1996). Chelating iron or increasing glutathione content protects 
oligodendroglial precursors from oxidative damage, suggesting glutathione plays an 
important role in antioxidant defense in these cells. Wullner et al. (1999) studied 
glutathione in cerebellar granule neurons in vitro, and found inhibition of cytosolic 
synthesis of glutathione by buthionine sulfoximine had little effect on mitochondrial 
glutathione or mitochondrial transmembrane potential. Direct conjugation of glutathione 
with ethacrynic acid resulted in a rapid depletion of both cytosolic and mitochondrial 
glutathione, and subsequent generation of ROS with impairment of the electrochemical 
mitochondrial gradient. When mitochondrial respiration was inhibited with rotenone, 
ROS production was suppressed, confirming mitochondria as the source of ROS in 
neurons.  Mizui et al. (1992) depleted rat brain glutathione with buthionine sulfoximine 
and found increased damage due to ischemic insult. 
Ushijima et al. (1986), using a peroxidase-anti-peroxidase immunohistochemical 
method, studied the distribution of glutathione peroxidase in rat brain. They found 
glutathione peroxidase was localized in the nuclei of some nerve cells in the cerebral 
cortex, hippocampus, and cerebellar cortex, and absent in the Purkinje cells of the 
cerebellum.   Distribution of cells lacking glutathione peroxidase coincided with those 
cells more vulnerable to hypoxia.  They concluded differences in the distribution of 
glutathione peroxidase in brain might contribute to the selective vulnerability of neurons 
in post-hypoxic damage.  Juurlink et al. (1998) examined astrocytes and 
oligodendrocyte precursors in culture, and found oligodendrocyte precursors to have 
50% of the glutathione reductase activity and 15% of the glutathione peroxidase activity 
of astrocytes. 
 
2.2.2.1.4 Response of tissue glutathione to dietary protein, energy and                
sulphur amino acids 
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Hepatic glutathione concentration is responsive to dietary protein (Bauman et 
al.,1988a).  There is a diurnal rhythm to liver glutathione in rats, with the level rising 
during the night as feeding proceeds, and falling during the day. When animals are 
fasted or given pure sucrose or fat diets, glutathione levels are low and the diurnal 
rhythm disappears (Beck et al.,1958). Liver glutathione responds to the sulphur amino 
acid (SAA) content of protein, and increasing protein levels above normal will not 
increase glutathione above those levels found when adequate protein is fed (Bauman et 
al.,1988a). When rats, however, were first fed low-protein diets and hepatic glutathione 
was depleted, supplementation with a cysteine precursor increased hepatic glutathione 
beyond physiological maximum (Bauman et al.,1988b; Taylor et al.,1992). Benuck et 
al. (1995) deprived both young and aged rats of food for forty-eight hours, and found 
loss of hepatic protein and glutathione, but no loss of brain glutathione and little change 
in brain protein or amino acid levels. They suggested there is relative stability of protein, 
amino acids and glutathione in brain in short-term food deprivation, and brain protein 
may be spared even in extreme conditions. In food deprivation, there appears to be 
recycling of glutathione constituents within the brain and/or transportation of precursors 
across the blood brain barrier (Dringen,2000). Seemingly in contrast, but likely due to 
the acute nature of the dietary treatment, our laboratory has recently shown that 
glutathione concentration is decreased in certain brain regions by an acute dietary SAA 
deficiency (Paterson et al.,2001). Although plasma glutathione and cysteine levels are 
determined by efflux of hepatic glutathione, which is decreased in protein deficiency 
(Adachi et al.,1992), levels and function of liver glutathione-synthesizing enzymes 
appear to be maintained in food deprivation (Tateishi et al.,1974). Enzymes involved in 
glutathione synthesis are present in brain (Dringen,2000), but their function in food 
deprivation has not been investigated. 
 
2.3  SULPHUR AMINO ACID METABOLISM 
2.3.1 Methionine  
 Methionine and cysteine have important roles in organism survival in their 
capacity as amino acids for protein synthesis, precursors to essential metabolites, and for 
their catalytic roles in the active sites of enzymes, primarily due to their sulphur content 
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(Griffith,1987). Homocysteine is readily converted to methionine in mammals, and is 
the intermediate in the transsulphuration pathway to cysteine, but is absent from 
mammalian diets, rendering methionine the only indispensable sulphur amino acid 
(Finkelstein,2000). One essential function of methionine is the synthesis of the primary 
methyl group donor in biological systems, S-adenosylmethionine, via the action of 
methionine adenosyltransferase. Cellular methionine is partitioned between protein 
synthesis and S-adenosylmethionine synthesis. Although S-adenosylmethionine was not 
thought to be exported from its cell of origin, recent evidence suggests the liver may 
export some S-adenosylmethionine to the CNS and other tissues (Finkelstein,2000).  
Approximately 95% of S-adenosylmethionine forms S-adenosylhomocysteine by 
transmethylation with an acceptor such as glycine, guanidinoacetate, 
phosphatidylethanolamine, the lysine residues in some proteins, pyrimidine and purine 
bases of tRNA, and some xenobiotics (Griffith,1987). The next step is the formation of 
homocysteine via adenosylhomocysteinase. If homocysteine is in excess, it is 
irreversibly converted to cystathionine with the addition of serine via cystathionine-β-
synthase, and cystathionine is cleaved to α-ketobutyrate and cysteine with γ-
cystathionase (Finkelstein,2000; Griffith,1987). Thus, cysteine is unable to serve as a 
precursor to homocysteine or methionine in mammals. Alternatively, excess 
homocysteine can be exported to the liver and other tissues. When in short supply, the 
homocysteine moiety is conserved in the methionine cycle, wherein homocysteine is 
converted to methionine by accepting a methyl group from betaine, which becomes 
dimethylglycine; or from 5-methyltetrahydrofolate, which becomes tetrahydrofolate. 
There is some competition for homocysteine between cystathionine-β-synthase and the 
two enzymes involved in homocysteine conservation, betaine homocysteine 
methyltransferase and methylfolate methyltransferase (Finkelstein,2000). Activity of 
cystathionine-β-synthase is increased in an oxidative environment, but methylfolate 
methyltransferase is vulnerable to oxidation. It is therefore plausible that conditions of 
oxidative stress tip the balance in favour of trans-sulphuration, cysteine production, and 
glutathione synthesis (Finkelstein,2000). As well, the enzymes of the methionine 
conserving cycle tend to be inhibited by their products, while the trans-sulphuration 
pathway enzymes tend to be activated by their metabolites. 
 32
 Methionine is transported by the sodium-independent system L, subject to trans-
stimulation, meaning an amino acid on one side of a membrane can stimulate transport 
of another amino acid on the other side (Bannai and Tateishi,1986; Lu,1999; Lu,2000). 
System L appears to consist of both a high affinity, low capacity phase and a low 
affinity, high capacity phase. In hepatocytes, methionine is transported by both phases 
(Lu,2000). 
  
2.3.2 Cysteine 
 Cysteine is a dispensable amino acid in mammals, but only if methionine intake 
meets the sulphur amino acid requirement. It follows, then, that the requirement for 
methionine in the diet is reduced if cysteine intake is adequate. Cysteine is unique in that 
it occurs predominantly in the oxidized form extracellularly as the disulphide cystine, 
but as the reduced sulphhydryl cysteine intracellularly.   
Cysteine is transported across membranes as a neutral amino acid via the ASC 
system, which is pH sensitive and decreased in acidic conditions (Kranich et al.,1996; 
Lu,1999). This may be significant in acidosis of ischemia, especially if cysteine has 
been depleted in diet, for example. The ASC system also transports other neutral amino 
acids of short length, such as alanine and serine, in a competitive fashion. This system is 
subject to trans-stimulation: intracellular cysteine depends on the intracellular and 
extracellular concentrations of other ASC amino acids. As well, increased extracellular 
cysteine will increase intracellular concentrations of other ASC amino acids in addition 
to cysteine because of competitive inhibition, termed cis-inhibition, thereby stimulating 
efflux of cysteine via trans-stimulation (Lu,1999). 
Cystine, with four ionizable groups, is present at neutral pH as the tetrapolar ion, 
while approximately 20% will exist as the tripolar ion at physiological pH. As covered 
under ‘oxidative glutamate toxicity’, cystine is generally transported via the sodium-
independent Xc- antiporter in a 1:1 exchange with glutamate. In culture, activity of the 
Xc- antiporter can be induced by exposure to electrophilic agents or oxygen, and 
inhibited by extracellular glutamate or homocysteate (Bannai,1986). In brain, transport 
of cystine is complex and not yet completely elucidated. In cultures of fetal or neonatal 
rat brain, both astrocytes and neurons appear to have a high affinity, low capacity 
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transport system for cystine, identified as the Xc- system (Allen et al.,2001; Murphy et 
al.,1990). In addition, astroglia have a sodium-dependent, low affinity, high capacity 
XAG- transport system that is inhibited by glutamate and D-aspartate (Allen et al.,2001; 
Murphy et al.,1990). Although the Xc- antiporter is enriched in brain membranes and 
concentrated in neurons, (Murphy et al.,1989; Sato et al.,1999), Sagara’s group 
(1993a;1993b) found neurons cannot take up cystine, but rely on astroglial cystine 
uptake and subsequent release of cysteine into the extracellular medium. Wade and 
Brady (1981) reported that they found no evidence for carrier-mediated uptake of 
plasma cystine in rat brain. 
Cystine entering the cell or released during protein catabolism is reduced by 
transhydrogenation with glutathione to cysteine. Cysteine is used for protein or 
glutathione synthesis, or catabolized by two distinct pathways. Both of these pathways 
generate pyruvate and sulphate, but only the cysteine sulphinate-dependent pathway, the 
major pathway for cysteine catabolism in mammals, can produce taurine (Griffith,1987). 
In the first step, cysteine dioxygenase catalyzes the formation of cysteine sulphinate, 
which then can be transaminated to β-sulfinylpyruvate ending in the production of 
pyruvate and sulphate. Alternatively, cysteine sulphinate can undergo decarboxylation 
via cysteine sulphinate decarboxylase to hypotaurine and finally oxidation to taurine 
(Bella and Stipanuk,1996). Partitioning between transamination and decarboxylation 
varies between mammalian species (Griffith,1987). The cysteine sulphinate-independent 
pathway involves γ-cystathionase and formation of pyruvate, ammonia and hydrogen 
sulphide from cysteine, or pyruvate, ammonia and S-mercaptocysteine from cystine. 
The S-mercaptocysteine is then reduced to cysteine and hydrogen sulphide. Cysteine is 
required for synthesis of pantetheine and enzyme CoA, which can be catabolyzed to 
cysteamine and further to hypotaurine and taurine. If intracellular cysteine accumulates 
above its normal 30-200µM concentration, it can react with the co-enzyme pyridoxal 
phosphate to produce a thiazolidine derivative, thus depleting pyridoxal phosphate. The 
multiple pathways of cysteine degradation may serve to prevent its toxic accumulation 
(Griffith,1987). 
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2.3.3 Cysteine delivery systems 
2.3.3.1  Cysteine 
A number of methods of increasing intracellular glutathione in conditions of 
oxidative stress have been investigated. Cysteine, the limiting amino acid in glutathione 
synthesis, can be administered, but it is toxic to neonatal rodents and cultured cells 
(Anderson and Luo,1998; Olney et al.,1971; Olney et al.,1972). Neonatal rats given a 
single intravenous dose of cysteine (1.52 or 1.14g/kg body weight) or OTC (1.8 or 
1.35g/kg body weight) had mortality rates of 80%, 50%, 10% and 0% respectively, 
demonstrating cysteine toxicity compared to OTC (White et al.,1993). Cysteine is 
rapidly oxidized to cystine which has limited solubility and poses physical 
administration problems (Anderson and Luo,1998).  
 
2.3.3.2  Glutathione 
Administration of glutathione has had limited success, since glutathione is 
generally not absorbed or transported intact, but is broken down to its constituents by γ-
glutamyl transpeptidases at the cell membrane. Administration of glutathione to rats 
increased plasma and urinary glutathione, but not tissue glutathione (Anderson and 
Luo,1998). Ozaki et al. (1994) starved rats overnight and gave an intraperitoneal dose of 
glutathione one hour before a one-hour hepatic ischemia epsiode. Glutathione had no 
effect on liver glutathione levels or lipid peroxidation. Gotoh and co-workers (1994) 
gave rats an intraperitoneal injection of glutathione after two and one-half hours of 
middle cerebral artery occlusion ischemia. They examined brain sodium, water and 
glutathione levels, and found no changes with glutathione administration compared to 
controls.  
 
2.3.3.3  N-acetylcysteine 
 N-acetylcysteine (NAC) is an effective intracellular cysteine delivery system.  
NAC is used clinically in acetaminophen overdose, as an antimucolytic agent, and more 
recently has been investigated in HIV infection. Oral NAC is absorbed, deacetylated and 
catabolyzed in the intestinal wall and liver, resulting in about 10% bioavailability (Bray 
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and Taylor,1994). NAC can also be given parenterally. Banks and Stipanuk (1994) 
cultured rat hepatocytes with [35S]NAC and found NAC was taken up by cells and 
converted to cysteine. Dringen and Hampbrecht (1999) cultured embryonal rat brain 
neurons with NAC and found increased intracellular glutathione, concluding neurons in 
culture contain acylase which can cleave NAC to cysteine for intracellular synthesis. 
However, NAC does not appear to cross the blood brain barrier (McLellan et al.,1995). 
Pretreatment of rats with intraperitoneal NAC before bilateral common carotid artery 
occlusion (BCCAO) increased hippocampal neuronal survival at seven days post-insult, 
but post-ischemic administration of NAC only partially improved neuronal survival in 
moderate insult (45mmHg hypotension during BCCAO) and offered no protection in 
severe insult (30mmHg) (Knuckey et al.,1995). High oral doses of NAC can cause 
nausea, vomiting and diarrhea, and intravenous doses can produce anaphylactic 
reactions such as angioedema, bronchospasm, flushing, and hypotension (Bray and 
Taylor,1994).  
 
2.3.3.4  L-2-oxothiazolidine-4-carboxylic acid 
2.3.3.4.1  In vitro studies 
 A thiazolidine analog of 5-oxoproline, OTC has been extensively studied as a 
cysteine precursor. OTC is transported into most cells and ring-opened by 5-
oxoprolinase to yield 5-carboxycysteine (rapidly decarboxylated to cysteine) and carbon 
dioxide, which is exhaled (Anderson and Luo,1998). All tissues except erythrocytes and 
the ocular lens contain 5-oxoprolinase (Bray and Taylor,1994), and incubation of 5-
oxoprolinase with OTC and ATP yields rapid formation of ADP and cysteine 
(Williamson and Meister,1981). Guinea pig liver and kidney homogenates incubated 
with OTC increased intracellular cysteine (Nishina et al.,1987).  Coloso et al. (1991) 
cultured each of [35S]OTC, [35S]methionine, and [35S]cysteine with rat hepatocytes, 
renal tubule cells, and enterocytes. All three compounds were metabolized to 
glutathione, inorganic sulphur and taurine by renal cells and enterocytes, although the 
transport and metabolic rate for OTC was slower than for the amino acids. Hepatocytes 
from weanling rats fed a protein-poor diet were incubated with OTC, methionine or 
cysteine. Glutathione levels depressed by the low protein diet (82% lower than controls) 
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were increased to normal levels in culture (Goss et al.,1994). Banks and Stipanuk (1994) 
incubated [35S]OTC, [35S]NAC, or [35S]cysteine with rat hepatocytes and measured 
intracellular sulphates, taurine and glutathione. OTC was transported into the cells, 
converted to cysteine, and glutathione was synthesized.  [35S]glutathione accounted for 
78% of OTC metabolism. Embryonal rat brain neurons cultured with OTC did not show 
increased glutathione levels (Dringen and Hamprecht,1999). 
 
2.3.3.4.2  Animal studies 
 Fasted mice given an intraperitoneal injection of OTC increased liver glutathione 
(Williamson and Meister,1981). Buthionine sulfoximine is a compound which 
irreversibly inhibits γ-glutamylcysteine synthetase (Pileblad and Magnusson,1992). 
Mice given intraperitoneal acetaminophen (to deplete glutathione) and then OTC had 
liver glutathione levels two and one-half times higher than controls, even when OTC 
was given two hours after acetaminophen. Subsequent administration of buthionine 
sulfoximine decreased liver glutathione, with no recovery after OTC addition, 
demonstrating OTC can be synthesized to glutathione (Williamson et al.,1982). Guinea 
pigs given intra-peritoneal OTC had increased liver and kidney glutathione and 
increased kidney cysteine levels compared to controls (Nishina et al.,1987). Both chicks 
and rats fed a cysteine-free diet with the addition of OTC had increased liver glutathione 
levels (Chung et al.,1990). Weanling PEM rats fed OTC and exposed to hyperoxia (85% 
oxygen) had increased glutathione levels in liver and lung, but not kidney and blood. 
These levels exceeded those in rats on a normal diet exposed to hyperoxia. Authors 
suggest oral OTC given to PEM rats is effective in protecting the lung against oxygen 
toxicity (Taylor et al.,1992). Jain et al. (1995) fed rats a sulphur amino acid-deficient 
diet supplemented with OTC for three weeks. Bronchoalveolar lavage fluid, liver, lung 
and lymphocyte glutathione levels increased over those of rats fed sulphur amino acid-
deficient diet alone. Rats supplemented with OTC gained more weight than sulphur 
amino acid-deficient rats (Jain et al.,1995). Weanling rats fed a protein deficient diet for 
fourteen days, then supplemented with OTC and exposed to hyperoxia (85% oxygen) or 
normoxia for four days showed decreased lung/body weight ratio (oxidative damage in 
lung increases the lung/body weight ratio) and increased lung glutathione compared to 
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protein deficient or protein sufficient rats (Levy et al.,1998). Elevation of lung 
glutathione via OTC was more effective than protein repletion in protecting against 
hyperoxia-induced lung damage in PEM rats. 
 Rats and mice given intraperitoneal [35S]OTC at various doses showed increased 
brain cysteine but little or no change in brain glutathione(Anderson and Meister,1989). 
OTC did appear to cross the blood brain barrier. Authors concluded the rate of transport 
of OTC to the brain is greater than the rate of conversion to cysteine, glutathione 
synthesis in the brain is slow, and cysteine concentration is not a factor in brain 
glutathione synthesis. In contrast, Mesina et al. (1989) gave rats subcutaneous injections 
of OTC and found brain glutathione to increase significantly over controls. 
Intraperitoneal administration of OTC to rats after a spinal cord crush injury decreased 
oxidative stress with a sparing of white matter at the site of injury, leading to partial 
return of function, while vehicle-treated animals remained paraplegic (Kamencic et 
al.,2001). 
 
2.3.3.4.3  Human studies 
 OTC has been studied in humans.  Porta (1991) and co-workers gave single oral 
doses of OTC to healthy volunteers and found increased plasma OTC and cysteine, no 
change in plasma glutathione, and increased lymphocyte glutathione and cysteine. OTC 
given twice weekly for six weeks to asymptomatic HIV positive volunteers increased 
whole blood glutathione (Kalayjian et al.,1994). In contrast, a single intravenous OTC 
infusion (4500mg) or multiple infusions (70 or 100mg/kg every eight hours for four 
doses) were given to fasting male volunteers. OTC increased total blood cysteine but not 
glutathione. OTC was 84% converted to cysteine in this study.  Small frequent doses 
were considered more efficient than a single large dose (Gwilt et al.,1998). Cudkowicz 
et al. (1999) gave a single intravenous OTC dose (4500mg) or oral OTC (3000mg three 
times a day for 29 days or [mean] 4.9 months) to volunteers with amyotrophic lateral 
sclerosis. Cerebrospinal fluid glutathione levels are not known to be depressed in 
amyotrophic lateral sclerosis, and there was no change after OTC administration. Both 
oral and intravenous OTC were well tolerated and OTC was found to enter 
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cerebrospinal fluid efficiently. Authors also noted cerebrospinal fluid glutathione level 
decreased with age. 
 
2.3.3.5  Esters and related compounds 
 There has been recent interest in a number of γ-glutamylcysteine esters and a 
glucose-cysteine adduct.  Anderson and Meister (1987) have reported administration of 
γ-glutamylcystine leads to increased renal glutathione. Gamma-glutamylcystine is 
transported intracellularly and hydrolyzed to γ-glutamylcysteine and cysteine, both of 
which can be synthesized to glutathione. Isolated rat hepatocytes pretreated with diethyl 
maleate (to deplete glutathione) and incubated with γ-glutamyl cysteine ester or 
glutathione (at two doses) demonstrated increased intracellular glutathione only with γ-
glutamyl cysteine ester (Nishida et al.,1996). 
Kobayashi et al. (1992) pretreated rats with γ-glutamylcysteine ethyl ester or 
glutathione before exposure to two hours of ischemia with or without one hour of 
reperfusion. Gamma-glutamylcysteine ethyl ester maintained liver glutathione and 
mitigated post-ischemic injury while glutathione had no effect. Rats starved overnight 
and then given an intraperitoneal injection of γ-glutamylcysteine ethyl ester, γ-
glutamylcysteine ethyl ester plus glycine, glycine or glutathione one hour before a one-
hour period of hepatic ischemia with reoxygenation showed decreased thiobarbituric 
acid reactive substances (TBARS), decreased lipid peroxidation and increased liver 
glutathione with γ-glutamylcysteine ethyl ester and γ-glutamylcysteine ethyl ester plus 
glycine (Ozaki et al.,1994). Hoshida and group (1994) exposed dogs to ninety minutes 
of coronary occlusion followed immediately by intravenous γ-glutamylcysteine ethyl 
ester (at two doses) and five hours of reperfusion. Infarct size was reduced and 
myocardial glutathione levels increased in dogs given γ-glutamylcysteine ethyl ester 
compared to controls.  
 YM737 (N-[N-r-L-glutamyl-L-cysteinyl]glycine 1-isopropyl ester sulphate 
monohydrate) was given as an intra-peritoneal injection zero, one, and two hours post-
ischemia in bilateral common carotid artery occluded rats, and inhibited lipid 
peroxidative responses in brain (Yamamoto et al.,1993). Gotoh et al. (1994) exposed 
rats to two and one-half hours of middle cerebral artery occlusion ischemia and gave 
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intraperitoneal YM737 or glutathione.  They found the post-ischemic brain increases in 
sodium and water were suppressed by YM737. There was amelioration of post-ischemic 
decrease in brain glutathione with YM737, but no change with glutathione. Yao et al. 
(1997) investigated the effect of a glucose-cysteine adduct, 2-(D-gluco-
pentahydroxypentyl)-thiazolidine-4-carboxylic acid, as an intraperitoneal injection in 
rats alone or after pre-treatment with diethyl maleate, on liver and kidney cysteine and 
glutathione. Liver and kidney cysteine increased and although there was no change in 
glutathione, depressed glutathione due to pre-treatment with diethyl maleate was 
restored. 
 
Summary 
 In summary, various methods of intracellular cysteine delivery have been 
investigated. Cysteine is considered toxic and difficult to administer.  Glutathione is 
broken down to its constituents before intracellular resynthesis. NAC is effective in 
increasing cysteine and glutathione in some tissues, but does not readily cross the blood 
brain barrier, and is associated with some adverse effects in humans. OTC is transported 
into many tissues, including brain, and its cysteine moiety can be used to synthesize 
glutathione. OTC moderately increases cellular glutathione in cultured cells, animal 
studies and human clinical trials. The γ-glutamylcysteine esters appear promising, and 
some glutathione mono and diesters have also been studied. 
 
2.4  ANIMAL MODELS OF STROKE 
 Although many different animal models of stroke have been developed, no 
single model has been able to successfully mimic the diverse etiologies and 
characteristics of human stroke. There are, however, advantages to animal models, in 
that physiological parameters can be strictly controlled, allowing for reproducible and 
systematic study of the mechanisms involved in ischemic damage (Ginsberg and 
Busto,1989). Ideally, an animal model would closely parallel human anatomy, 
physiology and function, suggesting the primate as most closely approximating the 
human condition.  Financial and animal welfare considerations render this and most 
large animal models all but impossible to study extensively. Rodents remain the most 
 40
accepted compromise for several reasons: cerebrovascular anatomy and physiology 
closely resemble that of higher species (Ginsberg and Busto,1989); they are small, easy 
to handle and relatively inexpensive to house, allowing for large numbers; their brain 
size is suitable for rapid fixation; intra-strain variability is relatively low (Ginsberg and 
Busto,1989; Seta et al.,1992). Disadvantages to the use of rodents include difficulty with 
physiological monitoring due to size constraints (blood gases, pressure, sampling, etc.); 
difficulty with neurological and functional assessments; respiratory, seizure and 
consciousness problems (Seta et al.,1992). The most commonly used models produce 
either focal or global ischemia. 
 
2.4.1 Focal ischemia 
 Embolism models generally do not require craniotomy, but lesions are 
unpredictable and permanent. They include such methods as homologous blood clot 
fragment injection, microsphere injection, arachidonate-induced thrombosis and 
photochemically initiated thromboembolism (Ginsberg and Busto,1989). Middle 
cerebral artery occlusion is focal, reversible, and highly mimics human ischemic stroke 
(Seta et al.,1992). The lesion presents with an ischemic core and a penumbric region, 
allowing for intervention strategies. The contralateral hemisphere conveniently provides 
an internal ‘control’. Surgical procedures, however, are invasive and traumatic, 
requiring skill and specialized equipment. Several techniques have been developed to 
produce middle cerebral artery occlusion, ranging from ligation of the artery to laser 
illumination after rose bengal injection to insertion of a microfilament of defined size 
(Seta et al.,1992). Ginsberg and Busto (1989) provide a comprehensive description of 
many methods. Cerebral hemorrhages and infarcts occur spontaneously in ~80% of 
males in the stroke-prone spontaneously hypertensive rat (SHRSP) strain (Okamoto et 
al.,1974). This rat strain has been extensively investigated and brain damage 
characterized in both spontaneous ‘strokes’ (Okamoto et al.,1974; Sadoshima et 
al.,1981; Yamasaki et al.,1991) and induced ischemia of various types (Brint et 
al.,1988; Carswell et al.,1999; Coyle,1984; Duverger and MacKenzie,1988; Gemba et 
al.,1992; Nordborg and Johansson,1996; Sadoshima et al.,1988; Shima et al.,1994; 
Slivka et al.,1995; Tagami et al.,1999; Watanabe et al.,1998).   
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2.4.2 Global ischemia 
 Induction of global cerebral ischemia in rodents involves mainly either two or 
four vessel occlusion. Since rats have an intact circle of Willis (posterior communicating 
arteries) in the brain, the four-vessel occlusion model was developed to produce 
forebrain ischemia. This involves occlusion, often by coagulation, of the vertebral 
arteries in a first procedure, followed about twenty-four hours later by isolation and 
transient occlusion of the common carotid arteries (Pulsinelli and Buchan,1988). This 
procedure induces a high-grade incomplete forebrain ischemia, but requires considerable 
expertise to avoid death from brainstem ischemia and post-ischemic seizures after the 
first stage (Ginsberg and Busto,1989). 
The two-vessel common carotid artery occlusion produces reversible forebrain 
ischemia similar in histopathology to the four-vessel occlusion.  In the rat and other 
animals with an intact circle of Willis, the procedure is combined with systemic 
hypotension to reduce forebrain blood flow. A similar model, of global hemispheric 
hypoxia-ischemia (GHHI), developed by Yager and group (Yager et al.,1996; Yager and 
Thornhill,1997), is a modification of the Levine preparation (Levine,1960). The right 
common carotid artery is exposed, ligated and severed, and the animal is subjected to a 
35-minute period of hypoxia (12% oxygen). Body temperature is controlled throughout.  
The advantages of this model are several: its size makes physiological monitoring 
possible, the surgical procedure is relatively minor and not subject to a hypermetabolic 
response, the model has been well-characterized, and the hemispheric nature of damage 
allows internal comparison with the contralateral side of the brain. However, this stroke 
model subjects the entire brain to a period of hypoxia, and ischemia is achieved by 
ligation and severing of the carotid artery. Thus reperfusion is somewhat compromised 
in this model. Results are variable, partially due to lack of control of blood glucose and 
head/brain temperature, both of which can contribute to variability (Dijk et al.,1994; 
Ginsberg and Busto,1989; Mhairi Macrae,1992). 
The Mongolian gerbil is unique in that it lacks a circle of Willis (Seta et 
al.,1992), thus avoiding the necessity of subjecting the animal to global hypoxia, 
hypotension or four-vessel occlusion to achieve mimicking of human stroke (Ginsberg 
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and Busto,1989). Bilateral transient occlusion of the common carotid arteries results in 
reproducible, consistent and well-characterized forebrain ischemic damage (Corbett and 
Crooks,1997; Corbett and Nurse,1998; Corbett et al.,1997; Nurse and Corbett,1994). 
Ischemia is of more abrupt onset and reversal than in the rat GHHI model. Surgical 
procedures are minor, as in the rat model, but due to the small size of the gerbil, 
physiological monitoring is usually limited to body and head/brain temperature. 
Functional and histological endpoints for this model have been published (Colbourne 
and Corbett,1994; Colbourne and Corbett,1995; Corbett and Nurse,1998; Ginsberg and 
Busto,1989). As well, oxidative stress has been demonstrated in susceptible brain 
regions by this model of ischemia (Baek et al.,2000; Candelario-Jalil et al.,2001; Park et 
al.,2000; Stanimirovic et al.,1988). Unilateral common carotid artery occlusion has also 
been used (Ginsberg and Busto,1989). The hippocampus is selectively vulnerable in 
models of transient ischemia (Akai and Yanagihara,1993; Nunn and Hodges,1994; 
Pulsinelli et al.,1982a; Schmidt-Kastner and Freund,1991). Temporary bilateral 
common carotid artery occlusion (TBCAO) in the gerbil produces delayed neuronal 
death mainly in the CA1 region of the hippocampus (Domanska-Janik et al.,1999; 
Kirino,1982; Kirino and Sano,1984; Kirino et al.,1986; Mitani et al.,1991), similar to 
vulnerability of human hippocampus to ischemia (Petito et al.,1987; Zola-Morgan et 
al.,1986).  
 
2.4.3 Evaluation of deficit after ischemia 
 Evaluation of the effects and impact of ischemia in laboratory animals has 
traditionally been confined to histological examinations such as quantifying damage via 
cell counts, assessing infarct size etc., and biochemical, immunocytochemical and 
Southern/Northern/Western blot methods to elucidate pathways and regulatory 
mechanisms. All of these are valuable in characterizing the damage wreaked by 
ischemia in the various animal models, but animals subjected to ischemia show learning 
and locomotor function deficits (Colbourne and Corbett,1995; Wang and Corbett,1990). 
Morphological damage does not necessarily correlate with functional outcome (DeVries 
et al.,2001). Neurons may have a normal or near-normal histological appearance but 
compromised function (Colbourne and Corbett,1994; Colbourne and Corbett,1995; 
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Colbourne et al.,1999; Corbett and Nurse,1998; Dong et al.,2001). Recently, researchers 
have been characterizing the electrophysiological properties of neurons, particularly the 
vulnerable CA1 neurons of the hippocampus, in an effort to better understand the 
functional state of neurons before, during and after ischemia, both in short-term and 
long-term survival (Dong et al.,2001; Hori and Carpenter,1994; Nurse and 
Corbett,1994; Shinno et al.,1997; Urban et al.,1989; Xu and Pulsinelli,1994). 
Ischemia in humans can result in profound impairments in memory, 
sensorimotor and cognitive function (DeVries et al.,2001; Petito et al.,1987; Zola-
Morgan et al.,1986). In Saskatchewan, 30% of stroke victims suffer permanent 
disability (Juurlink,1999). In the United States, stroke is the most common cause of 
permanent sensorimotor and cognitive disability (DeVries et al.,2001). Ultimately, it is 
brain function after stroke that is the most clinically significant outcome, and 
behavioural assessment of learning, memory and locomotor skills in animal ischemia 
models is essential to understanding implications of deficits. Many neurobehavioural 
tests have been developed, some of which are as follows: (1) tactile stimulation test, to 
measure recovery from lesion-induced somatosensory deficits (DeVries et al.,2001); (2) 
rotarod task, to assess fine motor and postural control (Hogg et al.,1998); (3) the 
elevated plus maze, to measure anxiety and motivation (Hogg et al.,1998); (4) the open 
field, to measure ability to habituate to a novel environment and possibly spatial 
mapping (Wang and Corbett,1990). The open field apparatus is simply a white box 
approximately 75cm square, with high walls. The animal is placed in one corner of the 
apparatus and activity recorded for ten minutes. An intact animal will typically 
investigate the entire apparatus, then decrease activity over the ten-minute period, or 
habituate, and on repeated exposure habituate more quickly. An animal that has suffered 
ischemia will tend not to habituate, or habituate more slowly, even with repeated 
exposure (Dowden and Corbett,1999; Dowden et al.,1999). There is some evidence the 
degree of CA1 neural loss is correlated with the inability to habituate, making this test a 
good indicator of ischemic damage to the hippocampus (Babcock et al.,1993; Mileson 
and Schwartz,1991; Wang and Corbett,1990). It is easy to perform, requires minimal 
equipment, and is non-invasive. 
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2.5  NUTRITIONAL REQUIREMENTS OF THE MONGOLIAN GERBIL  
The advantages of using the gerbil as an animal model of transient bilateral 
common carotid artery occlusion have been discussed, but little is known of the 
nutritional requirements of the gerbil, and the requirement for protein is not well 
established. The Mongolian gerbil (Meriones unguiculatus) is a desert rodent, used in 
research since 1893 (Cheal,1986). The gerbil is herbivorous in its wild habitat, 
consuming little water, eating leaves in summer and seeds in winter. Leaves and seeds 
have approximate protein contents of 2% and 11% wet weight respectively (Edwards et 
al.,1983).  The relatively low protein content of the natural diet can be an advantage in 
the desert environment when water supply is minimal, since the gerbil will not have to 
dispose of excessive amounts of urea, a process which requires water for osmotic 
reasons (Edwards et al.,1983). Laboratory gerbils, however, grow well on laboratory 
rodent chow, which is about 16-24% protein (water content usually less than 10%) 
(Arrington et al.,1973; Edwards et al.,1983). When protein content of a diet is higher 
than that of laboratory chow, gerbil intake will decrease and growth declines (Arrington 
et al.,1973). As well, consumption of purified diet tends to be low for the first two to 
three days, then increases to that of laboratory chow with satisfactory catch-up growth 
(Arrington et al.,1973).   
 The metabolic pathways for methionine, cyst(e)ine, choline are interdependent. 
While the S-adenosylmethionine pathway can fulfill the requirement for cyst(e)ine and 
choline in most laboratory animals, gerbils appear to have a requirement for choline 
(Otken and Yolanda,1983). When choline is absent from the diet, liver lipid increases 
(Otken,1984). When the dietary choline is adequate, but methionine is deficient, 
methionine deficiency develops very slowly in the gerbil, in contrast to the rat, 
suggesting gerbil sulphur amino acid metabolism may differ from that of the rat (Otken 
and Yolanda,1983). In the absence of cystine and choline, no amount of methionine 
supports good growth in the gerbil (Otken and Yolanda,1983), although methionine 
metabolism should provide some cysteine. Cereal grains have more cystine than 
methionine, in roots and nuts the proportion is about equal, and in meat methionine is 
greater than cystine (Otken,1984). Otken suggests the gerbil may have adapted to a diet 
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high in cystine. The gerbil also appears to have a requirement for taurine in the diet 
(Otken et al.,1985).  
 
2.6 HUMAN PROTEIN REQUIREMENT: DIETARY REFERENCE INTAKES 
2.6.1 Background 
Protein is a critical structural and functional component of all cells, comprising 
enzymes, hormones, transport molecules, intracellular matrices, collagen, keratin, 
portions of membranes, hair, and fingernails (Institute of Medicine of the National 
Academies,2002b). Mammalian proteins are macromolecules made up of long chains of 
α-amino acids and the α-imino acid proline. The amino acids are also precursors to 
nucleic acids, hormones, coenzymes and other physiologically important molecules such 
as glutathione, for example. The physical structure of proteins is complex: the primary 
structure is determined by the sequence of amino acids in the chain; the secondary 
structure, coiling and pleating, is due to hydrogen bonding between side chain residues; 
disulphide bonding and hydrophobic interactions between non-polar side chains are 
responsible for the tertiary structure that results in folding of helices on each other; and 
finally quaternary structure involves interaction of more than one protein molecule 
(subunit) with another, forming complex units with specific structures and functions 
(Institute of Medicine of the National Academies,2002b).  
Dietary protein is essential as a supply of amino acids. The following amino 
acids are considered indispensable, meaning they either cannot be synthesized in the 
body, or cannot be synthesized in sufficient quantities to meet metabolic needs, and 
must be supplied in the diet: histidine, leucine, isoleucine, lysine, methionine, 
phenylalanine, threonine, tryptophan and valine (Laidlaw and Kopple,1987). Some 
amino acids are conditionally indispensable, meaning a dietary source is required when 
endogenous production does not meet metabolic needs, such as in some physiological 
conditions or disease states; these are arginine, cysteine, glutamine, glycine, proline and 
tyrosine (Laidlaw and Kopple,1987). Finally, alanine, aspartic acid, asparagine, 
glutamic acid, serine and selenocysteine (Leinfelder et al.,1999) are dispensable amino 
acids, and can be synthesized in the body from other amino acids or complex 
nitrogenous metabolites (Laidlaw and Kopple,1987). 
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2.6.2 Protein digestion and absorption: a brief overview 
Dietary protein is denatured by stomach acid and cleaved into peptide fragments 
by pepsin, which is activated by the decrease in stomach pH upon feeding. The pancreas 
releases proteolytic enzymes such as trypsin, chymoptrypsin, elastase and 
carboxypeptidases into the small intestine, where peptides are hydrolyzed to smaller 
peptides and free amino acids. By various mechanisms, these small peptides and free 
amino acids enter intestinal mucosal cells and are subjected to further hydrolysis, 
whereupon free amino acids are either metabolized directly within the gut or released 
into the portal blood and transported to the liver. Some of these amino acids may be 
used within the liver, or secreted into the systemic circulation for use in peripheral 
tissues (Institute of Medicine of the National Academies,2002b). 
 
2.6.3 Body protein and obligatory losses 
Approximately half of body protein reserve is as skeletal muscle, about 15% 
each as skin and blood, and the remainder as liver, kidney, brain, lung, heart and body 
(Lentner, 1981). There exists in the body a small ‘labile protein reserve’, believed to be 
mainly in the liver and visceral tissues, which can be gained or lost as a short-term store 
to temper day-to-day variations in protein intake (Swick and Benevenga,1977). Body 
protein is continuously turned over, and determination of maintenance needs must take 
into account recycling of amino acids as well as obligatory losses of nitrogen. 
Protein secretion into the intestinal lumen, primarily from sloughed mucosal cells 
and proteolytic enzymes, occurs even in the absence of dietary protein intake. Fecal 
nitrogen losses (as bacteria in the feces) account for approximately 25% of obligatory 
nitrogen loss, and intestinal loss of amino acids is significant to maintenance protein 
needs (Fuller and Reeds,1998; Taverner et al.,1981). Other losses of intact amino acids 
occur in urine, sweat, hair and skin, all of which may be significant, especially when 
estimating protein requirements in disease states (Matthews,1999).  
 
2.6.4 Protein synthesis, degradation and turnover 
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The sequence of nucleotides on messenger RNA synthesized in the nucleus from 
DNA via transcription determines the sequence of individual amino acids in a protein. 
Transfer RNA in the cytoplasm binds each amino acid to the messenger RNA in a 
process known as translation, which is regulated by hormones and amino acids such as 
leucine.  In the steady state, although there is no net growth or loss of protein, protein 
synthesis is in balance with protein degradation. In conditions of inadequate protein 
intake, or imbalance of amino acid intake, the balance shifts such that the rate of some 
protein synthesis decreases, while protein degradation proceeds to effect an endogenous 
source of those amino acids most in need. 
Intracellular protein degradation occurs via two systems, lysosomal and 
proteasomal. The lysosomal system consists of membrane-enclosed, proteolytic 
enzyme-containing intracellular vesicles which engulf portions of cytoplasm and 
degrade proteins, usually unselectively (Cuervo and Dice,1998). Regulation of the 
lysosomes requires an acidic pH and insulin or glucocorticoids (Inubushi et al.,1996). 
The proteasomal system is ATP-dependent (Goldberg and Rock,1992). A molecule of 
ubiquitin ‘targets’ a specific protein for degradation by binding to its lysine residues. 
The proteasome is a protein complex which recognizes the targeted protein and degrades 
it. This process is selective and usually involves abnormal, damaged or regulatory 
proteins in the cell. 
Approximately 250g of protein are turned over daily in the adult male body, 
although daily intake is in the range of 55-100g (Waterlow,1984). Tissues differ in their 
protein turnover rate, such that liver and intestine account for almost 50% of the total 
(McNurlan and Garlick,1980; Waterlow,1984 ). Skeletal muscle, on the other hand, 
accounts for about 43% of body protein, but only 25% of protein turnover (Reeds and 
Garlick,1984; Waterlow,1984). Turnover is generally greater in infants and lower in the 
elderly. 
 
2.6.5 Dietary Reference Intakes for protein 
The Dietary Reference Intakes (DRIs) have defined adequacy of requirement as the 
lowest daily intake value for a nutrient that will meet the need for apparently healthy 
individuals (Institute of Medicine of the National Academies,2002b). The DRIs consist 
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of  the Recommended Dietary Allowance , Adequate Intake, Tolerable Upper Intake 
Level, and Estimated Average Requirement, defined as follows (Institute of Medicine of 
the National Academies,2002a): 
 
Recommended Dietary Allowance (RDA): the average daily dietary 
nutrient intake level sufficient to meet the nutrient requirement of 
nearly all (97-98 percent) healthy individuals in a particular life 
stage and gender group. 
Adequate Intake (AI): the recommended average daily intake level 
based on observed or experimentally determined approximations 
or estimates of nutrient intake by a group (or groups) of 
apparently healthy people that are assumed to be adequate- used 
when an RDA cannot be determined. 
Tolerable Upper Intake Level (UL): the highest average daily 
nutrient intake level that is likely to pose no risk of adverse health 
effects to almost all individuals in the general population. As 
intake increases above the UL, the potential risk of adverse effects 
may occur. 
Estimated Average Requirement (EAR): the average daily nutrient 
intake level estimated to meet the requirement of half the healthy 
individuals in a particular life stage and gender group.a 
 
 a In the case of energy, an Estimated Energy Requirement (EER) 
is provided; it is the average dietary energy intake that is 
predicted to maintain energy balance in a healthy adult of a 
defined age, gender, weight, height and level of physical activity, 
consistent with good health. In children and pregnant and 
lactating women, the EER is taken to include the needs associated 
with the deposition of tissues or the secretion of milk at rates 
consistent with good health. 
 
  
While protein is essential for proper function, diet must also be adequate in non-
protein components so that amino acids are not used for energy. Further, ingested amino 
acids must be in the correct balance so that utilization is maximized. To determine the 
DRIs for protein, the committees examined both factorial and nitrogen balance methods 
to estimate requirements, and in adults, conclusions were heavily drawn from a large 
meta-analysis by Rand et al. (2003). Conflicting reports of energy requirements of the 
elderly being greater (Roberts,1996) or less (Zanni et al.,1979) than younger adults were 
resolved by Rand’s analysis, which concluded there was no significant effect of age on 
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the protein requirement of older adults, recognizing that lean body mass as percent of 
body weight, and protein content of the body decrease with age. A summary of 
recommended protein intakes for all age groups is presented in Table 2.1 (Institute of 
Medicine of the National Academies,2002b). 
 
2.7 PROTEIN-ENERGY MALNUTRITION (PEM) 
2.7.1 Characteristics of PEM 
Undernutrition is defined as a disorder of nutritional status resulting from reduced 
nutrient intake, impaired metabolism, increased metabolic demands, or increased 
nutrient losses (Corish and Kennedy,2000). Undernutrition can cause alterations in 
 
 
 
Table 2.1. Dietary Reference Intakes for Protein* 
AI EAR RDA Age Gender 
 g/kg/day  
0-6 months M/F 1.52   
7-12 months M/F  1.1 1.5 
1-3 years M/F  0.88 1.1 
4-8 years M/F  0.76 0.95 
9-13 years M/F  0.76 0.95 
14-18 years M  0.73 0.85 
14-18 years F  0.71 0.85 
19-30 years M/F  0.66 0.8 
31-50 years M/F  0.66 0.8 
51-70 years M/F  0.66 0.8 
>70 years M/F  0.66 0.8 
Pregnancy F  0.88 1.1 
Lactation F  1.05 1.1 
*Institute of Medicine of the National Academies,2002b 
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structure and function of the gastrointestinal system leading to atrophy and impairment 
of epithelial integrity. Deterioration occurs in three stages: (1) availability of nutrients 
becomes inadequate due to poor diet, increased requirement, decreased utilization, or 
excessive loss, (2) nutrient stores become depleted and there is impairment of 
physiological and/or biochemical processes, (3) severe nutrient deficiency leads to 
cellular or tissue deterioration (Corish and Kennedy,2000). The consequences of 
undernutrition can include increased risk of respiratory and cardiac problems, immune 
dysfunction, infection, deep vein thromboses, pressure ulcers, peri-operative mortality, 
and multi-organ failure (Omran and Morley,2000). The prevalence of intake of too few 
macronutrients is estimated at 1-15% of the ambulatory population, 25-60% of 
institutionalized patients, and 35-65% of hospitalized patients (Omran and 
Morley,2000).  
PEM is characterized by muscle wasting and loss of subcutaneous tissue. In 
severe PEM, or kwashiorkor, particularly pediatric, serum albumin is decreased, skin 
and hair suffer dyspigmentation, sodium and water are retained resulting in edema, and 
the liver becomes fatty (Corish and Kennedy,2000; Rana et al.,1996; Swails et al.,1996; 
Waterlow,1975). In kwashiorkor, energy intake may be somewhat sufficient, but protein 
content is minimal. It has been suggested, but not proven, that the fatty liver results from 
a diet providing a relative excess of carbohydrate compared to protein (Waterlow,1975). 
Fatty liver cis believed to result from one of two main mechanisms: (1) factors leading 
to an increase in triglyceride synthesis beyond the capacity for their removal, or (2) 
factors blocking utilization of liver triglycerides which are normally excreted into 
plasma (Flores et al.,1970). It is thought the fatty liver in kwashiorkor is due to 
decreased ability for synthesis of the apolipoprotein required for low density lipoprotein 
transport of triglycerides out of the liver (Flores et al.,1970; Truswell et al.,1969; 
Waterlow,1975). Serum lipids, particularly triglycerides and β-lipoprotein cholesterol, 
are often decreased in kwashiorkor (Flores et al.,1970; Truswell et al.,1969). With 
recovery, serum lipids increase and liver fat decreases. Erythrocyte glutathione can be 
decreased in kwashiorkor (Golden and Ramdath,1987). Rana et al. (1996) fed rats a low 
protein (5%) or adequate protein (20%) diet for four weeks. They included a 20% 
protein group pair-fed to the intake of the 5% protein group, since appetite was 
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decreased by 65% of control in the 5% protein group. They found fatty liver and low 
blood glutathione in the 5% protein and 20% protein pair-fed groups.   
In marasmus, there is general insufficient energy intake with muscle wasting and 
loss of subcutaneous fat, but edema, hypoalbuminemia, or fatty liver are not seen 
(Corish and Kennedy,2000; Golden and Ramdath,1987).  Erythrocyte glutathione is 
normal in marasmus (Golden and Ramdath,1987). A combination of both conditions, 
marasmic kwashiorkor, characterized by wasting of muscle and fat with 
hypoalbuminemia, is most often seen in hospitalized patients (Corish and 
Kennedy,2000). 
Protein synthesis is necessarily decreased in PEM, for preservation of essential 
protein-dependant functions (Torun and Chew, 1999). In early PEM, there is some loss 
of visceral protein, but loss is primarily from skeletal muscle as the condition 
progresses, until nonessential tissue proteins are depleted, at which point further 
depletion of visceral protein may signal imminent death. When dietary protein is 
reduced, recycling of the free amino acid pool (from diet and body tissues) increases, 
while amino acid catabolism decreases compared to normal conditions. Albumin 
synthesis initially decreases, and within days its half-life increases. There is a shift of 
albumin from the extravascular pool into the blood. With severe protein depletion, 
however, albumin and other serum proteins decrease, reducing intravascular oncotic 
pressure, resulting in extravasation of water and edema, as is typical of advanced 
kwashiorkor.  
Hormonal changes and altered cellular responses to hormones occur in PEM in 
order to maintain energy homeostasis via increased glycolysis and lipolysis, 
mobilization of amino acids, preferential breakdown of skeletal muscle for preservation 
of visceral protein, decreased glycogen, fat and protein storage, and reduced energy 
metabolism (Torun and Chew, 1999). More specifically, there is reduced insulin 
secretion, tissue insulin sensitivity, somatomedin activity, and active thyroid hormone 
levels and higher glucagon secretion, epinephrine release, glucocorticoid production, 
and growth hormone levels (favouring amino acid recycling). 
Reduction of lean body mass in PEM and lowered physical activity level 
contribute to decreased oxygen consumption and need for hematopoiesis, further 
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conserving amino acids for more essential protein synthesis. Other body functions, 
however, are not as well-adapted. There can be reduced cardiac output and peripheral 
blood flow, immune system defects with depression of T lymphocytes and complement 
components, alterations in monokine response (mediators of response to injury), 
electrolyte imbalances, impaired gastrointestinal function, and compromised brain and 
central nervous system function.  
 
2.7.2 Assessment of PEM 
Nutritional status may be assessed by anthropometric measurements such as 
weight for height (current status) and height/length for age (past history); body mass 
index (Quetelet’s index) for adolescents and adults; triceps skin fold; mid-arm 
circumference; and upper-arm muscle circumference (Axelsson et al.,1988; Newmark et 
al.,1981; Torun and Chew,1999). Urinary creatinine excretion can be used to estimate 
body muscle mass. Serum protein concentrations may provide a useful estimation of 
protein status, but caution must be exercised in interpreting results. Serum albumin, as 
discussed above, may or may not be depressed in PEM, and with a half-life of eighteen 
to twenty days, may not provide information on more recent status. As well, albumin 
synthesis rate, distribution, and turnover rate can be altered by PEM (Benjamin,1989). 
Serum proteins with shorter half-lives, such as transferrin (T1/2 8-9 days), prealbumin 
(transthyretin, T1/2 2-3 days), retinol-binding protein (T1/2 12 hours), and somatomedin C 
(insulin-like growth factor-1, T1/2 2-6 hours) may be more sensitive indicators of recent 
status (Benjamin,1989). Tests of immunocompetence using injection of antigen to 
determine delayed cutaneous hypersensitivity can also be indicators of PEM (Newmark 
et al.,1981). Of course, diet histories, if obtainable, can also yield useful information. 
The Mini Nutritional Assessment has been developed as a quick, convenient tool for 
rapid assessment of the elderly in hospitalized settings (Guigoz et al.,1996; Vellas et 
al.,1999). No single parameter is sufficient to evaluate nutritional status, and depending 
on clinical situation, appropriate combinations of available tools need to be employed. 
  
2.8 STROKE AND PROTEIN-ENERGY STATUS 
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There has been a decrease in cerebrovascular disease mortality in Japan since 
1970, and increased per capita consumption of protein, especially animal protein (beef, 
eggs, dairy products) (Kodama,1993; Omura et al.,1987). The Honolulu Heart Program 
showed an inverse association between protein intake and stroke incidence, and a 
sixteen year follow-up showed consumption of animal protein was inversely associated 
with the incidence of thromboembolic stroke, independent of other risk factors (Kagan 
et al.,1985; Lee et al.,1988). There is a paradox of high risk of stroke in populations 
with a low risk of cardiovascular disease (Reed,1990). This is attributed to a diet low in 
animal sources. Animal studies with SHRSP rats have mimicked human epidemiology 
(Sarwar et al.,1999; Yamori et al.,1984). SHRSP rats fed a Japanese diet (15% protein) 
had higher incidence of stroke than those fed an American diet (22% protein), despite no 
differences in blood pressure. The American diet contained more methionine and lysine 
than the Japanese, suggesting more animal protein in this formulation.  
Of more relevance to this thesis are those studies that investigated the effect of 
PEM on stroke outcome. Although two studies did not find a relationship between 
protein intake and stroke mortality (Khaw and Barrett-Connor,1987; Lapidus et 
al.,1986), Klag and Whelton (1993) suggest the discrepancy with other studies could be 
due to the overall higher level and narrower range of protein intake in these two groups. 
The elderly are a group at high risk for stroke (Gariballa and Sinclair,1998), and many 
elderly have compromised nutritional status due to a variety of factors such as anorexia, 
poor dental status, drug therapy, decreased activity levels, and chronic diseases (Abbasi 
and Rudman,1994; Lipschitz,1991; Marcus and Berry,1998). Several studies have 
reported evidence of compromised protein/energy status at the time of admission to 
hospital for stroke and deterioration of this status during the hospital stay (Axelsson et 
al.,1988; Choi-Kwon et al.,1998; Davalos et al.,1996; FOOD Trial Collaboration,2003; 
Gariballa et al.,1998b; Gariballa et al.,1998a). Data from the National Health and 
Nutrition Examination Study I (NHANES I) suggest low serum albumin is a risk factor 
for stroke (Gillum et al.,1994). Although serum albumin is not necessarily the best 
indicator of protein status, low serum albumin has been associated with increased length 
of stay, complications, and death in medical, surgical and stroke patients, and is 
considered an indicator of poor outcome (Aptaker et al.,1994; Axelsson et al.,1988; 
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Choi-Kwon et al.,1998; Davalos et al.,1996; Finestone et al.,1996; Gariballa et 
al.,1998b; Gariballa et al.,1998a; Gariballa and Sinclair,1998). Finestone and co-
workers studied Canadian stroke patients at the time of admission to rehabilitation units, 
and reported PEM in 49% of admissions, with dysphagia in 47%. Authors suggested 
there was inadequate nutritional intervention immediately post-injury which could 
compromise antioxidant defense mechanisms (Finestone et al.,1995; Finestone et 
al.,1996).  Nyswonger et al. (1992) determined the length of time to start of feeding 
after stroke varies, and stroke patients fed within seventy-two hours of injury have a 
shorter hospital stay.  
Compromised nutritional status resulting in low protein status, particularly in the 
elderly, may be an important risk factor for stroke and for poorer outcome after stroke.  
Feeding after a stroke is often delayed, further exacerbating pre-existing poor nutritional 
status. There may be a ‘window of opportunity’ for optimizing survival and recovery 
from stroke with adequate nutritional support, especially with respect to increasing 
glutathione status.
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CHAPTER 3 
 
OVERVIEW OF EXPERIMENTAL PROGRESSION OF THESIS 
 
This thesis was investigated in two phases. Since glutathione is critical in 
antioxidant defense, and the sulphur amino acid cysteine, supplied primarily by dietary 
protein, is limiting at the cellular level for glutathione synthesis, we wanted first to 
explore one mechanism by which a dietary protein deficiency might limit antioxidant 
defense under the increased demands of oxidative stress in cerebral ischemia. In 
Experiment 1 of Phase 1, described in Chapter 5, a rat model of GHHI was used to 
examine the effect of an acute dietary sulphur amino acid deficiency on glutathione 
status and neural damage. In this model, the right common carotid artery was ligated, 
followed by a period of hypoxia, resulting in unilateral damage, providing an internal 
control with the contralateral (unaffected) hemisphere. The rat GHHI stroke model was 
well-established at the University of Saskatchewan (Yager et al.,1996). Our focus was 
on removing the dietary supply of the limiting glutathione precursor, cysteine. A rat 
dietary sulphur amino acid deficiency model had been previously established in our 
laboratory (Paterson et al.,2001). Neural damage was assessed in neocortex, 
hippocampus, striatum and thalamus, brain regions vulnerable to damage in this stroke 
model, and previously shown to be sensitive to dietary sulphur amino acid deficiency. 
We initially used a previously published semi-quantitative system of neural damage 
assessment, but as a more sensitive system of detecting damage was desirable, our 
laboratory also designed a more quantitative scoring system. This system, called the 
hippocampal grid score, became the preferred assessment tool. Rat brain sections, 
stained with hematoxylin and eosin (H&E), were evaluated with both systems, and 
results obtained with the two methods were well-correlated. Sections adjacent to those 
used for H&E were stained with antibody against microtubule-associated protein 2 
(MAP-2), the absence of which is an early indicator of neural damage (Kitagawa et
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 al.,1989; Matesic and Lin,1994). Although not quantified, areas of MAP-2 deficit 
correlated visually with areas of H&E-evaluated damage. This experiment demonstrated 
that neural damage in GHHI was exacerbated by an acute dietary sulphur amino acid 
deficiency. 
 To determine if the increased neural damage in sulphur amino acid deficient rats 
exposed to GHHI was due to glutathione depletion, glutathione concentration was 
determined in neocortex, hippocampus, striatum and thalamus at six and seventy-two 
hours after GHHI (for assay procedure, see Appendix A). Glutathione concentration was 
unchanged at six hours. At seventy-two hours after GHHI, glutathione concentration in 
the ipsilateral hemisphere was decreased in neocortex and striatum, with a trend towards 
significance in hippocampus. Glutathione concentration, however, was not different 
between neocortex taken from the two hemispheres at seventy-two hours, suggesting 
diet, but not GHHI, decreased glutathione in susceptible regions. These results were in 
agreement with those obtained previously in our laboratory in sulphur amino acid 
deficient rats not exposed to GHHI (Paterson et al.,2001).   
Given the hypothesis that a sulphur amino acid deficiency combined with an 
hypoxic-ischemic insult would deplete glutathione in specific brain regions, the effect of 
a cysteine precursor, OTC, was also tested, using the experimental conditions of 
Experiment 1, repeated in a two by two factorial design. Rats were fed an adequate or 
sulphur amino acid deficient diet, and given injections of OTC or saline immediately 
after GHHI, and every twelve hours for six additional doses. At seven days post-GHHI, 
brains were collected, sectioned and stained with H&E as in the first experiment. 
Assessment of neural damage was with the two scoring systems used previously. OTC 
did not have any effect on neural damage. The results of this experiment in rats fed a 
sulphur amino acid deficient diet were published in (Bobyn et al.,2002) and are 
discussed in Chapter 5. Appendix B describes results obtained in rats fed a sulphur 
amino acid sufficient diet. It was intended that this experiment be repeated with 
collection of tissue for glutathione concentration, but this was not pursued further due to 
the negative findings described in the paragraph above and the identification of a 
histological artifact, discussed below. 
 57
During H&E slide assessment, it became clear that damage appeared in regions 
not theoretically sensitive to GHHI, and in some cases there was more damage in the 
hemisphere contralateral to the occlusion. We were later able to attribute this 
phenomenon to the existence of ‘dark’ neuron, an artifact of post-mortem handling of 
tissue before complete fixation (Cammermeyer,1962). Chapter 4 of this thesis describes 
this artifact. All slides in Experiments 1 and 2 were re-evaluated, and although 
differences between groups remained relatively unchanged, overall damage in this 
GHHI model was concluded to be very mild and virtually non-existent in rats fed the 
control diet. The pattern of brain damage, however, was now consistent with what had 
been expected. At this point, it was also concluded that the GHHI model was not 
suitable for further investigations, since: 1) severing of the carotid artery precluded true 
reperfusion and thus perhaps generation of oxidative stress, 2) the level of hypoxia was 
mild and did not generate much neural damage, and 3) the damage was extremely 
variable.  
The experiments of Phase 1 investigated the effect of an acute dietary sulphur 
amino acid deficiency on outcome in global ischemia, recognizing the unlikelihood of 
humans suffering this selective deficiency. Part of the rationale for this thesis was based 
on evidence that approximately 16% of the elderly admitted to hospital for stroke suffer 
from PEM, and that this condition deteriorates during the course of hospital stay 
(Gariballa et al.,1998b; Gariballa et al.,1998a; Gariballa and Sinclair,1998). Elderly 
stroke victims who are malnourished have a longer hospital stay and worse outcome 
than well-nourished patients, such that almost half of those admitted to long-term care 
facilities after stroke have PEM (Finestone et al.,1995; Finestone et al.,1996). For these 
reasons, combined with mechanistic reasons previously discussed, Phase 2, described in 
Chapter 6, investigated the effect of PEM on outcome after global ischemia. Since 
oxidative stress and glutathione depletion is primarily expected during and after 
reperfusion, a global model of transient ischemia in the Mongolian gerbil was chosen to 
test this hypothesis. Because the gerbil lacks a circle of Willis, a transient bilateral 
occlusion of the common carotid arteries is sufficient to effect a reproducible, consistent 
model of global ischemia producing mainly CA1 hippocampal damage, well-
characterized in the literature (Kirino and Sano,1984). Functional (behavioural) and 
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histological outcomes in this ischemia model are well-documented (Babcock et al.,1993; 
Colbourne and Corbett,1995; Wang and Corbett,1990). Typically, brain temperature 
falls during ischemia, and can be neuroprotective (Babcock et al.,1993; Colbourne and 
Corbett,1995; Colbourne et al.,1993b; Wang and Corbett,1990). This can be overcome, 
since regulation of brain temperature is non-invasive, achievable, and reduces variability 
in this stroke model. The author spent two weeks at the Memorial University of 
Newfoundland learning the gerbil transient bilateral carotid artery occlusion model, 
histological evaluation (hippocampal neuron counting), and behavioural outcome (the 
open field and T-maze tests) from Dr. Dale Corbett. His laboratory uses a five-minute 
occlusion with controlled brain temperature, achieving consistent loss of CA1 
hippocampal neurons in the range of 90-95%. Since we theorized PEM might 
exacerbate neural damage, it was first necessary to vary ischemic conditions to achieve 
less neuronal loss. A pilot study tested various occlusion time and brain temperature 
combinations (four minutes at 37°C; three and one-half, four and five minutes at 
36.5°C). Variability was high with lower occlusion times, and maintaining constant 
brain temperature above 36.5°C was difficult, especially with a shorter occlusion time. 
Ultimately a five-minute occlusion at 36.5°C produced the most consistent results, 
presented in Appendix C. 
The nutritional requirements of the Mongolian gerbil, including protein, are not 
well investigated. It is known this animal does well on standard rodent laboratory chow, 
which is about 16-24% protein. An early pilot study, testing whether the response of the 
gerbil to a purified sulphur amino acid deficient diet was similar to that of the rat, 
determined that 1) the animals did as well on the ‘control’ (sulphur amino acids 
included) crystalline amino acid modified AIN-93G rat diet (for diet composition, see 
Appendix D) as on rodent laboratory chow, and 2) liver and brain neocortex glutathione 
concentrations were decreased by the sulphur amino acid deficient diet. For description 
of the pilot study and results, see Appendix D. Gerbils in this pilot study were housed 
individually in suspended stainless steel cages for six days. Without bedding and 
companionship, the gerbils appeared ungroomed and ‘jumpy’. These animals normally 
groom each other, construct nests out of their bedding, and sleep together buried within. 
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Phase 2 studies would therefore house gerbils in groups of three in shoebox cages with 
bedding material.  
A second pilot feeding study was designed, using a modified AIN-93M pelleted 
rodent diet without the antioxidant tertiary butyl hydroquinone (TBHQ), containing 
adequate or low protein∗, fed for four weeks as described in Appendix E. Gerbils on the 
low protein diet ate less, lost weight, and had increased liver lipid compared to the 
adequate protein group, confirming a model of PEM. These diets were thus used in 
Phase 2 experiments.  
In Phase 2 experiments, described in Chapter 6, two sets of gerbils were treated 
identically pre-ischemia/sham surgery. Gerbils were housed in groups of three in 
shoebox cages and randomized to adequate protein (control diet, C) or low protein 
(PEM§) pelleted diet, both without TBHQ. The diet was modified from the AIN-93M 
rodent diet (Reeves et al.,1993) and fed for four weeks. On day 28, gerbils were 
subjected to a five-minute bilateral carotid artery occlusion (I) or sham surgery (S). 
Following surgery, group one was continued on randomized diet for ten days, and tested 
in the open field on Days 3, 7, and 10. The open field test was chosen as an indicator of 
hippocampal function, well-documented in the literature as mentioned previously. Brain 
was harvested for histology after the Day 10 open field exposure. The brains from 
gerbils in group 2 were collected twelve hours after ischemia/sham surgery for 
biochemical analyses of indicators of oxidative stress. Glutathione concentration (see 
Appendix A), soluble protein content, glutathione reductase activity, and protein thiols 
concentration were determined in brain hippocampus and neocortex, while 
thiobarbituric acid reactive substances were determined in neocortex only, due to 
availability of tissue. Liver glutathione concentration and lipid were determined as 
measures of PEM.  Phase 2 experiments showed that 1) a gerbil model of moderate 
PEM was achieved; 2) ischemic gerbils fed the control diet recovered normal behaviour 
in the open field by Day 7 post-ischemia, while PEM ischemic gerbils did not recover 
even by Day 10; 3) although PEM did not affect the survival of hippocampal CA1 
                                                          
∗ Adequate protein and low protein diets were formulated to contain 12% and 2% protein as casein, 
respectively. 
§ Since gerbils fed the 2% protein diet voluntarily reduced intake, leading to a reduction in both protein 
and energy, the group fed the low protein diet was given the abbreviation of PEM. 
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neurons after ischemia, four of twelve PEM-ischemic gerbil brains had marked increases 
in hippocampal glia; 4) hippocampus protein thiol concentration was decreased by PEM 
and by ischemia. These results suggest PEM gerbils recover more slowly from ischemia 
and may experience more oxidative stress than ischemic animals fed a diet adequate in 
protein. 
A concurrent study, described in Appendix F, was conducted to characterize the 
temporal change in neocortex and hippocampus glutathione concentration in response to 
brain global ischemia in gerbils fed a nutritionally adequate diet. Glutathione 
concentration was determined in neocortex and hippocampus immediately after sham 
surgery, and after zero and thirty minutes, one, two, six, twelve, and twenty-four hours 
of reperfusion following ischemia. Although the literature reports decreases in brain 
glutathione concentration at early reperfusion periods (Baek et al.,2000; Candelario-Jalil 
et al.,2001; Park et al.,2000; Shivakumar et al.,1992), we were unable to reproduce 
these data.
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CHAPTER 4 
 
DARK NEURON 
 
Confronted, however, with the vast 
literature which has accumulated in the 
last 10 years on the dark and light liver 
cells, the statement that they are 
artifacts settles a question on which 
much work has been wasted. Ernest 
Scharrer, “On Dark and Light Cells in 
the Brain and in the Liver”, p.57 
(Scharrer,1938), quoted by Jan 
Cammermeyer (Cammermeyer,1962). 
  
A study in our laboratory of rats subjected to global hemispheric hypoxia-
ischemia (GHHI) yielded some unexpected results in brain tissue stained with 
hematoxylin and eosin (H&E). Dark, shrunken, and shriveled neurons were noticed 
during evaluations of tissue for neuronal damage. Initially these cells were thought to be 
damaged neurons and assessed as such, even though there was neither cytoplasmic 
eosinophilia nor chromatin clumping characteristic of injured neurons (Petito et 
al.,1987). There was no pattern to the occurrence of these ‘damaged’ neurons. They 
were seen randomly, in the hemisphere contralateral to carotid artery ligation (the 
control), in areas not vulnerable to damage in this stroke model, such as the dentate 
gyrus, or surrounding obvious tissue tears at the edge of the neocortex. We were unable 
to explain this pattern of ‘damage’. Further investigation yielded a wealth of literature 
on the ‘artifact complex’ and ‘dark’ neuron. The literature descriptions matched what 
we had seen on our slides. We had removed formalin:acetic acid:methanol-perfused 
brains from skulls immediately after perfusion with fixative, resulting in many 
postmortem artifactual ‘dark’ neurons. Re-evaluation of brain damage, armed with this 
new information, yielded quite different patterns and extent of neuronal damage that 
now fit the expected results for the model. Before recognition of ‘dark’ neuron, two
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 groups of rats subjected to GHHI had apparent damage scores of 1.9 and 3.2 out of 
maximum 8 using one scoring system, and 9.7% and 11.1% using a second scoring 
system, both described in Bobyn et al., 2002 (Table 4.1, Groups 2, 4). After re-
assessment, these scores were 0.1 and 0.4 out of 8, and 0.1% and 0%, showing 
essentially no brain damage from this stroke model once the artifact was identified. An 
additional two groups of rats (Table 4.1, Groups 1, 3) fed a sulphur amino acid-deficient 
diet for three days before and after GHHI had similar reductions in damage after artifact 
identification, although overall damage was greater than in Groups 2 and 4 in Table 4.1.   
In a subsequent experiment with gerbils, intact heads were refrigerated in 
phosphate buffered 10% formalin overnight after trans-cardiac whole body perfusion 
with saline followed by fixative. Brains were carefully removed from the skulls 18-24 
hours later. Only one brain of forty-five had some ‘dark’ neurons, this attributed (in 
retrospect) to forcing the severed head into a container whose opening was too small. In 
another study in our laboratory, dark neurons were noted in one brain from a gerbil 
improperly perfused with fixative (Figures 4.1, 4.2). 
Jan Cammermeyer has written many papers on the ‘dark’ neuron, and in his 
review (Cammermeyer,1962) discusses the history of observation of this phenomenon, 
identified as early as 1894 by Nissl, and again in 1903 (Turner), 1922 (Spielmeyer), 
1932 (Scherer), 1938 (Greenfield) and 1946 (Weil).  These researchers attributed the 
‘dark’ neuron to both pathology and postmortem artifactual change, but did not 
distinguish between the two. Others thought these neurons were a normal cell type, 
since they were found in normal brains as well as those exhibiting pathologies, and 
ignored them. By 1916, rapid perfusion of fixative was known to largely avoid ‘dark’ 
neuron, but even slight errors in technique could not wholly prevent its occurrence 
(Scharrer,1938). Cammermeyer demonstrated that ‘dark’ neurons could be avoided if 
several hours elapsed between perfusion fixation and removal of brain from the skull 
(Cammermeyer,1960). Following is a description of the ‘dark’ neuron as reviewed by 
Cammermeyer (Cammermeyer,1961; Cammermeyer,1962). Whatever the mode of 
death, fixation technique or staining method, ‘dark’ neurons have the same appearance 
in humans and animals. These neurons are more abundant near a cut or tear, and in 
compressed, bent or pulled areas. Pyknosis of nuclei in neuroglia and cerebral blood  
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Table 4.1.  The effect of ‘dark’ neuron identification on neural damage scores in rats 
exposed to global hemispheric hypoxia-ischemia‡ (GHHI), evaluated with two 
assessment systems† 
 Original 
Global Score* 
Revised 
Global Score* 
Original 
Hippocampal Grid 
Score** 
% 
Revised 
Hippocampal Grid 
Score** 
% 
Group 1# 4.1 ± 0.6 2.5 ± 0.7 44.0 ± 7.9 34.9 ± 9.3 
Group 2§ 1.9 ± 0.3 0.1 ± 0.1   9.7 ± 3.3   0.1 ± 0.1 
Group 3# 4.5 ± 0.4 1.9 ± 0.6 32.3 ± 9.1 25.6 ± 8.7 
Group 4§ 3.2 ± 0.3 0.4 ± 0.2 11.1 ± 2.3         0 
Mean ± SEM 
‡ Table shows original scores (before ‘dark’ neuron identification) and revised scores 
(after ‘dark’ neuron identification). 
 †For detailed explanation of scoring systems, see Bobyn et al.(2002). 
# Groups 1 & 3: rats fed sulphur amino acid deficient diet for 3 days before and after 
GHHI.  
§ Groups 2 & 4: rats fed purified crystalline amino acid defined AIN-93G diet (Paterson 
et al.,2001)  
*Global score: 0 = no damage; 1 = <50% damage; 2 = >50% damage; maximum score 
of 2 in each region (striatum, thalamus, neocortex, hippocampus) for total maximum 
score of 8. 
** Hippocampal Grid Score: a grid was superimposed on an image of the hippocampus; 
any grid square containing one or more damaged cells of 15-20 cells per grid was 
counted as one damaged square and the damage score was expressed as percentage of 
baseline squares.  
 
 
 
vessels are often seen as well, contributing to the broader ‘artifact complex’, of which 
the ‘dark’ neuron is only a part. The cytoplasm of the ‘dark’ cell is shrunken, the 
compacted basophil material therein causing the dark appearance. The cell may be 
separated from the parenchyma by a vacuole of varying size and shape. Often the 
shrunken nucleus is indistinguishable from the dark cytoplasm, yet is sometimes within 
a rim of clear cytoplasm. The nucleolus appears larger than normal because of the 
shrunken cytoplasm. The apical processes may have a corkscrew-like configuration. 
While there is often random occurrence of single ‘dark’ neurons (Cammermeyer,1978), 
haphazard mingling of ‘dark’ and unaffected neurons is common, as is a more ordered 
arrangement “lined up like schools of fish” (Cammermeyer,1961). Similarly, before 
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Figure 4.1. Gerbil hippocampus CA4 neurons. Abundant ‘dark’ neurons with twisted 
apical processes and surrounding vacuoles are shown. Arrows point to normal 
neurons. 
Figure 4.2. Gerbil hippocampus dentate gyrus. Abundant shrunken ‘dark’ neurons with 
surrounding vacuoles are shown. Arrows point to normal neurons. 
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awareness of the ‘dark’ neuron in our laboratory, this ordered arrangement was 
described by the author of this thesis as ‘soldiers standing at attention’, and was 
prominent in the dentate gyrus. The exact mechanism by which the artifact complex 
occurs has been a subject of much debate over the years, and is beyond the scope of this 
thesis. The reader is referred to reviews (Brierley et al.,1973; Brown and Brierley,1968; 
Cammermeyer,1960; Cammermeyer,1961; Cammermeyer,1962; Cammermeyer,1978; 
Cammermeyer,1979; Kepes et al.,1995). 
Others have discussed this artifact as well. Brown and Brierley (1968) talk of an 
“histological artefact of hyperchromatic neurons”, the result of trauma at the time of 
brain removal and immersion in fixative. They say this artifact can easily be confused 
with early ischemic damage.  Described are several brains exhibiting dark cells, 
shrunken, heavily stained, with corkscrew-like apical dendrites, occurring in brains 
removed immediately or soon after perfusion-fixation, and seen more frequently in 
ipsilateral hemispheres, likely due to inadequate perfusion of fixative. Levy et al. (1975) 
describe the location of artifactual ‘dark’ or ‘hydropic’ neurons occurring in brains with 
only fair perfusion-fixation, and provide an image as example. They also reiterate, 
described in their previous paper (Brierley et al.,1973), that 1) distribution of ‘dark 
cells’ may bear no relation to pattern of regions vulnerable to hypoxia, and 2) that the 
incidence of the ‘dark cells’ is not proportional to severity of hypoxia, as is true 
ischemic cell damage. Petito et al. (1987) describe a study of postmortem human brains 
after cardiac arrest, identifying criteria by which neuronal necrosis is distinguished from 
‘artifactually dark neurons’. Halsey et al. (1991) placed rat skulls in fixative overnight, 
recognizing that fixation artifact must be differentiated from severe neuron damage in 
evaluation, but did not elaborate further.  
In our laboratory, ‘dark’ neuron has now been largely avoided in experimental 
animals by trans-cardiac saline perfusion followed by buffered formalin and immersion 
of intact skull in refrigerated buffered formalin for eighteen to twenty-four hours before 
gentle removal of brain. Although the artifact complex is well-documented, its existence 
may not be widely appreciated or acknowledged. This was significant to our laboratory 
in that once the artifact was recognized and removed from tissue assessment, a model of 
 66
global ischemia thought to be inducing mild damage was found to result in no damage 
unless the animals were also subjected to a nutritional insult. 
Care to allow time for adequate tissue fixation before handling will be rewarded 
with specimens free of confounding ‘dark’ neurons. If conditions make this artifact 
unavoidable, familiarity with its description will assist in distinguishing it from true 
neuronal necrosis. 
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CHAPTER 5 
 
THE EFFECTS OF DIETARY SULFUR AMINO ACID DEFICIENCY ON RAT 
BRAIN GLUTATHIONE CONCENTRATION AND NEURAL DAMAGE IN 
GLOBAL HEMISPHERIC HYPOXIA-ISCHEMIA∗ 
 
5.1 ABSTRACT   
  Primary brain injury in stroke is followed by an excitotoxic cascade, oxidative 
stress and further neural damage. Glutathione is critical and depleted in oxidative stress. 
Since cysteine is limiting in glutathione synthesis, this study investigated the effect of 
dietary sulphur amino acid deficiency on neural damage in a rat model of global 
hemispheric hypoxia-ischemia. Animals were fed a sulphur amino acid deficient 
(‘deficient’) or control diet for 3 days, subjected to right common carotid artery ligation 
and hypoxia, and diet continued for 3 more days. Histologically evaluated neural 
damage at 7 days post hypoxia-ischemia was greater in ‘deficient’ rats, shown by mean 
(± SEM) global and hippocampal grid scores of 2.5 ± 0.7 and 34.9% ± 9.3 respectively 
vs. controls’ scores of 0.1 ± 0.1 and 0.1% ± 0.1 respectively. Mean brain (± SEM) 
reduced glutathione was not different between groups at 6 hours post hypoxia-ischemia, 
but was decreased in ‘deficient’ animals 3 days later in neocortex (1.46 µmole/g wet 
weight ± 0.05 vs. 1.67 ± 0.04 in controls) and thalamus (1.60 µmole/g wet weight ± 
0.05 vs. 1.78 ± 0.03 in controls). Administration of a cysteine precursor to ‘deficient’ 
animals did not ameliorate neural damage. These findings suggest that well-nourished 
but not ‘deficient’ animals tolerate a mild brain insult. The decline in brain glutathione 
in the ‘deficient’ animals may be one of several contributing mechanisms.
                                                          
∗ A modification of this chapter was published: Bobyn, P. J., J. L. Franklin, C. M. Wall, J. A. Thornhill, B. 
H. Juurlink and P. G. Paterson (2002). The effects of dietary sulfur amino acid deficiency on rat brain 
glutathione concentration and neural damage in global hemispheric hypoxia-ischemia. Nutr. Neurosci. 
5(6): 407-416., and is reproduced in this thesis by permission of Taylor and Francis Group, 
http://www.tandf.co.uk. 
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5.2 INTRODUCTION 
Stroke (ICD-9, 430-438), is a reduction in blood flow to an area of the brain, and 
the third most common cause of death in the developed world. Primary brain injury due 
to stroke is followed by activation of several mechanisms contributing to extensive 
further damage (Juurlink and Paterson,1998). These mechanisms include depletion of 
glucose, ATP and ADP, membrane depolarization, and glutamate release, initiating an 
excitotoxic cascade, calcium overload and finally production of reactive oxygen (ROS) 
and nitrogen species, leading to oxidative stress (Juurlink and Paterson,1998). The 
acidic conditions promote formation of the potent hydroxyl radical which can initiate 
peroxidation of membrane polyunsaturated lipids, a self-propagating process that 
ultimately alters membrane fluidity and function (Juurlink and Paterson,1998). Calcium 
influx activates an inflammatory cascade, resulting in production of more ROS and also 
isoleukotrienes, biologically active free radicals (Harrison and Murphy,1995). ATP 
depletion, excitotoxicity, increased intracellular calcium and oxidative stress eventually 
lead to cell death (Juurlink,1999). 
Glutathione (γ-glutamylcysteinylglycine) is the most prevalent cellular thiol, 
critical in antioxidant defense (Juurlink,1999). Vitamin E, whose regeneration is 
dependent on ascorbate and reduced glutathione, can convert lipid peroxyl radicals into 
less reactive lipid hydroperoxides. These hydroperoxides, however, in the presence of 
free iron released under acidic conditions, can be converted to alkoxyl and peroxyl 
radicals, potentially initiating more lipid peroxidation (Juurlink and Paterson,1998). 
Glutathione and the glutathione peroxidase family scavenge these radicals, and the GSH 
S-transferases detoxify the aldehyde breakdown products (Juurlink,1999). The 
transcription factor nuclear factor kappa B (NFκB) mediates the inflammatory response 
in brain ischemia, and glutathione can inhibit the signal transduction pathway that 
results in NFκB activation (reviewed in Christman et al.,2000; Juurlink,1999). That 
maintaining optimal glutathione levels is of principal importance in minimizing cell 
damage in stroke is supported by a report that glutathione depletion with buthionine 
sulfoximine exacerbates injury in a rat focal ischemia model (Mizui et al.,1992). N-
acetylcysteine, a cysteine precursor, or glutathione ester administration are also both 
neuroprotective in brain ischemia (Gotoh et al.,1994; Knuckey et al.,1995). 
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  Tissue glutathione concentration is determined by its utilization, reduction of 
oxidized glutathione (GSSG) by glutathione reductase, and de novo synthesis. 
Glutathione will be depleted in conditions of severe oxidative stress such as stroke. The 
sulphur amino acid (SAA) cysteine is limiting for glutathione synthesis. It has long been 
known that liver and lung GSH is responsive to dietary protein and SAA content of 
protein (Bauman et al.,1988a), and our laboratory has recently shown that glutathione 
concentration is decreased in certain brain regions by an acute dietary SAA deficiency  
(Paterson et al.,2001). Intracellular cysteine can also be increased by the administration 
of a cysteine precursor such as L-2-oxothiazolidine-4-carboxylic acid (OTC) 
(Juurlink,1999). OTC is transported into many tissues, incorporated into glutathione 
(Meister et al.,1986), crosses the blood brain barrier and increases brain cysteine 
(Anderson and Meister,1989) and glutathione concentrations (Mesina et al.,1989). Oral 
OTC given to protein-energy malnourished rats increases liver, lung and spleen 
glutathione, and protects against hyperoxia-induced lung damage (Bray and 
Taylor,1994; Taylor et al.,1992). Intraperitoneal administration of OTC to rats after a 
spinal cord crush injury decreases oxidative stress with a sparing of white matter at the 
site of injury and partial return of function, while vehicle-treated animals remain 
paraplegic (Kamencic et al.,2001). These encouraging results suggest OTC may have a 
beneficial effect in stroke, particularly if nutritional substrate for glutathione synthesis is 
compromised. 
  Our study investigated whether SAA deficiency would decrease rat brain 
glutathione and exacerbate neural damage in a rat model of global hemispheric hypoxia-
ischemia (GHHI). This model of stroke has been shown to cause neuronal cell loss in 
the hippocampus, striatum, thalamus and neocortex (Thornhill and Asselin,1999). We 
also investigated if OTC administration to SAA deficient animals would ameliorate 
neural damage due to GHHI. 
 
5.3 MATERIALS AND METHODS 
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5.3.1 Experiment 1 
5.3.1.1  Animals, diets and surgical procedures 
Male Long-Evans rats aged 9-10 weeks were acclimated for 10 days, then 
housed individually in suspended stainless steel cages and randomized to an amino acid-
based diet as previously described (Paterson et al.,2001), but without the antioxidant 
tertiary butylhydroquinone. Sulphur amino acids methionine and cysteine were omitted 
from the formulation for the sulpur amino acid deficient (-SAA) diet. The control diet 
(+SAA) was formulated to contain L-methionine (6g/kg diet) and L-cystine (4g/kg 
diet), levels recommended for a crystalline amino acid-based diet (Baker and 
Boebel,1981). Diets were made isocaloric and isonitrogenous by varying sucrose and 
glycine. Animals had free access to food and water, and daily body weights and feed 
intake were recorded. Diets were obtained from Dyets, Inc. (Bethlehem, PA, USA). The 
animals were maintained at 22°C with a 12-hour light/dark cycle. All animal care and 
procedures adhered to the Canadian Council on Animal Care guidelines and were 
approved by the University of Saskatchewan Committee on Animal Care and Supply. 
Control or -SAA diets were fed for 3 days before and after surgery (total 6 days), after 
which all animals were fed the control diet. Following 3 days on experimental diet, 
animals (aged 9-11 weeks) were subjected to GHHI according to a modification of the 
Levine preparation  (Levine,1960) described by Yager et al. (1996). Under halothane 
anesthesia, the right common carotid artery was isolated, ligated in 2 positions and 
severed. The wound was closed and after 5 minutes of stabilization, the animal was 
exposed to 35 minutes of 12% oxygen in nitrogen (hypoxic period) under light 
halothane anesthesia. Animals were recovered and returned to their cages. Throughout 
surgery, core temperature was monitored with a rectal probe and maintained at 36.6 ± 
0.5°C with a thermal blanket. There were no spontaneous deaths in any experiments 
(n=70). Any animals experiencing seizures post-GHHI (n=2; 3%), cessation of 
breathing during surgery (n=5; 7%), or opening of incision sites (n=2; 3%) were 
eliminated for an overall failure rate of 9 of 70 (13%). 
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5.3.1.2  Global scoring system for neural damage   
    Seven days after GHHI, rats were anesthesized with halothane and perfused 
transcardially with normal saline to remove blood contamination, followed by FAM 
fixative (formaldehyde 1 part, glacial acetic acid 1 part, methanol 8 parts) (n=15 per 
group). Brains were removed intact and stored in FAM. Brains were then embedded in 
paraffin, sectioned at coordinates of approximately -0.4mm (anterior section) and -
3.1mm (posterior section) from bregma, and stained with hematoxylin and eosin (H&E). 
Neural damage to neocortex, striatum, hippocampus and thalamus was assessed in H&E 
stained sections in the hemisphere ipsilateral to the ligated artery according to the semi-
quantitative method of Thornhill and Asselin (Thornhill and Asselin,1999): 0 = no 
damage; 1 = <50% damage; 2 = >50% damage; maximum score of 2 in each region for 
total maximum score of 8. Damage in the ipsilateral hemisphere was assessed against 
the contralateral hemisphere, to account for a possible effect of global hypoxia. To 
increase the sensitivity for detecting more subtle forms of neuronal dysfunction, 
adjacent sections were stained with a mouse monoclonal anti-microtubule-associated 
protein 2 (MAP-2) IgG, using the avidin-biotin method of immunocytochemistry with 
3,3’-diaminobenzidine tetrachloride as the chromagen (Miller,1996). All slides were 
assigned a blinded number to avoid assessment bias. 
 
5.3.1.3  Hippocampal grid scoring system   
    Since the global hemispheric hypoxia-ischemia model produces mainly 
forebrain damage, and the hippocampus is particularly vulnerable (Schmidt-Kastner and 
Freund,1991), our laboratory also developed a more quantitative scoring system 
restricted to the hippocampal region. The hippocampal area of the H&E stained 
posterior section of rat brain (approximately -3.1mm from bregma) was visualized at 
100 x magnification on a Zeiss microscope with attached SonyPowerHAD colour video 
camera, and images were captured on computer with Northern Eclipse 2.0 software. A 
grid was superimposed on each image, and a hardcopy composite image of the entire 
hippocampal area constructed (about 5-9 images per collage) using Microsoft 
PowerPoint (for representative image with superimposed grid, see Appendix G). The 
densest regions of the subiculum/CA1, CA2/CA3, CA4 and dentate gyrus were defined 
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on the collage and baseline numbers of grid squares in each area counted. Each grid 
square held approximately 15-20 cells. To score damage, slides were viewed under a 
microscope at 400 x magnification and damaged cells located and marked by hand on 
the corresponding composite image. Any grid square containing one or more damaged 
cells was counted as one damaged square and the damage score was expressed as 
percentage of baseline squares in each area of the hippocampus. This score will be 
called the ‘hippocampal grid score’ in this paper to differentiate from the score assigned 
to the hippocampal region in the original global scoring system. 
 
5.3.1.4  Brain and liver glutathione concentration 
    At 6 hours (n=8 per group) or 3 days (n=8, -SAA; n=7, +SAA) after GHHI, rats 
were anesthesized with halothane and perfused transcardially with cold phosphate-
buffered saline (PBS). Brains were quickly removed and cut coronally into 2mm 
sections (brain slicer from Zivic-Miller, Portersville, PA, USA), and neocortex, 
striatum, hippocampus and thalamus from the ipsilateral hemisphere dissected, quickly 
frozen in liquid nitrogen and stored at -70°C until analysis. Slicing and dissection were 
on ice. To examine whether any change in glutathione in brain was due to diet alone or 
exacerbated by the GHHI, glutathione level in neocortex was determined in the 
contralateral hemisphere at 3 days post-GHHI. Small portions of liver were also 
harvested, frozen and stored as for brain. All tissue collection was between 1100 hours 
and 1300 hours to minimize diurnal variation in glutathione content. Tissues were 
weighed, homogenized in 5% 5-sulfosalicylic acid containing 0.1mM EDTA (on ice) 
and centrifuged at 4°C, at approximately 12,000 x g for 15 minutes to separate the 
protein precipitate. The supernatant was stored at -70°C until analysis. Final dilutions 
for brain and liver were 1:50 and 1:200, respectively. Glutathione was analyzed in brain 
regions and liver by reverse-phase high performance liquid chromatography (HPLC) 
with ultraviolet detection and precolumn derivatization with 5,5’-dithio-bis(2-
nitrobenzoic acid) as previously described (Paterson et al.,2001). A standard curve was 
run with samples daily, all in duplicate. 
 
5.3.2 Experiment 2 
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    Under the same housing and surgical conditions as Experiment 1, a separate 
group of SAA deficient animals was randomized to receive injections of OTC (n=14) or 
placebo (PBS vehicle, n=15). Fifteen minutes after the end of hypoxia, animals were 
administered a subcutaneous injection of vehicle or 1 mol/L OTC (Sigma) in PBS, 
adjusted to pH 7-7.4 with NaOH at a dose of 12mmol/kg body weight, followed by 
4mmol/kg body weight every 12 hours for 6 doses. Injection regimen concluded at the 
same time as the test diet. Neural damage was assessed histologically at 7 days after 
GHHI by the methods described under Experiment 1. 
 
5.3.3 Statistical analysis 
    Global score of H&E stained slides was analyzed by Mann-Whitney U. The 
hippocampal grid score and GSH levels were analyzed by unpaired, 2-tailed Student’s t-
test. Differences between groups were considered significant at p<0.05.  SPSS 10 for 
Windows (SPSS Inc., Chicago, IL) was used for all statistics. 
 
5.4 RESULTS 
5.4.1 Experiment 1 
    Body weight at entry into the study was the same for both groups of rats. 
Animals on the -SAA test diet lost a mean (± SEM) of 64g (± 1.7) over the 6 day period 
while the +SAA animals gained a mean of 20g (± 2.6). Feed intake of the -SAA rats 
was about 40% that of the +SAA rats (Table 5.1). At three days post-GHHI, -SAA rats 
were given the +SAA diet for 4 days until tissue harvest for histology. During this time, 
their intake normalized (mean 4-day intake [± SEM] 130.5g ± 2.8 vs. original +SAA 
group 120.9g ± 2.5) and they gained weight (51.4g ± 2.4 vs. original +SAA group 21.1g 
± 3.1). Animals in both experimental groups ate little on the day of surgery, but returned 
to normal intake for the group within 24 hours (data not shown). 
    Using the global scoring system, rats in the -SAA group had significantly more 
damage in neocortex (p<0.05), striatum (p<0.01) and hippocampus (p<0.01) and a 
higher total score (p<0.01) when compared to those in the +SAA group (Table 5.2). 
Total damage scores in -SAA and +SAA animals ranged from 0 to 6 and 0 to 1 
respectively. Figure 5.1 illustrates total scores of (a) 0 and (b) 8. Adjacent sections  
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Table 5.1. Effect of sulfur amino acid deficiency on weight gain and food intake* 
 Sulfur amino acid 
deficient (-SAA) 
Sulfur amino acid 
sufficient (control, +SAA) 
Initial body weight (g) 356.1 ± 3.0 357.3 ± 2.2 
Total weight gain/6 days (g) -64.2 ± 1.7† 20.1 ± 2.6 
Total food intake/6 days (g) 70.2 ± 2.5† 177.0 ± 3.4 
*Values are expressed as mean ± SEM; n includes animals for histology (15/group) and 
for tissue GSH analysis (n=8 -SAA; n=7 +SAA) totaling n=23 -SAA and n=22 +SAA.  
†Indicates significant difference between groups by unpaired t-test (p<0.001). 
 
 
 
 
Table 5.2. Global score of neural damage in GHHI with dietary SAA deficiency* 
 Sulfur amino acid 
deficient (-SAA) 
Sulfur amino acid 
sufficient (control,+SAA)  
Neocortex 0.5 ± 0.2† 0 
Striatum 0.7 ± 0.2† 0.1 ± 0.1# 
Hippocampus 1.1 ± 0.3† 0.1 ± 0.1# 
Thalamus 0.2 ± 0.1 0 
Total Score 2.5 ± 0.7† 0.1 ± 0.1 
 *Values are expressed as mean ± SEM; n= 15/dietary treatment group; Global score: 0 
= no damage; 1 = <50% damage; 2 = >50% damage; maximum score of 2 in each 
region for total maximum score of 8. 
†Indicates significant difference between groups by Mann-Whitney U (p<0.02). 
#Only 1 animal of 15 showed damage to the striatum, and 1 animal showed damage to 
the hippocampus. 
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Figure 5.1. Hematoxylin and eosin stained anterior (~ -0.4mm from bregma, A) and 
posterior (~ -3.1mm from bregma, A’) sections of rat brain 7 days post global 
hemispheric hypoxia-ischemia showing (a) a global neural damage score of 0, and (b) a 
global neural damage score of 8; with corresponding adjacent MAP-2 stain (anterior, B, 
and posterior, B’). Global scoring: 0 = no damage; 1 = <50% damage; 2 = >50% 
damage; maximum score of 2 in each region for total maximum score of 8. 
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stained for MAP-2 were compared visually to the matched H&E stained slides. By 
visual inspection alone, areas and amounts of staining of MAP-2 appeared to correlate 
well with areas of damage on H&E stains (Figure 5.1). Using the hippocampal grid 
score, damage to the hippocampal area was significantly greater (p<0.01) in -SAA 
animals than in +SAA animals in the subiculum/CA1, CA2/CA3, CA4, hippocampus 
proper and total hippocampus areas (Table 5.3). Damage to the dentate gyrus was 
highly variable in -SAA animals (range 0-100%) and completely absent in +SAA 
animals.  
    At 6 hours after GHHI, representing approximately 3 days of dietary treatment, 
there was no significant difference in glutathione concentration between dietary 
treatment groups in any area of the brain analyzed (Figure 5.2a). Three days after GHHI 
(6 days of dietary treatment), there was a significant decrease in mean glutathione 
concentration of neocortex and thalamus (p < 0.01) in -SAA animals compared to 
+SAA, while the difference in glutathione in hippocampus approached significance at p 
= 0.06 (Figure 5.2b). There was no apparent difference in glutathione concentrations in 
striatum between groups.   
   At 3 days post-GHHI, mean glutathione (±SEM) concentration in ipsilateral and 
contralateral neocortex was 1.46 ± 0.05 and 1.39 ± 0.05 µmol/g wet weight respectively 
in -SAA animals, and 1.67 ± 0.04 and 1.67 ± 0.02 µmol/g wet weight in +SAA animals. 
Thus, there was no difference in neocortex glutathione between left and right 
hemispheres at 3 days post-GHHI. 
   Mean (± SEM) liver glutathione concentration was dramatically lowered in the -
SAA group at 3 days post-GHHI (-SAA 2.7µmol/g wet weight ± 0.4 vs. +SAA 
6.6µmol/g wet weight ± 0.5). 
 
5.4.2 Experiment 2     
Animals on the -SAA diet with vehicle or OTC injection lost a mean (± SEM) of 
57.1g ± 1.9 and 53.2g ± 3.0 respectively over the 6 day test diet period, and this was not 
statistically different between groups. Food intake was not different from that of -SAA 
animals in experiment 1 (data not shown). There was no effect of OTC on neural  
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Table 5.3. Hippocampal grid score of neural damage after GHHI and dietary SAA 
deficiency* 
 SAA deficient (-SAA) 
% 
Control (+SAA)  
Subiculum/CA1 51.9 ± 13.0 † 0.2 ± 0.2# 
CA2/CA3 24.1 ± 7.7† 0 
CA4 45.7 ± 12.7† 0 
Dentate Gyrus 15.2 ± 8.8 0 
Hippocampus Proper‡ 44.3 ± 11.3† 0.1 ± 0.1# 
Hippocampus Total¶ 34.9 ± 9.3† 0.1 ± 0.1# 
*Values are expressed as mean percent damaged grid squares per region ± SEM 
[(number of damaged grid squares / number of baseline grid squares) x 100]; n= 
15/dietary treatment group. 
‡Hippocampus Proper = Subiculum/CA1 + CA2/CA3 + CA4.   
¶Hippocampus Total = Hippocampus Proper + Dentate Gyrus. 
†Indicates significant difference between groups by unpaired t-test (p<0.01). 
# In +SAA, only 1 animal of 15 showed damage, in the subiculum/CA1 region. 
 
 
damage in any brain region assessed by the global scoring system (Figure 5.3a), or by 
the hippocampal grid score (Figure 5.3b). 
5.5 DISCUSSION 
    Rats fed the SAA deficient diet lost weight and consumed less food. The 
phenomenon of appetite loss is characteristic of amino acid imbalance (Harper et 
al.,1970), and would be expected to cause generalized reduced protein synthesis and 
enzyme function. Consistent with other studies of reduced sulphur amino acid or protein 
intake (Bauman et al.,1988a; Hum et al.,1992), liver glutathione was dramatically 
lowered after 6 days on the sulphur amino acid deficient diet, confirming that a sulphur 
amino acid deficiency was achieved. Brain glutathione was unaltered by a sulphur 
amino acid deficient diet fed for 3 days, when measured 6 hours after the hypoxic-
ischemic insult. By 3 days post-ischemia (6 days of dietary treatment), brain glutathione 
was significantly reduced in neocortex and thalamus of sulphur amino acid deficient 
rats, and a similar trend (p = 0.06) was observed in the hippocampus. Striatal  
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Figure 5.2.  Effect of dietary SAA deficiency on brain glutathione concentration. Values 
are expressed as mean ± SEM. At (a) 6 hours post-GHHI, there are no significant 
differences in any brain region between groups, n= 8/ group; (b) 3 days post-GHHI, n=8 
-SAA, n=7 +SAA. *Significantly different from control (+SAA) by unpaired t-test 
(p<0.01). Hippocampal GSH approached significance (p=0.06).  
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Figure 5.3. Effect of subcutaneous administration of L-2-oxothiazolidine-4-carboxylic 
acid (OTC) on neural damage in GHHI with dietary SAA deficiency. Values are 
expressed as mean ± SEM; n= 15 -SAA/-OTC; n=14 -SAA/+OTC. There was no effect 
of OTC in any brain region evaluated in -SAA animals by (a) global score: 0 = no 
damage; 1 = <50% damage; 2 = >50% damage; maximum score of 2 in each region for 
total maximum score of 8; using Mann-Whitney U; or (b) hippocampal grid score: 
percent damaged grid squares per region [(number of damaged grid squares/number of 
baseline grid squares) x 100]; Sub/CA1 = Subiculum/CA1, Hpc Proper = Hippocampus 
Proper (Sub/CA1 + CA2/CA3 + CA4), Hpc Total = Hippocampus Total (Hpc Proper + 
Dentate gyrus); using unpaired t-test. 
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glutathione did not respond to the dietary treatment. These regional differences are 
similar to what we have previously found (Paterson et al.,2001), suggesting the dietary 
sulphur amino acid deficiency decreased availability of cysteine for glutathione 
synthesis. Glutathione is synthesized in two steps in the cytosol of most cells, and 
concentration is highly regulated (Taylor et al.,1996). The formation of γ-
glutamylcysteine in the first step is catalyzed by glutamate-cysteine ligase (GL, γ-
glutamylcysteine synthetase, γ-GCS) and regulated by glutathione via negative feedback 
inhibition (Anderson,1997). Availability of cysteine from diet and/or trans-sulphuration 
of methionine in the liver and activity of γ-GCS are the rate-limiting factors in 
glutathione synthesis (Lu,1999). Glutamate and glycine are readily synthesized via 
several metabolic pathways, and are not believed to limit the rate of glutathione 
synthesis (Bannai and Tateishi,1986). When dietary cysteine is decreased, glutathione 
may be used to supply cysteine for critical proteins, whose synthesis is favoured over 
that of glutathione in response to cellular stress, limiting glutathione available for 
antioxidant defense (Hunter and Grimble,1997). Brain cells have been shown to release 
glutathione into the extracellular space during conditions such as ischemia (Janaky et 
al.,1999). Extracellular cysteine rapidly auto-oxidizes to cystine, which is transported 
into the cell via System Xc- in exchange for glutamate (Bannai and Tateishi,1986). If 
the normally steep glutamate concentration gradient is unbalanced, such as in the 
glutamate excitoxicity occurring following stroke, there may be temporary compromise 
of cystine transport. This could reduce intracellular glutathione synthesis at a time when 
demand for glutathione is critical (Griffith,1999; Schubert and Piasecki,2001). Changes 
in γ-GCS activity and gene expression will also alter glutathione concentration, and are 
mediated by factors such as oxidative stress, Phase II enzyme inducers, and antioxidants 
(Juurlink,2001; Lu,1999).  
    We suggest the decrease in glutathione concentration in certain brain regions of 
sulphur amino acid deficient rats is one of several mechanisms contributing to their 
greater neural damage following hypoxia-ischemia. Neural damage assessed by two 
scoring systems was significantly higher in the sulphur amino acid deficient rats than in 
controls. Cellular damage visible on MAP-2-stained slides mirrored that seen with 
hematoxylin and eosin staining. MAP-2, abundant in the dendrites of neurons, provides 
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information on dendritic function (Schwartz,1991). Absence of MAP-2 has been used as 
an early marker of ischemic damage (Kitagawa et al.,1989; Matesic and Lin,1994). 
Variability in brain damage was high among animals. Although core body temperature 
was controlled, variation in brain temperature may have contributed to variability in our 
model. Damage in this stroke model was mild, as shown by the mean score of 2.5 and 
0.1 out of 8 in sulphur amino acid deficient and control animals respectively. As well, 
there was no significant difference in GSH levels between ipsilateral and contralateral 
neocortex. This suggests the observed depletion of GSH in some brain regions of 
sulphur amino acid deficient rats was due primarily to decreased synthesis resulting 
from absence of cysteine in the diet; increased GSH utilization resulting from the 
hypoxia-ischemia appears to have made little contribution. GSH as an antioxidant 
becomes critical in reperfusion after stroke, as large quantities of reactive oxygen 
species are produced during this period, contributing to oxidative stress (Juurlink and 
Paterson,1998). Oxidative stress may have been milder than anticipated in the stroke 
model studied, as the brain may not be truly ischemic (Ginsberg and Busto,1989), and 
reperfusion may be compromised since the carotid artery was severed. We suggest this 
model did not adequately test the effect of nutrition on GSH homeostasis in ischemic 
brain. In contrast, some other rodent models of stroke deplete brain GSH markedly 
(Rehncrona et al.,1980; Shivakumar et al.,1995).   
    A pair fed control group was not included in this experiment. Since food intake 
was substantially decreased, we cannot be certain that SAA deficiency was the sole 
determinant of the increased neural damage and modest reduction in brain glutathione 
concentration that developed sometime between 6 hours and 3 days post-insult. 
Generalized lack of other essential nutrients may have exacerbated the findings. 
However, brain glutathione, in comparison with liver glutathione, is relatively protected 
in food deprivation (Benuck et al.,1995), when there appears to be recycling of 
glutathione constituents within the brain and/or transportation of precursors across the 
blood brain barrier (Dringen,2000). Although plasma glutathione and cysteine levels are 
determined by efflux of hepatic glutathione, which is decreased in protein deficiency 
(Adachi et al.,1992), levels and function of liver glutathione-synthesizing enzymes 
appear to be maintained in food deprivation (Tateishi et al.,1974). Enzymes involved in 
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glutathione synthesis are present in brain (Dringen,2000), but their function in food 
deprivation has not been investigated. 
    Histological assessment of neural damage showed no effect of administration of 
a cysteine precursor to SAA deficient animals subjected to global hemispheric hypoxia-
ischemia. Although we did not measure brain glutathione concentration following OTC 
administration, the dose given has been shown to partially replete spinal cord 
glutathione concentrations following a spinal cord crush injury (Kamencic et al.,2001). 
Activity of 5-oxoprolinase appears to be maintained during protein energy malnutrition 
(Tateishi et al.,1974; Taylor et al.,1992), and it was expected brain intracellular cysteine 
and glutathione levels would be increased. OTC releases cysteine slowly in the cell, 
avoiding the induction of cysteine dioxygenase, although feedback inhibition of 
glutathione synthesis can occur (Bray and Taylor,1994). However, since OTC cannot 
increase tissue glutathione concentration above a physiological maximum (Bauman et 
al.,1988b) and brain glutathione was not yet depleted at the time of hypoxia-ischemia 
by either sulfur amino acid deficiency or the ischemic insult, our study failed to 
adequately test the efficacy of OTC.  
   Several studies have reported compromised protein-energy status at the time of 
admission to hospital for stroke (Axelsson et al.,1988; Choi-Kwon et al.,1998; Davalos 
et al.,1996; Gariballa et al.,1998b). Feeding after a stroke is often delayed, further 
exacerbating pre-existing poor nutritional status. In our study, the almost complete 
absence of neural damage after GHHI in animals fed the control diet suggests a mild 
insult to the brain may be tolerated in an adequate nutritional state. Sulphur amino acid 
deficiency, in conjunction with poor food intake, however, rendered the animals in this 
study less able to cope with mild ischemia. Recognizing that acute sulphur amino acid 
deficiency is uncommon, this study attempted to examine a mechanism whereby 
protein-energy deficiency, which will be next examined, might play a role in neural 
damage due to stroke. Glutathione can be increased with nutritional intervention in 
animal studies of protein or sulphur amino acid deficiency, and animals 
‘preconditioned’ with decreased protein intake show an overshoot phenomenon of 
glutathione synthesis upon introduction of a cysteine precursor (Bauman et al.,1988b). 
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There may exist a ‘window of opportunity’ for nutritional support after stroke, 
especially with respect to optimizing glutathione status in malnourished patients.
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CHAPTER 6 
 
PROTEIN-ENERGY MALNUTRITION ALTERS OXIDATIVE STRESS AND 
FUNCTIONAL OUTCOME, BUT NOT ISCHEMIC CELL DEATH IN A 
GERBIL MODEL OF STROKE 
 
6.1 ABSTRACT 
Primary brain injury in stroke is followed by an excitotoxic cascade, oxidative 
stress and further neural damage. Since glutathione (GSH), a key component of 
antioxidant defense, is sensitive to protein-energy malnutrition (PEM), we investigated 
whether PEM would deplete brain GSH concentration, increase oxidative damage, and 
exacerbate neural damage after global ischemia. In a 2 x 2 factorial design, adult male 
gerbils were fed an adequate protein (12%;C) or low protein (2%;PEM) diet for 4 
weeks, then subjected to 5 minutes of bilateral carotid artery occlusion (I, ischemia) or 
sham surgery (S). After 12 hours of reperfusion, hippocampus and neocortex, brain 
regions selectively damaged by this stroke model, and liver were collected from half the 
gerbils in each group for biochemical analyses. The remaining gerbils were continued 
on pre-surgery diets for 10 more days. To assess functional consequences of global 
ischemia, gerbils were placed in an open field on Days 3, 7 and 10 after I or S. On Day 
10, viable hippocampal CA1 neurons were counted in 3 stained brain sections.  By 
surgery day, PEM gerbils consumed 15% less food, lost 13% of initial body weight, and 
had 62% higher liver lipid and 49% lower liver GSH concentration than C gerbils, 
confirming PEM. C-I gerbils did not habituate as readily in the open field on Day 3 as 
sham-operated gerbils, but normalized by Day 7. PEM-I gerbils did not habituate well 
by Day 10, traveled greater distance than all other gerbils, and 7 of 12 displayed 
thigmotaxis in the open field. Mean CA1 neuron loss in I was 61.5% of S, but not 
different between PEM and C. Four of 12 PEM-I gerbils had marked increases in 
hippocampal glia.  Hippocampus protein thiols were significantly reduced in PEM
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 compared to C (p<0.05), and in I compared to S. There was a trend for ischemia to 
reduce hippocampus GSH concentration (p=0.08), but diet or surgery did not alter 
neocortex GSH concentration. Neocortex thiobarbituric acid reactive substances were 
unaffected by any treatment. There was a trend for ischemia to reduce hippocampus 
GSH reductase activity in PEM but not C gerbils (p=0.07). Although ability to maintain 
brain GSH concentration was not altered by PEM, these results suggest PEM gerbils 
experienced more oxidative stress and recovered normal activity more slowly following 
global ischemia than well-nourished animals. This is clinically relevant because many 
elderly stroke victims suffer from PEM at the time of ischemia, which may compromise 
recovery. 
 
6.2 INTRODUCTION 
Stroke (ICD-9, 430-432, 434, 436), usually associated with the elderly, occurs in 
all age groups and at 7% of all deaths remains the third most common cause of death in 
Canada.  Although mortality rates for all cardiovascular disease have been declining 
since the 1960s, and rates of ischemic heart disease and acute myocardial infarction 
continue to decline modestly, mortality rates for stroke have not changed significantly in 
the last ten years in Canada. At present, no specific therapy for stroke is available, with 
the exception of thrombolytic treatment (del Zoppo et al.,2000). There is a need to 
identify potential factors that either have detrimental effects on or improve outcome 
after stroke.  
Primary brain injury in stroke is followed by an excitotoxic cascade, calcium 
overload, production of reactive oxygen and nitrogen species, oxidative stress, and 
eventual cell death extending into the penumbra surrounding the infarct region (Juurlink 
and Paterson,1998). Post-ischemic inflammatory processes are also important 
contributors to secondary brain damage in stroke ( for reviews, see del Zoppo et 
al.,2000; Feuerstein et al.,1997; Hallenbeck,1996; Kogure et al.,1996; Tomita and 
Fukuuchi,1996). 
Glutathione (γ-glutamylcysteinylglycine) is the most prevalent cellular thiol, 
critical in antioxidant defense (Lu,1999) and depleted in conditions of oxidative stress 
such as stroke (Candelario-Jalil et al.,2001; Rehncrona et al.,1980; Shivakumar et 
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al.,1995). Synthesis of glutathione is limited by availability of the sulphur amino acid 
cysteine, supplied primarily by dietary protein (Anderson,1997). Liver and lung 
glutathione concentration is sensitive to dietary protein and to sulphur amino acid 
content of dietary protein (Bauman et al.,1988a), and is reduced by severe protein-
energy malnutrition (PEM) (Taylor et al.,1992).  Although brain glutathione 
concentration is not responsive to decreased dietary protein intake alone (Zhang et 
al.,2002), dietary protein deficiency may limit brain glutathione synthesis during 
oxidative stress, when the demand for glutathione is high. This laboratory has previously 
shown that glutathione concentration in some brain regions is decreased by an acute, 
severe dietary sulphur amino acid deficiency (Paterson et al.,2001), and that rats fed a 
sulphur amino acid-deficient diet suffer more neuronal loss after a mild global ischemia 
than well-nourished rats (Bobyn et al.,2002). Further, animals fed a diet containing 
protein-deficient (6% protein or less) diet will voluntarily reduce intake (Eisenstein and 
Harper,1991; Hum et al.,1992; Rana et al.,1996), resulting in both protein and energy 
malnutrition. 
Compromise of antioxidant defense in brain by PEM at the time of a stroke is a 
clinically relevant problem. The elderly are a group at high risk for stroke (Gariballa et 
al.,1998a), and many elderly have compromised nutritional status due to a variety of 
factors  (Abbasi and Rudman,1994; Lipschitz,1991; Marcus and Berry,1998).  Several 
studies have reported evidence of PEM in the elderly at the time of admission to hospital 
for stroke and deterioration of this status during the hospital stay (Axelsson et al.,1988; 
Choi-Kwon et al.,1998; Davalos et al.,1996; Gariballa et al.,1998b; Gariballa et 
al.,1998a).  Pre-existing PEM, particularly in the elderly, may be an important risk 
factor for poorer outcome after stroke, when feeding is often delayed.   
  This study investigated the effect of PEM on functional, histological and 
biochemical outcome in a gerbil model of global ischemia. We hypothesized PEM 
would increase neural damage due to increased oxidative stress secondary to limited 
supply of essential precursors for glutathione antioxidant defense, and negatively affect 
functional outcome. The ischemia model used in our study produces neural damage 
mainly in the CA1 region of the hippocampus (Kirino and Sano,1984; Pulsinelli et 
al.,1982a), and we assessed neuronal survival in this brain region by counting viable 
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neurons ten days after ischemia. The ability to habituate to an open field was utilized as 
a measure of hippocampal function (Babcock et al.,1993; Wang and Corbett,1990). 
Glutathione concentration, protein thiols, glutathione reductase activity, and 
thiobarbituric acid reactive substances were measured as indices of oxidative stress in 
susceptible brain regions after twelve hours of reperfusion following ischemia. 
 
6.3 METHODS 
6.3.1 Animals and diets  
Adult male Mongolian gerbils (Meriones unguiculatus, Charles River Canada, 
Saint-Constant, QC, Canada), age eleven to twelve weeks, were acclimated for seven 
days, and then randomized to adequate protein¶ (control diet, C) or low protein¶ (PEM∗) 
pelleted diet (Dyets, Inc., Bethlehem, PA, USA). The basal diet was modified from the 
AIN-93M rodent diet (Reeves et al.,1993), and did not contain the antioxidant tertiary 
butyl hydroquinone (Table 6.1). Diets were made isocaloric by varying cornstarch and 
dextrinized cornstarch. Animals were housed at 22○C with a twelve-hour light/dark 
cycle in groups of three in shoebox cages with CareFRESH® (Absorption Corp, 
Bellingham, WA, USA) bedding and free access to food and water. Biweekly body 
weights and daily food intakes were recorded. Food pellets were white, facilitating 
retrieval of food wastage from the brown bedding. All animal care and procedures 
adhered to the Canadian Council on Animal Care guidelines and were approved by the 
University of Saskatchewan Committee on Animal Care and Supply. Diets were fed for 
twenty-eight days.  
 
6.3.2 Surgical Procedures 
On day 28, gerbils were subjected to a five minute bilateral carotid artery occlusion 
(ischemia, I) or sham surgery (S) according to the procedure of Dowden and Corbett 
(1999). Under 1.5%-2.0% isoflurane anesthetic with 30% O2, the common carotid 
arteries were isolated through a ventral midline incision. A continuous thread of surgical  
silk, passed under both arteries, was looped to allow gentle lifting of the arteries. Core 
                                                          
¶ Adequate and low protein diets were formulated to contain 12% and 2% protein as casein, respectively. 
∗ Since gerbils fed 2% protein will voluntarily reduce intake, leading to a reduction in both protein and 
energy, the group fed the low protein diet was given the abbreviation of PEM. 
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Table 6.1. Modified AIN-93M Rodent Diet 
Component 
 
Adequate protein§ (Control, C) 
g/kg  
Low protein§§ (PEM) 
g/kg 
Vitamin free casein 140 22.4 
L-cystine 1.8 0.29 
Sucrose 100 100 
Cornstarch 465.7 543.049 
Dextrinized Cornstarch 155 181.001 
Soybean oil 40 40 
Cellulose 50 50 
Mineral mix*  35 35¶ 
Calcium phosphate dibasic 0 12.4 
Calcium carbonate 0 3.36 
Vitamin mix†  10 10 
Choline bitartrate 2.5 2.5 
§ Control diet was formulated to contain 12% protein, 10% fat, 78% carbohydrate. 
§§ PEM diet was formulated to contain 2% protein, 10% fat, 88% carbohydrate. 
* AIN-93M mineral mix (Reeves et al.,1993). 
¶ AIN-93M modified mineral mix: calcium and phosphorus deleted, potassium 
citrate·H2O increased from 28 to 226.55g/kg, sucrose increased from 209.806 to 618.256 
g/kg mineral mix. 
† AIN-93M vitamin mix (Reeves et al.,1993). 
 
 
 
 body temperature was monitored with a rectal probe and maintained at 37 ± 0.5○C with 
a homeothermic blanket (Harvard Apparatus Canada, Saint-Laurent, QC, Canada). 
Brain temperature was approximated with a tympanic membrane probe (Barnant Type T 
Digi-Sense Thermometer) and maintained at 36.5 ± 0.2○C throughout occlusion with a 
Mul-T-Pad® water-heated blanket (Global Medical Products, Inc., Burlington, ON, 
Canada) wrapped around the head. When brain temperature was stable at 36.5○C, 8 x 
1.5mm micro-aneurysm clips providing 60g pressure (World Precision Instruments, 
Inc., Sarasota, FL, USA) were applied to the arteries for five minutes. Blockage of blood 
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flow was visually verified. After clip removal, carotid artery reflow was visually 
confirmed and the incision closed. Animals were warmed with a red 40 watt bulb in an 
overhead lamp for thirty to sixty minutes until they became active, and returned to their 
shoebox cages. For sham surgery animals, procedures were identical: arteries were 
isolated, looped with silk and released, but not occluded, and the incision was closed. 
Groups were as follows: control diet with sham surgery (C-S, n=21), control diet with 
ischemia (C-I, n=24), PEM with sham surgery (PEM-S, n=21), and PEM with ischemia 
(PEM-I, n=24).  
 
6.3.3 Assessment of Protein-Energy Malnutrition 
On day 28, twelve hours after surgery, half the gerbils in each group were 
anesthesized with isoflurane, perfused trans-cardially with heparinized saline, and livers 
and brains collected on ice (C-S, n=10; C-I, n=13; PEM-S, n=12; PEM-I, n=12). Whole 
organ weights were recorded. Since liver glutathione concentration is responsive to 
PEM (Taylor et al.,1992), samples of liver (C-S, n=7; C-I, n=8; PEM-S, n=8; PEM-I, 
n=8) were analyzed for glutathione using reverse-phase high performance liquid 
chromatography with ultraviolet detection and pre-column derivatization with 5,5΄-
dithio-bis(2-nitrobenzoic acid) as previously described (Paterson et al.,2001) (See 
appendix A). Brain hippocampus and neocortex regions were dissected on ice and 
frozen at -70○C until biochemical analyses (see below, Biochemical Assessment of 
Oxidative Stress). Liver lipid can be elevated in PEM (Rana et al.,1996; 
Waterlow,1975), and was analyzed using a modification of the methods of Folch et 
al.(1956), and Miyazawa et al. (1994) (C-S, n=10; C-I, n=13; PEM-S, n=12; PEM-I, 
n=12). Liver was homogenized with 0.1M NaCl, and lipid extracted with 
chloroform:methanol 2:1. After centrifugation at 1000 x g for ten minutes, the upper 
layer was removed with a glass pipet and discarded. Anhydrous Na2SO4 was added to 
remaining tissue/chloroform layer to dehydrate, and tube contents filtered through #1 
Whatman paper into a pre-weighed glass tube. Solvent was evaporated under N2 gas for 
fifteen to thirty minutes at 37○C, until dry. The tube was re-weighed to determine lipid 
content. 
 
 90
6.3.4 Behavioural testing 
The remaining gerbils in each group were continued on pre-surgery diet for ten 
additional days. On Days 3, 7, and 10 after surgery, animals were weighed and placed in 
an open field (75 x 75 x 75cm) for ten minutes of exploration, similar to the protocol of 
Colbourne and Corbett (1995). The open field was surrounded by sound-absorbing free-
standing partitions in a secluded room with constant lighting conditions during testing. 
Activity was recorded continuously for ten minutes with a suspended video camera, and 
analyzed later with an EthoVision Basic Program (Version 2.3.19, Noldus Information 
Technology): (1) by using the entire field, and (2) by dividing the field into an inner 
zone and a perimeter zone measuring approximately one and one-half times gerbil body 
width at mid-hip.  
 
6.3.5 Histology 
Following the Day 10 open field exploration, gerbils were anesthesized with 
isoflurane, and perfused trans-cardially with heparinized saline (four minutes at 
12mL/min) followed by 10% phosphate-buffered formalin (eight minutes at 12mL/min). 
To minimize the occurrence of dark neuron artifact (Cammermeyer,1962), intact heads 
were refrigerated in the formalin for eighteen to twenty-four hours, then brains gently 
removed and stored in formalin until paraffin embedding. Brains were sectioned in 6µm 
thicknesses and stained with hematoxylin and eosin (H&E). Viable-looking neurons, 
non-eosinophilic with defined cell membrane and nucleus, were counted bilaterally in a 
200µm square grid (10 x 10) at median, middle and lateral sectors in the CA1 region of 
the hippocampus at levels ‘A’ (anterior, ~-1.7mm from bregma) and ‘B’ (middle, ~-
2.2mm from bregma) and in the middle sector at level ‘C’ (posterior, ~-2.7mm from 
bregma) at 400 x magnification (Colbourne and Corbett,1995) (Figure 6.1). The slides 
were assigned a blinded number to avoid assessment bias. 
 
6.3.6 Biochemical Assessment of Oxidative Stress 
Twelve hours after surgery, brain hippocampus and neocortex (collected as described 
under Assessment of Protein-Energy Malnutrition) were analyzed for reduced 
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Level A 
~ -1.7mm
from bregma
Level B 
~ -2.2mm
from bregma
Level C 
~ -2.7mm
from bregma
Hematoxylin & eosin stain. Bar = 2.5 mm
Copyright 1995 by the Society for Neuroscience 
(Colbourne & Corbett, 1995)
 
 
Figure 6.1.  Hippocampal CA1 neuron regions for histological assessment. 
 
 
 
GSH using the same method as for liver. Although the hippocampus is selectively 
vulnerable in this model of ischemia, variable damage can also be seen in the neocortex 
in similar models (Pulsinelli et al.,1982a; Stanimirovic et al.,1988). The gerbil 
hippocampus is very small, providing limited amounts of tissue for biochemical 
analyses, and thus neocortex collection allowed for additional analyses. Since 
glutathione reductase activity can be reduced by oxidative stress (Barker et al.,1996; 
Powell and Puglia,1987; Stanimirovic et al.,1988), glutathione reductase was analyzed 
in hippocampus and neocortex using a modification of the methods of Carlberg and 
Mannervik (1975;1985) and Racker (1955). Tissue was homogenized 1:10 in 20mM 
sodium phosphate buffered saline containing 1mM Na2EDTA·2H2O (pH 7.6) on ice and 
centrifuged at 4○C at 16,000 x g for thirty minutes. Supernatant was further diluted to 
1:40 with incubation buffer (0.1M sodium phosphate buffer, pH 7.6 containing 0.5mM 
Na2EDTA·2H2O). The reaction mixture of 140µL incubation buffer, 30µL 1mM 
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NADPH in 0.1% NaHCO3, and 100µL sample was incubated at room temperature in a 
96-well plate for 10 minutes, followed by addition of 30µL 10mM oxidized glutathione 
(GSSG) in incubation buffer and immediate reading at thirty second intervals for four 
minutes at 340nm in a Spectramax 190® plate reader, analyzed with SOFTmax PRO® 
software (both Molecular Devices Corp., Sunnyvale, CA, USA). A standard calibration 
curve was prepared using incubation buffer and NADPH, and a molar absorption 
coefficient for NADPH of ε = 6.22 x 103M-1cm-1. All analyses were run in triplicate.  
Protein thiols are susceptible to oxidation and thus decreased under conditions of 
oxidative stress (Castilho et al.,1996; Netto et al.,2002). Protein thiols were analyzed in 
hippocampus and neocortex with a modification of the methods of Netto et al. (2002) 
and Visser et al. (2002). Tissue was homogenized on ice, 1:25 in 10mM HEPES, pH 
7.4, containing 137mM NaCL, 4.6mM KCL, 1.1mM KH2PO4, 0.6mM MgSO4, and 
1.1mM Na2EDTA·2H2O, with the following protease inhibitors added immediately 
before homogenization (final dilutions): 0.5µg/mL leupeptin, 0.7µg/mL pepstatin A, 
40µg/mL phenylmethylsulfonylfluoride (PMSF), and 0.5µg/mL aprotinin. Leupeptin 
and aprotinin were initially dissolved in HEPES buffer pH 7.4, pepstatin A in methanol 
and PMSF in isopropanol. Homogenate was centrifuged at 4○C at 16,000 x g for fifteen 
minutes. To precipitate proteins, equal volumes (100µL) of supernatant and 4% 
sulphosalicylic acid were allowed to stand at room temperature for fifteen minutes, 
centrifuged, and supernatant discarded. The protein pellet was re-suspended in 50µL 
10% sodium dodecyl sulphate (sodium lauryl sulphate) with vortexing, then incubated in 
the dark for twenty minutes after addition of 950µL 0.5M TRIS buffer, pH 8.3 
containing 0.5mM Na2EDTA·2H2O and 100µM 5,5’-dithio-bis(2-nitrobenzoic acid) 
(DTNB, Ellman’s reagent). Absorbance was read at 412nm in a 96-well plate, in 
triplicate, with the plate reader and software described above. A standard calibration 
curve was prepared using glutathione and the same TRIS buffer containing EDTA and 
DTNB. 
As a measure of lipid peroxidation, thiobarbituric acid reactive substances 
(TBARS) were analyzed in neocortex only, due to availability of tissue samples, using a 
modification of the method of Ohkawa et al. (1979). Tissue was homogenized on ice 
with 1.15% KCl (1:9), then 50µL added to a glass tube containing 100µL 8.1% SDS, 
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750µL 20% acetic acid at pH 3.5, 20µL 2% butylated hydroxytoluene in methanol and 
330µL deionized, distilled water, followed by addition of 750µL 0.8% thiobarbituric 
acid. A glass marble was placed on the top of the tube during incubation for one hour at 
95○C. After cooling, 500µL deionized, distilled water was added, followed by 2500µL 
n-butanol:pyridine 15:1. The glass tube was stoppered, shaken vigourously and 
centrifuged at 1000 x g for 10 minutes. The tube was allowed to stand for thirty to sixty 
minutes until the two layers were completely clear. Absorbance of the upper, organic 
layer was read in triplicate in a 96-well plate with reader and software as described, at 
532nm. A standard calibration curve was prepared using 1,1,3,3-tetramethoxypropane 
(malondialdehyde bis[dimethylacetal] ) reacted with 1% H2SO4 to yield 
malondialdehyde, and 1.15% KCl for dilutions.  
Neocortex and hippocampus soluble protein content was determined with each 
assay using the bicinchoninic acid (BCA) method of Smith et al. (1985), and the 
appropriate homogenization buffer. Tissue was homogenized ~1:10 in buffer, 
centrifuged, and supernatant diluted to 1:250. To 20µL sample in a 96-well plate was 
added 200µL working BCA solution (1 part 4% cupric sulphate pentahydrate:50 parts 
stock BCA solution [Sigma B-9643]), in triplicate. The plate was incubated for thirty 
minutes at 37○C, cooled to room temperature, and absorbance read at 562nm with the 
above microplate reader and software as described. Standard calibration curves were 
prepared for each assay using dilutions of 1mg/mL bovine serum albumin in the 
homogenization buffers specific to each assay. 
 
6.3.7 Statistical analyses 
 All statistical analyses were conducted using SPSS 11.0 for Windows (SPSS 
Inc., Chicago, IL). Body weights, feed intake, and organ weights used for the 
assessment of the PEM model were analyzed by unpaired Student’s t-test. Open field 
data were analyzed using General Linear Model Repeated Measures or two-way 
ANOVA accordingly, followed by posthoc LSD means comparison where appropriate.  
Biochemical data, including liver lipid and glutathione concentration, were analyzed by 
two-way ANOVA, followed by posthoc LSD means comparison where appropriate. 
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Differences were considered statistically significant at p< 0.05. All data are presented as 
means ± SEM. 
 
6.4 RESULTS 
6.4.1 Exclusions 
 There were ninety-six gerbils at the beginning of the study. Two gerbils were 
excluded due to inadequate  brain temperature control during occlusion, three died 
within twenty-four hours of surgery (two PEM-I and one C-S), and one gerbil was 
excluded due to abnormal toenail formations, enlarged spleen and liver growths. The 
overall failure rate was 6.25%. 
 
6.4.2 PEM Model 
Except for liver lipid (vide infra), there were no differences between sham-
operated and ischemic animals within each dietary treatment group (data not shown) for 
any of the parameters used to assess PEM. Initial mean body weight (± SEM) was not 
different between experimental groups, but by day 28, PEM mean weight was 
significantly lower than that of gerbils fed control diet (p<0.001) (Table 6.2). PEM 
gerbils lost 13% of initial body weight, and mean feed intake of PEM was 85% that of 
gerbils fed control diet over the 28-day period. Liver gross weight or weight per g body 
weight, and gross brain weight of PEM were significantly lower than those of gerbils in 
the control diet group, while brain weight per g body weight was significantly higher in 
PEM (all p<0.001). Liver lipid content was higher in PEM gerbils compared to those fed 
control diet (p<0.001), and was increased by ischemia in both dietary treatment groups 
(p=0.01). Liver from PEM gerbils contained a lower concentration of glutathione than 
that of gerbils fed control diet (p<0.001), but this parameter was unaffected by ischemia. 
Body weight on Day 10 after surgery was lower in PEM gerbils than those fed 
the control diet (p<0.001), and lower in ischemic gerbils than sham-operated (p=0.03), 
but there was no interaction of diet and surgery (Table 6.3). During the ten post-surgical 
days, PEM gerbils ate less than those fed control diet (p<0.001), but there was no 
difference between PEM-ischemic and PEM sham-operated animals. On the other hand, 
ischemic gerbils fed control diet ate significantly less than sham-operated (p<0.001).  
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Table 6.2.  Effect of experimental diet on body weight, feed intake, organ weights, liver 
lipid and liver glutathione concentration 
 
Parameter Adequate Protein 
Diet (Control diet, C) 
Low Protein Diet 
(PEM) 
Initial body weight (g)† 67.5±0.7 69.1±0.5 
Day 28 body weight (g) † 72.1±0.7 59.5±0.4* 
28-day feed intake (g) † 111.2±1.3 94.7±0.7* 
Liver weight (g)¶  2.4±0.1 1.7±0.1* 
Liver weight (mg/g body wt.) ¶ 34.5±0.7 28.7±0.4* 
Brain weight (g) ¶ 1.03±0.01 0.99±0.01* 
Brain weight (mg/g body wt.) ¶ 14.8±0.2 16.7±0.1* 
 C-S C-I PEM-S PEM-I 
Liver lipid (mg/g wet wt.)‡ 35.4±1.4a 46.5±2.9b 58.0±3.2c 77.7±3.8d 
Liver GSH (µmole GSH/g wet wt.)§ 5.6±0.4 5.5±0.2 3.1±0.4∆ 2.6±0.2∆ 
Mean ± SEM.                                                                                                                       
† n=45 per group; ¶ C, n=22; PEM, n=24; tissue weights obtained after whole body 
perfusion with heparinized saline; ‡ C-S, n=10; C-I, n=12; PEM-S, n=13; PEM-I, n=12; 
§ C-S, n=7; C-I, n=8; PEM-S, n=8; PEM-I, n=8.                                                                
* Indicates significant difference from control group by unpaired t-test, p<0.05.        
Letters indicate significant difference between groups by two way ANOVA followed by 
posthoc LSD test of means, p<0.05.                                                                                                                             
∆ Indicates significant difference between dietary treatment groups by two way 
ANOVA, p<0.05. 
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Table 6.3. Effect of ischemia on post-surgical feed intake and body weight 
 C-S PEM-S C-I PEM-I 
Body weight Day 10 post-
surgery 
74.3 ± 1.3 59.9 ± 1.2Φ 72.8 ± 1.1# 55.4 ± 0.9#Φ 
Feed intake:10 post-surgical 
day total 
36.4 ± 0.9a 26.6 ± 0.8c 32.6 ± 1.0b 27.3 ± 0.9c 
Mean ± SEM; C-S, n=11; PEM-S, n=9; C-I n=11; PEM-I, n=12. 
# Indicates significant difference between surgical treatment groups by two way 
ANOVA. 
ΦIndicates significant difference between dietary treatment groups by two way ANOVA.                         
Letters indicate significant differences between groups by two way ANOVA followed 
by posthoc LSD test of means, p<0.05. 
 
 
 
6.4.3 Behavioural Testing 
Decreasing activity level during an exposure to the open field, measured as total 
distance traveled, is an indicator of ability to adapt or habituate to a novel environment. 
Sham-operated gerbils in both dietary treatment groups habituated well in the open field 
beginning on Day 3 post-surgery (Figure 6.2). Ischemic gerbils did not habituate on Day 
3, but by Day 7, ischemic gerbils fed control diet habituated as well as their sham-
operated controls. PEM ischemic gerbils failed to habituate even by Day 10. Although 
not statistically different from gerbils fed the control diet, PEM sham-operated gerbils 
tended to have a lower overall activity level. Total distance traveled significantly 
decreased on repeated exposure to the open field (p<0.001) in all groups (within-
subjects effects). Collapsed across days, total distance traveled was greater in ischemic 
than in sham-operated gerbils (p<0.001), and in PEM ischemic gerbils compared to 
ischemic gerbils fed the control diet (p=0.005, between-subjects effects) (Figure 6.3). 
The three-day average of total distance traveled was significantly greater for PEM 
ischemic gerbils compared to all other groups (p=0.002). 
Seven of twelve PEM ischemic gerbils, and one of eleven ischemic gerbils fed 
control diet displayed marked thigmotaxis, a wall-hugging behaviour, readily apparent  
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Figure 6.2.  Distance traveled in the open field.  Closed squares: control diet, sham 
surgery, n=11; open squares: control diet, ischemia, n=11; closed triangles: PEM, sham 
surgery n=9; open triangles: PEM, ischemia, n=12. 
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Figure 6.3.  Three-day average of total distance traveled in the open field. C-S: control 
diet with sham surgery; PEM-S: PEM with sham surgery; C-I: control diet with 
ischemia; PEM-I: PEM with ischemia 
 
 
 
on videotape (Figure 6.4). The percent of distance traveled spent in the outer zone 
remained constant in sham-operated gerbils from day to day, but decreased on repeated 
exposure to the open field in ischemic gerbils (Figure 6.5). Analysis of between-subjects 
effects showed the percent of distance traveled spent in the outer zone was greater in 
PEM than in gerbils fed the control diet (p=0.03), and greater in ischemic than in sham-
operated gerbils (p=0.005)(Figure 6.6). Post hoc LSD means comparison of percent of 
distance traveled in the outer zone also showed significantly greater values for PEM 
ischemic gerbils compared to all other groups. 
To examine the pattern of habituation during each open field exposure from day 
to day, the approximated slopes of the ten-minute activity patterns within each day were 
calculated using the difference between distance traveled in minute one and minute ten, 
normalized by dividing this value by the sum of distance traveled in minute one and 
minute ten (Figure 6.7). Repeated measures analysis of within-subjects effects showed 
the effect of ischemia on pattern of habituation from day to day was altered by diet 
(p=0.01). A repeated measures analysis of pattern of habituation by individual group 
showed a change in pattern of activity over repeated exposures for the.PEM  
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Figure 6.4.  Tracks from videotape of ten-minute exposure to the open field. (A): 
Normal activity pattern of sham-operated gerbil fed control diet; (B): Thigmotaxis 
observed in protein-energy malnourished ischemic gerbil.  
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Figure 6.5.  Open field: percent of total distance traveled spent in the outer zone. C-S: 
control diet with sham surgery; PEM-S: PEM with sham surgery; C-I: control diet with 
ischemia; PEM-I: PEM with ischemia. 
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Figure 6.6.  Open field: three-day average of percent of total distance traveled spent in 
the outer zone. C-S: control diet with sham surgery; PEM-S: PEM with sham surgery; 
C-I: control diet with ischemia; PEM-I: PEM with ischemia. Letters indicate significant 
differences among groups by two way ANOVA followed by posthoc LSD test of means, 
p<0.05. 
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Figure 6.7.  Open field: pattern of habituation. C-S: control diet with sham surgery; 
PEM-S: PEM with sham surgery; C-I: control diet with ischemia; PEM-I: PEM with 
ischemia. 
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sham-operated group only. This group had a flattening of the approximated ‘slope’ by 
Day 10, due to lower activity in the first few minutes of placement in the open field. 
This was in sharp contrast to the PEM ischemic group, which did not change the pattern 
of activity over all three days. Looking at each day individually using two-way 
ANOVA, surgical treatment was significant (p=0.001) for Day 3, while the interaction 
between diet and surgery was significant for Day 7 (p=0.03). By Day 10, only dietary 
treatment had an effect on the pattern of habituation (p<0.001). Between groups, 
collapsing all three days, the ‘slope’ of habituation was independently flattened by PEM 
(p=0.005) and ischemia (p=0.02) (Figure 6.8).  
 
6.4.4 Histology 
 The number of viable hippocampal CA1 neurons at each level, and totalled was 
unaffected by dietary treatment, in sham or ischemic gerbils. Ischemia resulted in a 
mean of ~63% and ~ 60% total loss of CA1 neurons in the representative sectors in 
gerbils fed control diet and PEM gerbils, respectively (Figure 6.9). There was no  
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Figure 6.8.  Open field: pattern of habituation averaged over three days of exposure.     
C-S: control diet with sham surgery; PEM-S: PEM with sham surgery; C-I: control diet 
with ischemia; PEM-I: PEM with ischemia. 
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Figure 6.9.  Viable hippocampal CA1 neurons ten  days post-surgery. C-S: control diet 
with sham surgery; PEM-S: PEM with sham surgery; C-I: control diet with ischemia; 
PEM-I: PEM with ischemia. Letters indicate significant differences among groups by 
two way ANOVA followed by posthoc LSD test of means, p<0.05. 
 
 
 
significant interaction between diet and ischemia in effects on histological outcome. 
Four of twelve PEM ischemic brains had a marked increase in numbers of hippocampal 
glia, a phenomenon not seen in any other group (Figure 6.10). Among a subset of 
ischemic gerbils displaying thigmotaxis in the open field (n=1, C-I and n=7, PEM-I), 
which included all four gerbils with increased glial numbers, viable CA1 neuron 
numbers at any level were not different between gerbils with and without increased glial 
numbers (data not shown). All ischemic gerbils displaying visually observed 
thigmotaxis, however, had significantly fewer surviving CA1 neurons than those 
ischemic gerbils not displaying thigmotaxis, at levels B (p=0.01) , C (p=0.01)and total 
of A,B and C (p=0.02), while level A approached significance at p=0.07 (Table 6.4).  
 
6.4.5 Biochemical assessment of tissue protein and oxidative stress 
Protein content of hippocampus was higher in ischemic than in sham-operated 
gerbils in both dietary treatment groups (p=0.04), while neocortex protein was not 
affected by diet or ischemia (Table 6.5). Hippocampus protein thiols were significantly 
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Figure 6.10.  Representative images of hippocampal CA1 neurons at ~ - 1.7mm from 
bregma: intact neurons from sham-operated gerbil fed (A) control diet, (B) PEM diet; 
neuronal damage in ischemic gerbil fed (C) control diet, (D) PEM diet; and (E), 
increased number of glial cells in ischemic gerbil fed PEM diet.  
 
 
 
Table 6.4.  Numbers of viable hippocampal CA1 neurons in ischemic gerbils, 
categorized by observation of thigmotaxis in the open field 
 
Ischemic gerbils Level A Level B Level C Total all levels 
Thigmotaxis‡ 60 ± 4  66 ± 5* 26 ± 3* 152 ± 9* 
No thigmotaxis§ 124 ± 24 158 ± 24 59 ± 9 341 ± 55 
Mean ± SEM. 
‡ Control diet, n=1; PEM, n=7.  
§ Control diet, n=10; PEM, n=5. 
* Indicates significant difference between groups by unpaired by t-test, p< 0.05. 
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Table 6.5. Effect of dietary treatment and ischemia on tissue soluble protein and 
biochemical assessment of oxidative stress in hippocampus and neocortex 
 
Experimental Groups§  
Assessment  
 
Region¶ 
C-S PEM-S C-I PEM-I 
Protein*  
(mg/g wet wt) 
HPC 42.4 ± 2.1 43.6 ± 2.1 46.0 ± 2.6# 49.3 ± 1.5# 
 NC 46.5 ± 2.9 49.7 ± 3.0 45.2 ± 1.0 47.4 ± 2.3 
      
GSH*  
(mMol GSH/mg 
protein) 
HPC 
 
NC 
26.4 ± 1.9 
 
27.7 ± 4.4 
24.9 ± 1.4 
 
26.4 ± 2.7 
22.8 ± 1.6 
 
28.6 ± 1.5 
22.2 ± 2.0 
 
25.2 ± 2.1 
      
GSH Reductase†  
(nMol NADPH/min/ 
mg protein) 
HPC 
 
NC 
24.9 ± 2.1 
 
19.7 ± 1.4 
26.3 ± 1.1 
 
17.0 ± 1.1 
25.9 ± 1.8 
 
19.0 ± 0.8 
21.6 ± 0.7 
 
20.9 ± 1.3 
      
Protein Thiols* 
(nMol GSH 
equiv/mg protein) 
HPC 
 
NC 
93.5 ± 6.8 
 
78.2 ± 1.0 
83.5 ± 1.1Φ 
 
75.1 ± 2.5 
87.2 ± 3.4# 
 
82.6 ± 1.9# 
75.8 ± 3.2Φ# 
 
84.0 ± 3.4# 
      
TBARS‡  
(nMol MDA/g wet 
wt.) 
NC 371.9 ± 71.9 415.9 ± 70.8 282.7 ± 57.2 339.3 ± 60.0 
Mean ± SEM. 
§ C-S = control diet, sham surgery; PEM-S = PEM, sham surgery; C-I = control diet, 
ischemia; PEM-I = PEM, ischemia. 
¶ HPC = hippocampus; NC = neocortex. 
# Indicates significant difference between surgical treatment groups by two way 
ANOVA. 
Φ Indicates significant difference between dietary treatment groups by two way 
ANOVA. 
*C-S, n=7; PEM-S, n=8; C-I, n=8; PEM-I, n=8. 
† C-S, n=7; PEM-S, n=8; C-I, n=8; PEM-I, n=7. 
‡ C-S, n=5; PEM-S, n=7; C-I, n=7; PEM-I, n=4.  
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reduced in PEM gerbils compared to those fed control diet (p=0.004), and in ischemic 
gerbils compared to sham-operated (p=0.04), but there was no interaction between 
effects of diet and ischemia . Neocortex protein thiols were increased by ischemia 
(p=0.01) but unaffected by diet; there was no interaction between diet and ischemia. 
There was a trend for ischemia to reduce hippocampus glutathione concentration 
(p=0.08), however diet had no effect. Reduction of hippocampus glutathione reductase 
activity by ischemia approached significance in PEM (p=0.07), but not in gerbils fed 
control diet. In contrast, neocortex glutathione reductase activity tended towards an 
increase in PEM (p= 0.06) compared to gerbils fed control diet. There were no 
independent or interactive effects of diet or surgery on neocortex TBARS. 
 
6.5 DISCUSSION 
 Little is known of the nutritional or protein requirements of the Mongolian 
gerbil, but this animal appears healthy when fed laboratory rodent chow containing 16-
24% protein (Arrington et al.,1973; Edwards et al.,1983). The decreased feed intake, 
loss of body weight, decreased liver glutathione and increased liver lipid seen in this 
study all suggest a gerbil model of moderate PEM was achieved by feeding 2% protein 
for four weeks. Various other rodent models of dietary protein deficiency have shown 
voluntary decreases in food intake and decreased liver glutathione concentration, 
consistent with our findings (Bauman et al.,1988a; Bauman et al.,1988b; Eisenstein and 
Harper,1991; Hum et al.,1992; Taylor et al.,1992). Our model can be distinguished from 
that of milder protein deficiency (7.5% protein) where food intake did not decrease 
(Zhang et al.,2002; Bauman et al.,1988a), or more severe PEM, where rats developed 
edema, diarrhea, steatorrhea, mucosal lesions, sparse hair and staggering gait after 
eating a protein-free diet fed for about two weeks (Leme-Brasil et al.,1980; Flores et 
al.,1970). PEM is characterized by muscle wasting and lossof subcutaneous tissue. Rana 
et al. (1996) fed rats a low protein (5%) or adequate protein (20%) diet for four weeks. 
Appetite and body weight decreased, and the liver was ‘fatty’ in the 5% protein group. It 
has been suggested, but not proven, that the fatty liver results from a diet providing a 
relative excess of energy from carbohydrate compared to protein or from decreased 
ability for synthesis of the apolipoprotein required for transport of triglycerides out of 
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the liver (Flores et al.,1970; Truswell et al.,1969; Waterlow,1975). The increase in liver 
lipid in ischemic gerbils may be a response to surgical stress. Surgery stimulates 
adrenocorticotropic hormone (ACTH) release from the pituitary, which elevates 
circulating corticosteroids such as cortisone, corticosterone and cortisol for up to 
twenty-four hours after insult, and activates the sympathetic system to release 
epinephrine and norepinephrine (Guyton, 1982; Souba and Wilmore, 1999). 
Epinephrine, norepinephrine, ACTH and cortisteroids activate triglyceride lipase, 
causing rapid breakdown of stored triglycerides and mobilization of fatty acids, such 
that the blood free fatty acid concentration rises. Epinephrine and norepinephrine also 
suppress insulin and raise glucagon, stimulating hepatic gluconeogenesis and 
glycogenolysis. Higher liver lipid after ischemia may be only transient, reflecting 
corticosteroid influence on lipid metabolism.  
Hippocampal CA1 neurons are particularly sensitive to brief periods of global 
ischemia, surviving initially, but succumbing to programmed (delayed) neuronal death 
over a period of two to four days after the insult (Kirino,1982; Pulsinelli et al.,1982a) 
This delayed death provides a window of opportunity for intervention and neuronal 
preservation. In humans, a brief episode of global ischemia results in severe 
hippocampal CA1 injury with resultant anterograde amnesia (Zola-Morgan et al.,1986). 
In gerbils, certain behaviour tests, such as the open field, are effective in assessing 
hippocampal function after an ischemic insult (Babcock et al.,1993; Colbourne and 
Corbett,1995; Corbett and Nurse,1998; Wang and Corbett,1990).  Decreasing activity 
level during exposure to the open field is an indicator of ability to adapt or habituate to a 
novel environment, testing working memory (Mileson and Schwartz,1991; Nurse and 
Corbett,1994). An increase in open field activity, or failure to habituate, can be a 
predictor of histological outcome and selective injury to hippocampal CA1 neurons 
(Dowden et al.,1999), although after ischemia, morphologically normal-appearing cells 
may be functionally incompetent (Bothe et al.,1986; Hori and Carpenter,1994; Ishimaru 
et al.,1995). Ischemic gerbils in both dietary treatment groups did not habituate well on 
novel exposure to the open field, three days after surgery. By the second exposure, one 
week after surgery, well-nourished ischemic gerbils habituated as well as all sham-
operated gerbils, suggesting recovery or adaptation. Hippocampal damage in our 
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ischemia model was less severe and more variable than expected. Others have reported 
more severe, consistent damage with the same global ischemia model, where, in contrast 
to our results, ischemic gerbils fed a normal diet could be differentiated from sham-
operated animals on all three post-surgical exposures to the open field (Colbourne and 
Corbett,1995; Dowden and Corbett,1999).  
Protein-energy malnourished ischemic gerbils in our study, however, still did not 
habituate well by Day 10 post-surgery. Indeed, the activity of these gerbils could be 
differentiated from PEM sham-operated gerbils on all three days of open field exposure. 
This was in contrast to gerbils fed the control diet, despite almost identical CA1 neuron 
loss from ischemia in both dietary treatment groups. Seven of the twelve gerbils in the 
PEM ischemic group spent over 87% of the total distance traveled in the outer perimeter 
of the open field. This was in sharp contrast to findings in the ischemic gerbils fed 
control diet, where only one of eleven showed this increased affinity for the outer 
perimeter. All other gerbils showed a range of 65-70%, and no sham-operated gerbils 
exhibited this behaviour. Thigmotaxis is considered indicative of ‘behaviour trapping’ 
or anxiety (Schallert et al.,1980; Simon et al.,1994). 
All gerbils except those in the PEM sham-operated group had a similar pattern of 
habituation over each ten-minute exposure from one test day to the next. The lack of 
habituation on first exposure to the open field in ischemic gerbils fed the control diet 
lost significance when averaged over all three exposures. The PEM sham-operated 
group, however, became less active over repeated exposures, and by Day 10 post-
ischemia, although the approximated ‘slope’ of activity over ten minutes suggested no 
habituation, the activity level was slightly lower than that of all gerbils fed the control 
diet, and dramatically lower than that of PEM ischemic gerbils. This suggests the 
continuation of the PEM diet for an additional ten days after sham surgery has a 
depressing effect on level of activity, independent of ischemia. Similar reductions in 
level of physical activity and/or ability to perform manual labour in conditions of PEM 
have been reported in monkeys (Chopra et al.,1987) and humans (reviewed in 
Shetty,1999). In contrast, PEM ischemic gerbils maintained a higher than normal level 
of activity throughout the post-ischemic period, suggesting abnormal hippocampal 
function.  
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Ischemia resulted in a significant loss of hippocampal CA1 neurons, but PEM 
had no additional effect on neuronal death. Unexpectedly, four of twelve PEM ischemic 
gerbils had marked increases in numbers of hippocampal glia, suggesting inflammation, 
although these cells have not yet been stained to identify glial cell types. After ischemia, 
glia are activated to form reactive microglia and reactive astrocytes (reviewed by Liu et 
al.,2001). In transient global ischemia, there is microglial activation very early in 
reperfusion, with a return to normal conditions by seven days post-injury in the 
penumbral region, though microglia may persist in the hippocampal CA1 region for up 
to one month (reviewed by Kato and Walz,2000). Reactive astrocyte proliferation 
appears later, reaching maximal accumulation in hippocampus at three to seven days 
post-ischemia (Domanska-Janik et al.,2001; Kato et al.,1994; Liu et al.,1998). This 
response to ischemia has not been studied in PEM. While lowered immune response is 
one component of PEM, chronic inflammation can occur (reviewed in Mora,1999). 
Inflammatory response in PEM can be abnormal and/or prolonged (Leme-Brasil et 
al.,1980; Wan et al.,1989). A prolonged inflammatory response in PEM may explain in 
part the glial proliferation seen throughout the hippocampus and neocortex in the four 
PEM ischemic gerbil brains. All four gerbils with increased hippocampal glial numbers 
exhibited thigmotaxis in the open field. Ischemic gerbils not displaying thigmotaxis in 
both dietary treatment groups had more surviving CA1 neurons in caudal sections 
(levels B and C) than ischemic gerbils exhibiting thigmotaxis, linking more extensive 
damage with abnormal behaviour in the open field.  
While we did not observe any effect of PEM, in the absence of ischemia, on 
surviving CA1 neurons, others have shown that prolonged PEM in postnatal or adult life 
in rats for fifty days and six months, respectively, resulted in decreased numbers of 
neurons and altered dendritic trees and synapses (Lima et al.,1999; Lukoyanov and 
Andrade,2000). Brock and Prasad (1992) found dendritic spine densities in some brain 
regions of rats were sensitive to dietary protein, while others were spared. To our 
knowledge, there have been no studies on the effect of short term PEM on hippocampal 
neuron numbers, and we did not expect the diet alone to affect this parameter in the 
adult brain.  
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Behaviour in the open field in this experiment was not reflected by extent of 
neuronal loss. Histology cannot predict communication within and between cells, 
making correlation between morphology and functional outcome difficult (DeVries et 
al.,2001). Using the same ischemia model as in this study, Corbett and Crooks 
preconditioned gerbils with two short occlusions seventy-two hours before five minutes 
of ischemia. Ten days later, preconditioned ischemic gerbils had lost only 19% of 
hippocampal CA1 neurons, yet showed significant impairments in the open field 
(Corbett and Crooks,1997). Similar results have been shown by others (Bothe et 
al.,1986; Dooley and Corbett,1998; Kudo et al.,1990). In another study from Corbett’s 
laboratory, the amplitude of CA1 dendritic field excitatory postsynaptic potentials 
(fEPSP) recorded ten days after ischemia in preconditioned gerbils was significantly 
lower than that of sham animals, although CA1 neuron loss was only about 12%. The 
lower fEPSP amplitudes correlated well, however, with increased activity in the open 
field (Dowden and Corbett,1999). These findings emphasize the importance of 
functional testing as an outcome measure in global ischemia models in addition to 
examining morphology. 
The brain, responsible for 20% of body oxygen consumption, is rich in 
polyunsaturated fatty acids and susceptible to free radical damage and lipid peroxidation 
(Comporti,1993; Siesjo et al.,1989). Production of reactive oxygen species during 
reperfusion after transient ischemia can ultimately lead to (1) oxidation of thiol groups 
on proteins and on susceptible enzymes such as glutathione reductase, essential for 
regenerating GSSG, and (2) initiation of lipid peroxidation with resultant decomposition 
of membrane fatty acids (Comporti,1993). Measurement of protein thiols, glutathione 
reductase activity, glutathione concentration and lipid peroxidation products may be 
used as indicators of oxidative stress, a condition in which free radical production 
exceeds antioxidant capacity (Shivakumar et al.,1995). We investigated whether the 
abnormal brain function of PEM gerbils measured post-ischemically could be partially 
attributable to glutathione depletion and increased oxidative stress. To our knowledge, 
the combined influence of PEM and ischemia on brain glutathione concentration and 
markers of oxidative stress has not been studied.  
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Hippocampus protein thiols were independently reduced by PEM and by 
ischemia, but the magnitude of the response to ischemia was not affected by diet. 
Protein thiol groups are susceptible to oxidation (Balijepalli et al.,2000; Sen and 
Packer,2000) and have been shown to decrease at one hour of reperfusion after thirty 
minutes of ischemia and return to normal levels at twenty-four hours (Shivakumar et 
al.,1995). That PEM alone decreases protein thiols may be partially supported by the 
hypothesis of Golden and Ramdath (1987), who suggest some of the pathogenesis in 
PEM is due to favourable conditions for production of free radicals and lipid 
peroxidation, in the milieu of low glutathione status due to high antioxidant demand and 
poor nutritional intake. Surprisingly, neocortex protein thiols did not appear to have 
been oxidized and were increased after ischemia in both dietary treatment groups. The 
neocortex is variably and less vulnerable to damage compared to the hippocampus in 
this model of ischemia. Soluble protein in this region was unchanged by ischemia (vide 
infra), thus it is unlikely there was overall increased protein synthesis or extravasation of 
plasma proteins into the parenchyma to account for the protein thiol content. It is 
possible there was selective synthesis but not inactivation, of sulphhydryl-containing 
proteins important in antioxidant defense, such as glutathione reductase, for example, in 
response to adjacent hippocampal injury or stress. The trend for increased glutathione 
reductase activity in PEM gerbil neocortex would support this suggestion. 
 There was a trend for ischemia to reduce hippocampus glutathione reductase in 
PEM, but not in adequately-nourished gerbils. Glutathione reductase is a flavoprotein 
utilizing NADPH to catalyze the reduction of GSSG to glutathione (Carlberg and 
Mannervik,1985). The thiol groups on glutathione reductase can be oxidized, 
inactivating the enzyme in conditions of oxidative stress (Barker et al.,1996). There is 
some evidence, however, that ischemia may need to be longer than five minutes to see a 
change in the hippocampus (Shivakumar et al.,1995; Stanimirovic et al.,1988; 
Stanimirovic et al.,1994). An interesting theory is proposed by Powell and Puglia 
(1987), who found that a 75% reduction in glutathione reductase activity did not alter 
brain glutathione concentration in a study of oxygen-induced CNS toxicity, and suggest 
under normal conditions, the brain may have an excess capacity for reduction of 
oxidized glutathione.  
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Compared to liver glutathione, brain glutathione is relatively protected in forty-
eight-hour food deprivation (Benuck et al.,1995), and is not altered in mice or rats fed a 
low protein diet (Adachi et al.,1992; Li et al.,2002; Stipanuk et al.,2002; Zhang et 
al.,2002). Various rodent models of stroke have been shown to deplete brain glutathione 
at early reperfusion timepoints (Baek et al.,2000; Candelario-Jalil et al.,2001; Park et 
al.,2000; Rehncrona et al.,1980; Shivakumar et al.,1992; Shivakumar et al.,1995), 
followed by a return to normal levels four to twenty-four hours later (Candelario-Jalil et 
al.,2001; Shivakumar et al.,1992; Shivakumar et al.,1995). We expected that the high 
demand for glutathione in oxidative stress might deplete brain glutathione when 
challenged with limited availability of precursors for glutathione synthesis in PEM. 
Although there was a trend for ischemia to reduce hippocampus glutathione, differences 
among groups were not significant. The extent of lipid peroxidation in neocortex 
measured by TBARS was not affected by diet or ischemia, and variability was high, 
consistent perhaps with variability of this region to damage in this stroke model. Since 
the hippocampus is the region most affected by this model of global ischemia, it would 
have been valuable to assess hippocampus TBARS.  
Although not a marker of oxidative stress, tissue soluble protein was used as a 
means of standardizing cellular content of other measured indices. Neocortex protein 
content was not affected by any treatment, but ischemia significantly increased 
hippocampus protein content in both dietary treatment groups. This may be due to 
increased production of pro-inflammatory enzymes/proteins such as adhesion molecules 
and growth factors, and even immune complement components in response to ischemia 
(reviewed in Petty and Wettstein,2001). Further, post-ischemic edema, with 
extravasation of plasma and accompanying proteins into the parenchyma across a 
compromised blood-brain barrier has been well-documented, and may have contributed 
to the increased hippocampal protein content (Lo et al.,2001; Okada et al.,1994; Petty 
and Lo,2002; Petty and Wettstein,2001; Sato et al.,2003). The change in hippocampus 
protein content may have influenced results of the markers of oxidative stress. 
Our assessment of oxidative stress is limited to one time-point post-surgery. It is 
possible this single timepoint missed detection of critical transient changes in the 
parameters measured, since other rodent models of ischemia have shown hippocampal 
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glutathione concentration (Baek et al.,2000; Candelario-Jalil et al.,2001; Park et 
al.,2000), glutathione reductase activity (Shivakumar et al.,1992), and protein thiols 
(Shivakumar et al.,1995) to be decreased during the first six hours of reperfusion. Tissue 
concentration is only a snapshot, and cannot give information about transport, synthesis, 
and efflux, further limiting assessment of the influence of ischemia on oxidative stress. 
Enzymes important for glutathione synthesis, γ-glutamyl cysteine synthetase and 
glutathione synthetase, are present in brain (Dringen,2000), but to our knowledge, their 
function in ischemia has not been investigated in vivo. Brain γ-glutamyl cysteine 
synthetase activity was found not to respond to a low protein diet fed for two weeks 
(Stipanuk et al.,2002). 
The gerbil brain is fragile and the hippocampus is very small, presenting 
difficulties with dissection and assays, possibly contributing to increased variability 
within groups. As well, since the CA1 region of the hippocampus is selectively damaged 
with this ischemia model, we might not see widespread biochemical changes in the 
hippocampus. The entire hippocampus was harvested from each brain hemisphere and 
used for one analysis, hence our assays might not have been sensitive enough to detect 
small changes primarily limited to the CA1 region. Moreover, our ischemia model 
produced a relatively mild and variable degree of hippocampal damage as evidenced 
from neuron counts, thus may not have generated sufficient oxidative stress to 
adequately test the hypothesis. Variability could also be attributed to individual variation 
amongst gerbils, since there may be a partial or complete circle of Willis in up to half of 
gerbils (Delbarre et al.,1991; Field and Sibold,1999; Ginsberg and Busto,1989). Since 
not all parameters used to assess oxidative stress are likely to be temporally matched, 
further studies should investigate both earlier and later timepoints. 
Although ability to maintain brain glutathione concentration was not 
significantly altered by PEM, the overall results of this experiment indicate PEM gerbils 
recovered normal activity more slowly following global ischemia than well-nourished 
animals. These results are even more dramatic given that significant changes in mean 
functional outcome were observed in PEM gerbils despite the high variability in their 
response to the ischemic insult. While PEM gerbils subjected to global ischemia may 
experience more oxidative stress, the evidence for this was not strong. Although the 
 113
evidence for increased oxidative stress may be strengthened by decreasing variability in 
the ischemia model and examining other timepoints post-ischemia, other mechanisms by 
which PEM exacerbates neural injury following stroke must be explored.  
Compromised nutritional status resulting in PEM, particularly in the elderly, is 
an important risk factor for stroke and for poorer outcome after stroke. Finestone and 
co-workers (1995;1996) studied Canadian stroke patients at the time of admission to 
rehabilitation units, and reported PEM in 49% of admissions, with dysphagia in 47%. 
Authors suggested there was inadequate nutritional intervention immediately post-
injury, further exacerbating pre-existing poor nutritional status and compromising 
antioxidant defense mechanisms at a time when demand for antioxidants and their 
precursors is high. The Feed Or Ordinary Diet trial (FOOD), a robust multicentre 
randomized trial evaluating various feeding policies after stroke, has shown that 
nutritional status early after stroke is independently associated with long-term outcome 
(FOOD Trial Collaboration,2003). Undernutrition immediately after stroke reduced 
survival, functional ability and living circumstances six months later. Nyswonger et al. 
(1992) determined the length of time to start of feeding after stroke varies, and stroke 
patients fed within seventy-two hours of injury have a shorter hospital stay. There may 
be a ‘window of opportunity’ for optimizing survival and recovery from stroke with 
adequate nutritional support, especially with respect to increasing glutathione and 
antioxidant defense status. Dietary supplementation with cysteine prodrugs were shown 
to increase tissue glutathione, restore redox status, and normalize NFκB activation and 
pro-inflammatory cytokine production in mice with protein malnutrition (Li et 
al.,2002a; Li et al.,2002b). This promising alternative to protein repletion may be 
especially beneficial when feeding difficulties occur after stroke. The additional 
influence of inflammation, chronic due to PEM, and acute due to ischemia, must not be 
overlooked.
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CHAPTER 7 
 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
 Reports in the literature suggest a proportion of the elderly admitted to hospital 
for stroke suffer from protein-energy malnutrition at the time of admission, and that this 
condition not only deteriorates after the stroke, but lengthens hospital stay and worsens 
outcome (Axelsson et al.,1988; Gariballa et al.,1998a). Much of the secondary brain 
damage in ischemia-reperfusion injuries such as stroke can be attributed to generation of 
reactive oxygen and nitrogen species during reperfusion, leading to oxidative stress in 
the penumbra surrounding the primary lesion and delayed neuronal death. The 
experiments described in this thesis examined whether part of the mechanism of 
worsened outcome in stroke with pre-existing protein-energy malnutrition could be due 
to impaired antioxidant defense secondary to reduced availability of precursors for 
glutathione synthesis. Glutathione, critical in antioxidant defense, is the most abundant 
thiol in the CNS, and its synthesis depends in large part on supply of amino acids from 
dietary protein. 
 The first experiments with rats were designed to examine the role of dietary 
sulphur amino acids, methionine and cysteine, in maintaining brain glutathione 
concentration following global hemispheric hypoxia-ischemia, when demand for 
antioxidant defense and glutathione synthesis is high. Since cysteine is limiting in 
glutathione synthesis, and the indispensable amino acid methionine can supply cysteine, 
removal of these amino acids from the diet for only five days is sufficient to induce 
weight loss, reduced intake, and reduced glutathione concentration in liver and some 
brain regions (Paterson et al.,2001). The effect of dietary sulphur amino acid deficiency 
on brain glutathione concentration and neural damage after stroke had not been 
previously assessed. It was hypothesized the dietary deficiency would compromise 
antioxidant defense after hypoxia-ischemia, secondary to glutathione depletion, thereby 
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exacerbating neural damage. It was further hypothesized that administration of a 
cysteine precursor, OTC, would restore brain glutathione depleted by dietary treatment 
and hypoxia-ischemia and ameliorate neural damage. Administration of OTC to rats 
after spinal cord trauma restored tissue glutathione depleted by the insult, decreasing 
damage and improving lower limb locomotion (Kamencic et al.,2001). A number of 
animal studies have shown that OTC can restore glutathione in various tissues after 
dietary sulphur amino acid or protein deficiencies (Chung et al.,1990; Jain et al.,1995; 
Levy et al.,1998; Taylor et al.,1992).  
 Although dietary sulphur amino acid deficiency did decrease glutathione 
concentration in rat brain neocortex and thalamus after six days, the hypoxia-ischemia 
administered on day three did not appear to exacerbate this decline, since there was no 
difference in neocortex glutathione concentration in the contralateral hemisphere in both 
deficient and control dietary treatment groups three days later. Neural damage, however, 
was increased in rats fed the sulphur amino acid deficient diet for six days compared to 
those fed control diet, suggesting an effect of diet as opposed to ischemia. That this 
finding was due to compromised antioxidant defense and increased oxidative stress in 
the animals fed the deficient diet was not supported by brain glutathione concentration. 
Measurement of glutathione concentration alone, however, may not have been sufficient 
to predict glutathione status or antioxidant status. The sulphur amino acid deficient diet 
was adequate in other components, but the rats fed this diet voluntarily reduced intake, 
and may therefore have been lacking all essential nutrients to some degree. Possible 
contribution of this added factor to the increased neural damage in the deficient group 
cannot be discounted. There was neither a sham-operated group nor a control group 
pair-fed adequate diet at the intake level of the deficient diet rats. Thus the effect of diet 
independent of ischemia, or reduced intake of all nutrients with and without ischemia on 
neuronal survival could not be evaluated. It was not possible to attribute observed results 
to lack of sulphur amino acids alone. Moreover, since the model of ischemia produced 
virtually no damage in adequately nourished rats, generation of reactive species and 
oxidative stress may have been limited. Reactive species are produced primarily during 
reperfusion (Grace,1994; Juurlink and Paterson,1998; Shivakumar et al.,1995; Yano et 
al.,1998). Although restoration of oxygen supply after thirty-five minutes of hypoxia 
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should generate some oxidative stress, severing of the common carotid artery 
compromised reperfusion in this stroke model. The brain also may not have been truly 
ischemic (Ginsberg and Busto,1989). Another difficulty with this model was that the 
hypoxia was by necessity applied to the entire brain, while only one carotid artery was 
severed, and the contralateral hemisphere was used as an internal control. Hypoxia alone 
of the degree and duration used in this experiment is not sufficient to produce neural 
damage (Levine,1960), but the lack of control groups (sham-operated, hypoxia alone, 
artery ligation alone) may have clouded assessment. Body temperature was controlled 
during ischemia, but brain temperature was not. Brain temperature is known not to be 
reflected by body temperature (Busto et al.,1987; Ginsberg and Busto,1989; Moyer et 
al.,1992; Warner et al.,1993), and typically falls during ischemia, which can be 
neuroprotective (Babcock et al.,1993; Colbourne and Corbett,1995; Colbourne et 
al.,1993b; Wang and Corbett,1990). Lack of brain temperature regulation during 
hypoxia-ischemia may have lessened neural damage and increased variability in the 
model. Other factors unregulated in this experiment may also have influenced variability 
and extent of damage: 1) hyperglycemia during hypoxia-ischemia as a stress response 
(Dijk et al.,1994; Ginsberg and Busto,1989), 2) blood gases and blood pressure can 
influence cerebral blood flow, introduce variability and confound results (Ginsberg and 
Busto,1989; Mhairi Macrae,1992). 
 There was no demonstrable effect of OTC administration to rats fed either 
sulphur amino acid deficient or sufficient diet. Given that there was no observed damage 
from ischemia in rats fed the control diet, OTC could not have had any effect in this 
group. The lack of brain glutathione depletion at the time of ischemia and mildness of 
the insult likely did not generate much, if any, oxidative stress, explaining the lack of 
effect of OTC in the sulphur amino acid deficient group. Glutathione concentration was 
not evaluated in the OTC experiment, but it would have been helpful to determine if 
OTC corrected the decreased brain glutathione seen three days after ischemia in the 
sulphur amino acid deficient rats. Although mouse brain glutathione and glutathione 
redox status were unaffected by three weeks of a low protein diet followed by addition 
of various dietary cysteine prodrugs, other tissues were responsive to the diet and to 
precursor repletion, suggesting OTC may have an effect if glutathione is first depleted 
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(Li et al.,2002a; Li et al.,2002b). The rat global hemispheric hypoxia-ischemia model 
failed to adequately test the hypothesis of dietary sulphur amino acid deficiency 
increasing oxidative stress. Repeating this experiment using either a focal model of 
ischemia or a global model producing more severe damage, and evaluating additional 
parameters such as protein and lipid oxidation and activity of enzymes sensitive to 
oxidative stress could yield data valuable to the original hypothesis. 
The first experiments progressed to completion before awareness of the 
existence of the ‘dark’ neuron, an artifact of post-mortem handling of brain tissue before 
adequate fixation. Initially, ‘dark’ neurons were evaluated as neural damage. Subsequent 
reassessment of damage after identification of the ‘dark’ neuron revealed virtually no 
brain damage in the adequately nourished rats, and only mild damage in sulphur amino 
acid deficient animals, confirming that this ischemia model may not have adequately 
tested the hypothesis. 
The rat sulphur amino acid deficient diet produced a severe, acute deficiency. It 
is unlikely a similar situation could occur in humans. More clinically relevant is 
moderate protein-energy malnutrition, relatively common in the elderly with stroke. It 
was hypothesized that protein-energy malnutrition would limit supply of essential 
precursors for glutathione production, compromising antioxidant defense and 
exacerbating neural damage in transient global ischemia-reperfusion. A gerbil model of 
temporary bilateral carotid artery occlusion is known to produce selective hippocampal 
damage similar to that observed in humans and primates after global ischemia (Zola-
Morgan et al.,1986; Zola-Morgan et al.,1992). Most gerbils lack branches connecting 
the basilar artery branches and the posterior cerebral arteries, resulting in an incomplete 
circle of Willis (Ginsberg and Busto,1989). Forebrain ischemia is easily achieved with a 
two-vessel occlusion and minimal surgical intervention, and brain temperature is easily 
controlled with the use of a water-heated blanket in close contact with the head (Nurse 
and Corbett,1994). Tympanic temperature approximates brain temperature (Brambrink 
et al.,1999; Mariak et al.,1994; Schuhmann et al.,1999) and allows minimal trauma to 
the animal. Neural damage and functional outcome in this gerbil transient ischemia 
model have been well-characterized (Colbourne and Corbett,1995; Corbett and 
Crooks,1997; Kirino and Sano,1984). The gerbil model of transient bilateral carotid 
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artery occlusion was thus chosen for the next phase of this research, even though the 
small size of the gerbil does preclude intra-ischemic monitoring and control of blood 
glucose, gases and pressure, introducing the possibility of more variability than desired. 
Gerbil nutritional and protein requirements are not well known (Arrington et 
al.,1973), and only one paper describing the response of the gerbil to a low protein diet 
was found in the literature (Leitch et al.,1993). Since the response was unpredictable, 
young adult gerbils were chosen as being more robust than older animals to establish 
protein-energy malnutrition, recognizing this as a limitation in clinical relevance of 
findings with respect to the basis for the hypothesis. Gerbils were fed adequate protein 
(control) or low protein diets. The voluntary reduction in food intake in the low protein 
group constituted the energy reduction needed to produce a model of protein-energy 
malnutrition. A limitation of reduced intake is possible inadequacy of other nutrients 
besides protein, and the unknown contribution of same to measured outcomes. This was 
considered unlikely since reduction of intake was not severe and micronutrients are 
provided at greater than requirement levels in the diet formulation. This is in contrast to 
the rat experiments where intake of the sulphur amino acid deficient diet was greatly 
reduced. Based on food intake, weight loss, liver lipid and liver glutathione 
concentration, a gerbil model of moderate protein-energy malnutrition was achieved. 
The gerbils remained well-groomed and active, with no signs of fur abnormalities or 
skin lesions characteristic of more severe malnutrition (Golden and Ramdath,1987).  
Functional, histological and biochemical outcomes were evaluated in a two by 
two factorial design, with two dietary treatments (control and low protein), and two 
surgical treatments (sham and ischemia). The effect of protein-energy malnutrition on 
brain damage after transient global ischemia, assessed by the stated parameters, has not 
been investigated. The open field was used as a test of hippocampal function, testing 
working memory (Babcock et al.,1993; Mileson and Schwartz,1991; Nurse and 
Corbett,1994; Wang and Corbett,1990). Gerbils were exposed to the open field for ten 
minutes on Days 3, 7, and 10 after surgery. Typically a gerbil will explore the field 
vigourously for the first half of the exposure, and decrease activity, or habituate during 
the latter half. A gerbil suffering hippocampal damage will not habituate (Dowden et 
al.,1999). Ischemic gerbils fed the control diet did not habituate on novel exposure to 
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the open field, but recovered similar activity to sham-operated animals one week after 
ischemia. Protein-energy malnourished ischemic gerbils, however, failed to habituate 
even by Day 10, traveling significantly more distance than other groups. As well, half of 
these animals exhibited a wall-hugging behaviour known as thigmotaxis, indicative of 
anxiety or behaviour-trapping (Schallert et al.,1980; Simon et al.,1994). Only one well-
nourished ischemic gerbil exhibited this activity. Sham-operated protein-energy 
malnourished gerbils were lethargic in the open field by Day 10, consistent with reports 
of reduced energy expenditure in similarly malnourished humans (Shetty,1999). Protein-
energy malnutrition had no effect on numbers of surviving CA1 neurons ten days after 
ischemia. This finding strengthens the importance of conducting functional as well as 
histological assessments, as discussed by others (Bothe et al.,1986; Colbourne and 
Corbett,1995; Dowden and Corbett,1999; Hori and Carpenter,1994). Surprisingly, 
dramatically increased numbers of glial cells were evident in brain sections of one third 
of the ischemic protein-energy malnourished gerbils, suggesting inflammation. Pro-
inflammatory cytokine production and NFκB activation has been shown in mice with 
protein malnutrition (Li et al.,2002a). Chronic inflammation is often seen in humans 
with protein-energy malnutrition (Mora,1999), and pro-inflammatory responses to 
ischemia have been identified (Kato and Walz,2000; Petty and Wettstein,2001). 
Identification of the glial cell types is beyond the scope of this thesis, but is ongoing in 
our laboratory at the time of writing. This phenomenon was not seen in any other 
groups. 
Biochemical evidence for increased oxidative stress in ischemic malnourished 
gerbils compared to those well-nourished was not overwhelming, but nevertheless 
noteworthy. Hippocampus protein content was increased in all ischemic gerbils, 
possibly explained by an inflammatory response, compromise of the blood brain barrier 
and extravasation of plasma proteins (Petty and Wettstein,2001). Protein thiols, sensitive 
to oxidative stress, were reduced by ischemia and further by protein-energy 
malnutrition. Although not significant, there was a trend for ischemia to decrease 
hippocampus glutathione concentration and glutathione reductase activity in 
malnourished gerbils. Taken together, these findings indicate protein-energy 
malnourished gerbils suffered more oxidative stress than adequately-nourished gerbils. 
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The hypothesis of the high demand for glutathione in oxidative stress depleting brain 
glutathione concentration in protein-energy malnutrition was not strongly supported by 
the data, however.  
The temporal change in brain glutathione concentration in rodent models of 
ischemia has been reported in the literature as decreasing during early reperfusion 
timepoints (Park et al.,2000), followed by a return to normal levels within twenty-four 
hours (Shivakumar et al.,1992; Shivakumar et al.,1995), and a further decrease at later 
timepoints (Candelario-Jalil et al.,2001). Protein thiols have been shown to decrease at 
one hour of reperfusion after thirty minutes of ischemia and return to normal levels at 
twenty-four hours (Shivakumar et al.,1995). The glutathione reductase enzyme is 
susceptible to oxidative damage because of its thiol groups, and varied temporal changes 
have been reported (Shivakumar et al.,1995; Stanimirovic et al.,1988). Hippocampus 
glutathione reductase activity is decreased at forty-eight to ninety-six hours (Candelario-
Jalil et al.,2001), and thiobarbituric acid reactive substances are increased at four to 
fourteen days (Haba et al.,1991) after ischemia, following initial early decrease and 
subsequent return to normal levels. The timing suggests these results may be linked to 
delayed neuronal death. The above-mentioned ischemia models did not control brain 
temperature and were of varying durations of ischemia and reperfusion, and none was 
identical to the model used in this research. Comparison of findings therefore cannot be 
made directly. Only one timepoint was examined in the study for this thesis. Critical 
transient changes in measured parameters could easily have been missed. The gerbil 
hippocampus is small, and tissue dissection difficult due to the fragility of gerbil brain. 
The entire hippocampus tissue from each hemisphere was used for one assay, and if 
changes in biochemical indices were concentrated mainly in the susceptible CA1 region, 
the relatively small differences may not have been detectable. As well, it could not be 
expected that all parameters were temporally matched in response to ischemia. In order 
to construct a more complete picture of the evolution of oxidative stress in the ischemia 
model used in this research, it would be helpful to examine biochemistry at multiple 
reperfusion timepoints, in addition to assessment of oxidized glutathione and oxidation 
ratio (to assess glutathione redox status) (Baek et al.,2000), glutathione synthesis, and 
glutathione reductase up/down-regulation. Other markers such as 4-hydroxynonenal-
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modified proteins (Urabe et al.,2000), 8-hydroxy-2’-deoxyguanosine (Baek et al.,2000), 
protein carbonyls (Evans et al.,1999), 4-hydroxyalkenals (Kawai et al.,1998), lipid 
hydroperoxides (Nourooz-Zadeh,1999) could also be considered in order to provide a 
broader spectrum of oxidative stress. 
The damage in this gerbil ischemia model was milder and more variable than 
expected, yet there were still significant effects of protein-energy malnutrition on 
behaviour in the open field and moderate effects on oxidative stress. It was expected that 
the dietary deficiency would exacerbate neuronal damage, and thus length of ischemia 
was chosen to produce less than 90% neuronal loss as observed with the same model in 
another laboratory (Corbett and Crooks,1997).  Greater variability can be expected with 
milder damage. Up to half of gerbils may have a partial or complete circle of Willis, and 
it was impossible to detect vascular anomalies in this research. Selecting only those 
gerbils without the circle of Willis, through examination of retinal blood flow for 
example, would ensure greater homogeneity in response to ischemia (Delbarre et 
al.,1991). The experiments could be repeated with a more severe ischemia, increasing 
likelihood of detecting changes in oxidative stress and perhaps reducing variability.  
In humans, feeding after a stroke is often delayed, exacerbating pre-existing 
protein-energy malnutrition. Secondary brain damage in stroke occurs through delayed 
neuronal death, providing a potential window of opportunity for intervention and 
amelioration of this damage. Further studies designed to feed protein-energy 
malnourished animals an adequate protein diet after ischemia could assess the effect of 
early dietary intervention. The increases in glial cells in some malnourished ischemic 
gerbil brains suggested an inflammatory process. Future studies should incorporate 
assessment of these cell types and testing for markers of inflammation. The open field 
test is a good general indicator of hippocampal malfunction. More specific tests 
designed to detect anxiety, irritability, fine motor function, and memory would add 
greatly to understanding functional behaviour. Young adult gerbils were used in this 
study, but the initial hypothesis was based on epidemiological evidence in the elderly. 
Repeating the experiments with aged gerbils would be more clinically relevant. 
Ischemic gerbils fed the control diet recovered normal behaviour in the open field one 
week after the insult. It is possible that malnourished gerbils may also have recovered or 
 122
adapted, given dietary repletion and/or enough time. Extending the post-ischemic period 
to thirty to sixty days or longer would also be more clinically relevant (see FOOD trial 
below), and the long-term effects of protein-energy malnutrition and ischemia on 
neuronal survival could be evaluated.  
In summary, the research described in this thesis was designed to test the 
hypothesis of dietary deficiencies influencing oxidative stress and antioxidant defense 
after global ischemia. The hypothesis was investigated in two rodent species with two 
models of ischemia. The first phase examined the effect of an acute sulphur amino acid 
deficiency on neural damage and brain glutathione concentration after hemispheric 
ischemia in the rat, while the second phase encompassed the influence of protein-energy 
malnutrition on functional, histological and biochemical outcomes after transient global 
ischemia in the gerbil. Both ischemia models produced relatively mild brain damage, 
and well-nourished animals generally tolerated this insult well. In both phases, however, 
malnourished animals suffered more brain damage and, although evidence was not 
robust, may have experienced more oxidative stress. Behaviour remained abnormal in 
malnourished ischemic gerbils ten days after the brain insult. The results of this research 
are clinically relevant to those suffering from protein-energy malnutrition at the time of 
stroke, and support the compromised outcome observed in this group of individuals. The 
Feed Or Ordinary Diet trial (FOOD), a robust multicentre randomized trial evaluating 
various feeding policies after stroke, has shown that nutritional status early after stroke 
is independently associated with long-term outcome (FOOD Trial Collaboration,2003). 
Undernutrition immediately after stroke reduced survival, functional ability and living 
circumstances six months later. Although the mechanism for sub-optimal recovery has 
not been clearly elucidated by the research described in this thesis, increased oxidative 
stress may be a contributing factor, emphasizing the need to intervene during the 
window of opportunity immediately after stroke. Future studies with swift dietary 
repletion may determine if oxidative stress can be reduced, delayed neuronal death 
diminished and outcome improved for malnourished stroke victims.
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APPENDIX A 
 
Analysis of tissue glutathione concentration 
 
Methods 
 
Tissue homogenization 
Frozen liver sample was weighed and homogenized on ice with 10 volumes of 
cold 5% sulphosalicylic acid containing 0.1mM Na2EDTA·2H2O, using a Brinkmann® 
Polytron Model PT10-35, at 5 intervals of 6 seconds each, pausing for 30 seconds 
between intervals to allow cooling of homogenate. The homogenate was centrifuged at 
16,000 x g for 15 minutes in a refrigerated Eppendorf® centrifuge model 5415C, and the 
supernatant frozen in liquid nitrogen and stored at -70ºC until analysis. Brain tissue was 
treated in the same fashion as liver, using a Skil®Pistol Grip Drill Model 6225 instead of 
the Polytron. 
 
Analysis of GSH 
Phase 1- Rat Sulphur Amino Acid Study 
GSH (as free reduced sulphhydryl groups) was assayed using a modification of 
the method of Komuro et al. (Komuro et al.,1985), described by Katrusiak et al. 
(Katrusiak et al.,2001) and Paterson et al. (Paterson et al.,2001), by reverse-phase high 
performance liquid chromatography (HPLC) using pre-column derivatization with 5,5’-
dithio-bis(2-nitrobenzoic acid) (Ellman’s reagent, DTNB) and ultraviolet detection at 
330nm. Sulphhydryl-DTNB derivatives were detected using isocratic elution at 37ºC on 
a Supelco LC-18T (150 x 4.6mm, 3µm; Supelco, Bellefonte, PA, USA) with a 
Supelguard LC-18T 2cm pre-column. The mobile phase was 12.5% v/v methanol / 87.5 
% 100mmol/L KH2PO4 (pH 3.89), run for 9 minutes at a flow rate of 1.1mL/minute.  
Excess DTNB was eluted from the column over 7 minutes with  40% methanol / 60% 
100mmol/L KH2PO4 (pH 3.89), and the system was flushed for 12 minutes with the 
12.5% methanol mobile phase before injection of the next sample. The HPLC system 
was Shimadzu® (Tokyo, Japan) SCL-10A system controller, SPD-10A variable 
wavelength spectrophotometric detector, SIL-10A automatic sample injector, LC-10AT 
solvent delivery system, and X-Act-4-channel degasser. A Shimadzu EZChrom version 
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3.2 software program was used to collect data. The program measured peak areas and 
results were expressed as the ratio of peak area of sample or standard to peak area of 
internal standard. A standard (containing L-cysteine, cysteinyl-glycine, glutathione and 
DL-homocysteine) curve was prepared and run daily with each set of samples, all in 
duplicate. 
The reaction mixture, prepared on ice, contained 500µL Tris-HCl buffer (pH 
8.9), 130µL sample or standard, 20µL deionized distilled water, and 20µL internal 
standard (400µM D(-)penicillamine in 5% sulphosalicylic acid containing 0.1mM 
Na2EDTA·2H2O). After addition of 350µL 10mM DTNB in 0.5M K2HPO4 (pH 7.2), the 
mixture was allowed to sit off ice for 5 minutes for derivatization. The reaction mixture 
was acidified by the dropwise addition of 50µL 7N orthophosphoric acid (H3PO4) while 
vortexing, and 50µL injected into the HPLC system for analysis.  Representative 
chromatograms of standard (Figure A.1) and a rat liver sample (Figure A.2) follow. 
 
Phase 2- Gerbil PEM study 
 Analysis of GSH concentration in gerbil tissues was identical to the procedures 
used in Phase one, with the following exceptions: 
1- Mobile phases were prepared at pH 3.85. 
2- The final reaction mixture contained 45 µL 7N H3PO4. 
3- DL-homocysteine was omitted from the standard curve. 
4- The HPLC system consisted of the following: Waters® (Waters Canada, 
Missisauga, ON) Automated Gradient Controller, 486 Tunable Absorbance 
Detector, 717plus Autosampler, 510 HPLC Pump, Temperature Control 
Module. Data were collected with Waters Millenium®32 Chromatography 
Software, Version 4.00(© 2001 Waters Corporation). 
Representative chromatograms of standard (Figure A.3) and a gerbil brain 
(hippocampus) sample (Figure A.4) follow. 
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Figure A.1. Representative HPLC chromatogram of a thiol standard containing cysteine, 
cysteinyl-glycine (Cys-gly), glutathione and homocysteine 
 
 
 
 
Figure A.2. Representative HPLC chromatogram of thiols in rat liver diluted 1:200 
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Figure A.3. Representative HPLC chromatogram of a thiol standard containing cysteine 
(Cys), cysteinyl-glycine (Cys-gly) and glutathione (GSH) 
 
 
 
 
Figure A.4. Representative HPLC chromatogram of thiols in gerbil hippocampus diluted 
1:50 
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APPENDIX B 
 
Administration of L-2-oxothiazolidine-4-carboxylic acid (OTC) following global 
hemispheric hypoxia-ischemia (GHHI) in the Long-Evans rat 
 
Purpose 
 The purpose of this experiment was to investigate whether the administration of 
a cysteine precursor, OTC, after GHHI would ameliorate neural damage secondary to 
increased availability of cysteine and enhanced synthesis of glutathione. 
 
Methods 
Under the same housing, surgical, and OTC treatment regimen described in 
Experiment 2 of Chapter 5 of this thesis, rats were fed a sulphur amino acid sufficient 
crystalline amino acid defined AIN-93G diet without antioxidant (for diet composition 
see Appendix D). After 3 days on diet, rats were subjected to GHHI, and randomized to 
receive injections of OTC (12mmol/kg body weight) or placebo (phosphate-buffered 
saline,equivalent volume) 15 minutes after completion of GHHI and every 12 hours 
thereafter for 6 additional doses at 4mmol/kg body weight. As described in Chapter 5, 
neural damage was assessed by 2 scoring systems and data were analyzed with SPSS for 
Windows 11.0, using Mann-Whitney U for global score, and unpaired student’s t-test 
for hippocampal grid score. 
 
Results 
 GHHI in adequately-nourished rats did not result in any appreciable neural 
damage, assessed by the semi-quantitative global score (Table B.1) or the more 
quantitative hippocampal grid score (Table B.2), and thus there was no significant effect 
of OTC.  
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Table B.1. Effect of global hemispheric hypoxia-ischemia and L-2-oxothiazolidine-4-
carboxylic acid on global score* of neural damage in adequately nourished rats  
 
 Neocortex Striatum Hippocampus Thalamus Total score 
Placebo 0.1 ± 0.1 0.3 ± 0.2 0 0 0.4 ± 0.2 
OTC 0 0 0.1 ± 0.1 0 0.1 ± 0.1 
Mean ± SEM; Placebo, n=15; OTC, n=14. 
*Global score: 0 = no damage; 1 = <50% damage; 2 = >50% damage; maximum score 
of 2 in each region (striatum, thalamus, neocortex, hippocampus) for total maximum 
score of 8. 
 
Table B.2. Effect of global hemispheric hypoxia-ischemia and L-2-oxothiazolidine-4-
carboxylic acid on hippocampal grid score* of neural damage in adequately nourished 
rats 
 
 Subiculum/CA1 CA2/CA3 CA4 Dentate 
gyrus 
Hippocampus 
Proper† 
Hippocampus 
Total‡ 
Placebo 
(%) 
 
0 0 0 0 0 0 
OTC 
(%) 
4.6 ± 4.6 0 0 0 2.5 ± 2.5 1.7 ± 1.7 
Mean ± SEM; Placebo, n=15; OTC, n=14. 
*Hippocampal Grid Score: a grid was superimposed on an image of the hippocampus; 
any grid square containing one or more damaged cells of 15-20 cells per grid was 
counted as one damaged square and the damage score was expressed as percentage of 
baseline squares.  
†Hippocampus Proper = Subiculum/CA1 + CA2/CA3 + CA4.   
‡Hippocampus Total = Hippocampus Proper + Dentate Gyrus. 
 
 
Conclusion 
 Since the model of ischemia used in this experiment did not produce any neural 
damage in adequately-nourished rats in the areas evaluated, it was impossible to 
demonstrate any improvement with the administration of a cysteine precursor. The 
reasons for the failure of the model have been discussed in Chapter 5. This experiment 
was undertaken before the awareness of the ‘dark’ neuron artifact, discussed in Chapter 
4, at a time when it was thought there was a mild degree of neural damage produced by 
the GHHI model, and that administration of a cysteine precursor might enhance 
glutathione synthesis and ameliorate neural insult. This experiment was conducted in 
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conjunction with a second group of rats fed a diet deficient in sulphur amino acids, and 
randomized to receive placebo or OTC injection post-GHHI. That portion of the 
experiment has been discussed in Chapter 5. 
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APPENDIX C 
 
Transient bilateral carotid artery occlusion pilot study 
 
 The gerbil model of transient bilateral carotid artery occlusion (TBCAO) is well-
established in the literature, as discussed in the body of this thesis. The author visited the 
laboratory of Dr. Dale Corbett at the Memorial University of Newfoundland (MUN) to 
learn the model. His laboratory uses a 5-minute occlusion with controlled brain 
temperature (36.5°C), achieving consistent loss of CA1 hippocampal neurons in the 
range of 90-95%. Since we theorized PEM would exacerbate neural damage, we 
required a stroke model with baseline neuronal loss in the range of 70-75%.  
 
Purpose 
 To vary duration of ischemia and/or brain temperatures during ischemia to 
achieve 70-75% hippocampal CA1 neuronal loss while maintaining low variability with 
the model. 
 
Methods  
Male Mongolian gerbils aged 16-18 weeks were subjected to a 5-minute 
TBCAO, with brain temperature (estimated by tympanic temperature) maintained at 
36.5ºC throughout ischemia, or sham surgery, as described in Chapter 6.  
The following variations of the model were evaluated: 
1) 4-minute ischemia with brain temperature of 37°C (at MUN) 
2) 3.5-minute ischemia with brain temperature of 36.5°C (at U of S)  
3) 4-minute ischemia with brain temperature of 36.5°C (at U of S) 
4) 5-minute ischemia with brain temperature of 36.5°C (at U of S) 
On day 10 after surgery, gerbils were anesthesized with isoflurane and perfused trans-
cardially with heparinized saline followed by 10% phosphate buffered formalin. Heads 
were refrigerated in formalin for 18-24 hours before brain removal and embedding in 
paraffin. Brains were sectioned in 6 micron thicknesses and hippocampal CA1 neurons 
counted as described in Chapter 6. 
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Results (Table C.1) 
1) 4-minute ischemia with brain temperature of 37°C  
Neuronal loss was consistent at ~89%. Maintaining constant brain temperature at 37◦C 
was difficult, especially with an ischemia time of 4 minutes. Target mean brain 
temperature (37°C ± 0.2°C) was achieved in only 5 of 10 gerbils.  
2) 3.5-minute or 4-minute ischemia with brain temperature of 36.5°C  
Variability in neuronal loss was high with these ischemia times (range 0-80%, 3.5-
minute; 0-88%, 4-minute) and mean neuronal loss was low. 
3) 5-minute ischemia with brain temperature of 36.5°C 
This model produced an acceptable level of damage with lower variability than other 
durations of ischemia.  
 
Table C.1.  Hippocampal CA1 neuron loss: varied  ischemia times and brain 
temperatures 
Duration of ischemia 4 minutes 3.5  minutes 4 minutes 5 minutes
Brain temperature (°C) 37 36.5          36.5       36.5
% CA1 Neuron Loss*  89 ± 2.2 28.7 ± 8.8    43.2 ±14.4  68.2 ± 5.6
Laboratory MUN U of S U of S U of S
n 5 10 7 7
*Mean ± SEM 
 
Conclusion 
To allow room for the PEM model to exacerbate brain injury in the TBCAO 
model of stroke, we aimed to achieve neuron loss of 70-75%, with low variability. 
Although the 4-minute, 37°C model had consistent damage, the neuron loss was 
considered too high, and the failure rate of 50% in maintaining target brain temperature 
was unacceptable. The 3.5-minute and 4-minute, 36.5°C models produced little mean 
damage with high variability. In our laboratory, a 5-minute ischemia at 36.5°C produced 
the most consistent results with an acceptable level of neuronal loss. The 5-minute 
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ischemia with brain temperature maintained at 36.5°C was used for the main gerbil 
study. 
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APPENDIX D 
 
Gerbil pilot feeding study: A comparison of laboratory chow with purified 
crystalline amino acid defined diets with and without sulphur amino acids 
 
 At the beginning of Phase 2 of this thesis, whether to use a sulphur amino acid 
deficiency in the gerbil was investigated. The response of the rat to a purified dietary 
sulphur amino acid deficiency had been established in our laboratory. The response of 
the gerbil to the same diet was unknown. The nutritional requirements of the gerbil are 
not well-investigated, but since this animal does well on laboratory rodent chow, we 
wanted to compare chow to the sulphur amino acid sufficient and deficient diets used in 
the rat.  
 
Purpose 
1) To test the response of the gerbil to an amino acid defined diet compared to 
laboratory rodent chow. 
2) To test whether the response of the gerbil to a sulphur amino acid deficient 
diet was similar to that of the rat. 
 
Methods 
 Male Mongolian gerbils aged 19-20 weeks were housed individually in 
suspended stainless steel cages and randomized to standard laboratory rodent chow, or 
AIN-93G diet modified to contain crystalline amino acids, with or without sulphur 
amino acids cystine and methionine (n=5 per group) (Table D.1). Diets were fed ad 
libitum for 6 days, with free access to water. Gerbils were maintained at 22°C with a 12-
hour light/dark cycle. Daily food intake, food wastage and body weights were recorded. 
On day 6, gerbils were anesthetized with isoflurane and perfused trans-cardially with 
saline. Brain neocortex and liver were collected on ice, and analyzed for glutathione 
concentration as described in Chapter 5 and Appendix A. Data were analyzed using one 
way ANOVA followed by LSD means test where appropriate, significance p<0.05. 
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Table D.1. Composition of the purified crystalline amino acid based diets 
Component 
  
Sulphur amino acid deficient 
(g/kg) 
Sulphur amino acid sufficient 
(g/kg) 
L-amino acids* 161.3 167 
Cornstarch 419.086 419.086 
Dextrinized cornstarch 140 140 
Sucrose 105.7 100 
Cellulose 50 50 
Soybean oil 70 70 
Mineral mix† 35 35 
Sodium bicarbonate 6.4 6.4 
Vitamin mix¶ 10 10 
Choline bitartrate 2.5 2.5 
* Sulphur amino acid deficient diet supplied the following amino acids (g/kg diet): L-
arginine, 12; L-histidine, 6; L-lysine-HCl, 14; L-tyrosine, 4; L-tryptophan, 2; L-
phenylalanine, 8; L-threonine, 8; L-leucine, 12; L-isoleucine, 8; L-valine, 8; glycine 
24.3; L-proline, 5; L-glutamic acid, 30; L-alanine, 5; L-asparagine·H2O, 5; L-serine, 5; 
L-glutamine, 5. The sulphur amino acid sufficient diet was supplemented with 4g/kg L-
cystine and 6g/kg L-methionine, and L-glycine content was reduced to 20g/kg diet. 
† Modified from that used in the AIN-93G diet to be sulphur-free. 
¶ Vitamin mix was identical to that used in the AIN-93G diet (Reeves et al.,1993). 
 
Results 
 Initial body weights were the same in each group (Table D.2). There was no 
significant difference in weight gain, food intake, liver or neocortex glutathione 
concentration between laboratory chow and sulphur amino acid sufficient diet (p>0.05). 
Gerbils on the sulphur amino acid deficient diet, however, lost weight, ate less food, and 
had reduced liver and neocortex glutathione concentration compared to those in the 
other 2 groups.  
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Table D.2. The effects of feeding adult gerbils purified crystalline amino acid-based 
diets with and without sulphur amino acids 
 
 Laboratory Chow +SAA Diet -SAA Diet 
Initial Weight (g) 73.1 ± 1.2a  75.6 ± 1.3a  75.2 ± 0.5a 
Total weight gain (g)   1.2 ± 1.1a  - 1.7 ± 1.1a -10.9 ± 1.2b 
Total food intake (g) 44.1 ± 2.9a  36.8 ± 3.5a  23.0 ± 2.5b 
Liver [GSH] (µmole/g wet 
weight) 
  6.1 ± 0.3a    5.9 ± 0.2a    3.3 ± 0.2b 
Neocortex [GSH] (µmole/g 
wet weight) 
  1.9 ± 0.1a    1.7 ± 0.0a    1.6 ± 0.1b 
Mean ± SEM; 6 days total treatment; n=5 per group 
a,b Letters indicate significant difference between groups by one way ANOVA, followed 
by posthoc LSD means test, p<0.05 
 
Conclusions 
 According to the parameters measured, gerbils fed the purified crystalline 
sulphur amino acid sufficient diet maintained comparable status to those fed rodent 
chow. The response of the gerbil to a dietary sulphur amino acid deficiency was similar 
to that of the rat (for rat data, see Chapter 5). 
Gerbils are communal animals, grooming each other frequently. In the 
laboratory, gerbils dig in and shred their bedding. They sleep together, hidden inside 
nests of bedding material. By the end of 6 days in suspended individual cages, all gerbils 
were ‘jumpy’ and appeared ungroomed. For this reason, gerbils in Phase 2 of this study 
were housed in shoebox cages, in groups of three, with bedding. 
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APPENDIX E 
 
Gerbil pilot feeding study: A comparison of laboratory chow with purified diets 
containing adequate or low protein 
 
 To test the hypothesis that PEM would exacerbate brain damage in stroke, we 
needed to establish a gerbil PEM model. In the sulphur amino acid pilot feeding study, 
gerbils were found to do well on rodent laboratory chow and an amino acid defined diet 
previously used in the rat. Since the protein requirements of the gerbil are not well-
established, the diet composition in this pilot study was based on rat requirements. 
 
Purpose 
1) To test the response of the gerbil to a rodent casein-based diet compared to 
laboratory rodent chow. 
2) To establish a gerbil model of PEM. 
 
Methods 
 Male Mongolian gerbils aged 11-12 weeks were housed individually in 
suspended stainless steel cages and randomized to standard laboratory rodent chow, or a 
modified AIN-93M pelleted rodent diet without antioxidant, formulated to contain 12% 
protein (adequate) or 2% protein (low) as casein, fed for 4 weeks (n=4 per group). For 
diet composition, see Chapter 6. Diets were fed ad libitum for 28 days, with free access 
to water. Gerbils were maintained at 22°C with a 12-hour light/dark cycle. Daily food 
intake and food wastage and weekly body weights were recorded. On day 28, gerbils 
were anesthetized with isoflurane and perfused trans-cardially with saline. Liver, and 
brain neocortex and hippocampus were collected on ice, and analyzed for glutathione 
concentration as described in Chapter 5. Liver lipid was analyzed as described in 
Chapter 6. Tissue analyses were conducted on adequate and low protein groups only. 
Data were analyzed using one way ANOVA followed by posthoc LSD means tests 
where appropriate, significance p<0.05. 
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Results 
 Initial body weights were the same across groups (Table E.1). Feed intake was 
significantly different between all 3 groups, and highest in gerbils fed laboratory chow. 
Weight gain was the same in gerbils fed laboratory chow and those fed the adequate 
protein diet. Gerbils fed the low protein diet lost more weight than those fed chow, ate 
less than those on both other diets, and had increased liver lipid compared to the group 
fed adequate protein. Glutathione concentration in gerbils fed the low protein diet was 
decreased in liver, unchanged in hippocampus, and increased in neocortex compared to 
gerbils fed the adequate protein diet. 
Table E.1. Influence of feeding a low protein diet to the gerbil 
 Laboratory Chow Adequate 
Protein 
Low Protein 
Initial weight (g) 63.1 ± 1.2a 63.9 ± 0.6a 62.1 ± 0.9a 
Weight gain (g/28days) 12.4 ± 3.5a   5.5 ± 5.7a,b -4.2 ± 1.7b 
Food intake (g/day)   8.2 ± 0.3a   6.3 ± 0.2b   5.5 ± 0.2c 
Liver lipid (mg/g wet wt) N/A 37.3 ± 0.7a 50.7 ± 1.7b 
Liver [GSH] (µmol/g wet wt) N/A   6.8 ± 0.6a   3.5 ± 0.4b 
Hippocampus [GSH] (µmol/g wet wt) N/A   2.6 ± 0.3a   2.5 ± 0.2a 
Neocortex [GSH] (µmol/g wet wt) N/A   2.1 ± 0.1a   2.5 ± 0.1b 
Mean ± SEM; n=4 per group 
Letters indicate significant difference across groups by one-way ANOVA, followed by 
posthoc LSD means test, p<0.05   
 
Conclusion 
 The response of measured parameters was similar in gerbils fed the adequate 
protein diet and those fed laboratory chow. Gerbils fed the low protein diet voluntarily 
reduced intake and as such were lacking in both protein and energy, a phenomenon 
observed in other rodent models of dietary protein content less than 6% (Eisenstein and 
Harper,1991; Hum et al.,1992; Rana et al.,1996). The results measured in gerbils fed the 
low protein diet suggest a moderate model of PEM was achieved, and this diet was used 
for the Phase 2 gerbil study. That neocortex glutathione concentration was elevated in 
the low protein group cannot be explained. As in the sulphur amino acid pilot feeding 
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study, these gerbils were housed individually in suspended steel cages, and were not 
well groomed. Communal housing in shoebox cages with bedding is preferable. 
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APPENDIX F 
 
Characterization of temporal change in brain glutathione concentration at various 
reperfusion time-points after temporary bilateral carotid artery occlusion 
(TBCAO) 
 
With several rodent global ischemia models, the literature reports decreases in 
brain glutathione concentration at early time-points of reperfusion, with a return to 
normal levels between 4-24 hours(Baek et al.,2000; Candelario-Jalil et al.,2001; Park et 
al.,2000; Shivakumar et al.,1992). We wanted to compare the temporal change in 
neocortex and hippocampus glutathione concentration in our model of TBCAO and 
controlled brain temperature to other models in the literature. 
 
Purpose 
To determine brain neocortex and hippocampus glutathione concentrations at 
various reperfusion time-points after a 5-minute TBCAO with brain temperature 
maintained at 36.5 ± 0.2ºC. 
 
Methods 
 Male Mongolian gerbils aged 14-18 weeks were acclimated for 10 days on a 
purified sulphur amino acid sufficient AIN-93G diet modified to contain crystalline 
amino acids (for diet composition, see Appendix D). On day 10, gerbils were subjected 
to a 5-minute TBCAO with brain (tympanic) temperature maintained at 36.5± 0.2ºC 
throughout ischemia or sham surgery, as described in Chapter 6.  Reperfusion time-
points were as follows: 0, 0.5, 1, 2, 6, 12, and 24 hours after occlusion (n=6 per time-
point; exception, n=7 at 1 hour). At each time-point gerbils were re-anesthetized with 
isoflurane and perfused trans-cardially with heparinized saline. Brain neocortex and 
hippocampus were collected on ice and analyzed for glutathione concentration as 
described in Chapter 5 and Appendix C. Data were analyzed by one way ANOVA 
followed by posthoc LSD means test where appropriate, significance p<0.05. 
 
Results 
 175
 There was no significant difference in neocortex glutathione concentration at any 
timepoint compared to that in sham-operated animals (Table F.1). Hippocampus 
glutathione concentration was elevated compared to that in sham-operated controls at 
0.5, 1 and 2 hours of reperfusion. 
 
Table F.1. Hippocampus and neocortex glutathione concentration at various reperfusion 
times after 5-minute TBCAO* 
Hippocampus       Neocortex  Reperfusion time 
µmoleGSH/g wet wt. 
Sham 2.5 ± 0.2a 2.4 ± 0.03 
0 hour 2.5 ± 0.1a 2.1 ± 0.1 
0.5 hour 2.8 ± 0.1b 2.2 ± 0.1 
1 hour 2.9 ± 0.1b 2.4 ± 0.04 
2 hours 2.9 ± 0.1b 2.4 ± 0.02 
6 hours 2.6 ± 0.1a 2.2 ± 0.1 
12 hours 2.5 ± 0.1a 2.3 ± 0.1 
24 hours 2.7 ± 0.1a 2.3 ± 0.2 
* Brain temperature (estimated by tympanic temperature) maintained at 36.5± 0.2ºC. 
Mean ± SEM; n=6 per reperfusion time except n=7 at 1 hour. 
a,b Letters indicate significant differences from sham surgery within brain region by one 
way ANOVA followed by posthoc LSD means test, p<0.05. 
 
Conclusion 
 We were unable to reproduce temporal changes in brain glutathione 
concentration reported in the literature after TBCAO, although our model varied 
somewhat from those in the literature. The increase in hippocampal glutathione 
concentration at some time-points was unexpected. In tissues such as artery 
endothelium, lung epithelium and kidney, exposure to oxidative stress has been shown 
to upregulate mRNA expression and activity of γ-GCS, the rate-limiting enzyme in 
glutathione synthesis, with subsequent increases in glutathione concentration in these 
cells (Day et al.,2002; Diaz et al.,2001; Rahman and MacNee,2002; Ray et al.,2002; 
Woods and Ellis,1995; Woods et al.,1999). It is possible a similar response occurs in 
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brain, explaining the findings in this study. This is further supported by the lack of 
response in neocortex, a region less vulnerable to damage in this ischemia model. 
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APPENDIX G 
Rat hippocampus: representative image used to evaluate hippocampal grid score of 
neural damage 
The hippocampal area of the H&E stained posterior section of rat brain 
(approximately -3.1mm from bregma) was visualized at 100 x magnification on a Zeiss 
microscope with attached SonyPowerHAD colour video camera, and images were 
captured on computer with Northern Eclipse 2.0 software. A grid was superimposed on 
each image, and a hardcopy composite image of the entire hippocampal area constructed 
(about 5-9 images per collage) using Microsoft PowerPoint. The densest regions of the 
subiculum/CA1, CA2/CA3, CA4 and dentate gyrus were defined on the collage and 
baseline numbers of grid squares in each area counted. Each grid square held 
approximately 15-20 cells. To score damage, slides were viewed under a microscope at 
400 x magnification and damaged cells located and marked by hand on the 
corresponding composite image. Any grid square containing one or more damaged cells 
was counted as one damaged square and the damage score was expressed as percentage 
of baseline squares in each area of the hippocampus. 
 
 
 
 
 
Figure G.1. Rat hippocampus: representative image used to evaluate hippocampal grid 
score of neural damage 
